CancerPPD 2.0 - Browse by Length

Browsing by Length

Browse Results:

Filter by Year
From
Upto

ID	PMID	YEAR	Sequence	Name	Length	Linear/Cyclic	Chirality	Chem-MOD	C-ter MOD	N-ter MOD	Nature	Origin	Cell Line	Cancer Type	Assay	Activity	Testing Time	Tissue Affected	Patents
7722	None	2020	LKKWWKKVKGLLGGLLGKVKKVIK	Seq ID No. 17 from patent ID US202000079827A1	24	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Synthetic	NCI-H460	Lung Cancer	Tetrazolium-based assay	Cell viability > 50% at 20 μM	2-h	Lung	US20200079827A1
7721	None	2020	LKKWWKKVKGLLGGLLGKVKKVIK	Seq ID No. 17 from patent ID US202000079827A1	24	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Synthetic	HOP-062	Lung Cancer	Tetrazolium-based assay	Cell viability > 50% at 20 μM	2-h	Lung	US20200079827A1
7720	None	2020	LKKWWKKVKGLLGGLLGKVKSVIK	Seq ID No. 16 from patent ID US202000079827A1	24	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Synthetic	Calu-1	Lung Cancer	Tetrazolium-based assay	Cell viability > 50% at 20 μM	2-h	Lung	US20200079827A1
7719	None	2020	LKKWWKKVKGLLGGLLGKVKSVIK	Seq ID No. 16 from patent ID US202000079827A1	24	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Synthetic	NCI-H460	Lung Cancer	Tetrazolium-based assay	Cell viability > 50% at 20 μM	2-h	Lung	US20200079827A1
7718	None	2020	LKKWWKKVKGLLGGLLGKVKSVIK	Seq ID No. 16 from patent ID US202000079827A1	24	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Synthetic	HOP-062	Lung Cancer	Tetrazolium-based assay	Cell viability > 50% at 20 μM	2-h	Lung	US20200079827A1
7717	None	2020	LKKWWKKVKGLLGGLLGKVTSVIK	Seq ID No. 15 from patent ID US202000079827A1	24	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Synthetic	Calu-1	Lung Cancer	Tetrazolium-based assay	Cell viability < 50% at 20 μM	2-h	Lung	US20200079827A1
7716	None	2020	LKKWWKKVKGLLGGLLGKVTSVIK	Seq ID No. 15 from patent ID US202000079827A1	24	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Synthetic	NCI-H460	Lung Cancer	Tetrazolium-based assay	Cell viability < 25% at 20 μM	2-h	Lung	US20200079827A1
7715	None	2020	LKKWWKKVKGLLGGLLGKVTSVIK	Seq ID No. 15 from patent ID US202000079827A1	24	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Synthetic	HOP-062	Lung Cancer	Tetrazolium-based assay	Cell viability ~ 50% at 20 μM	2-h	Lung	US20200079827A1
7714	None	2022	RRWKRFFKRWKGGVIGVTFPF	ATRA1-R3W2 - HYD	21	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	H-358	Lung Cancer	Cytotoxicity assay	LD₅₀ ~24.5 μM	6-h	Lung	US011447533B2
7709	37853814	2024	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Free	Free	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	MTT assay	52.5 ± 5.0% cell viability at 150 µM	24-h	Breast	None
7708	37853814	2024	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Free	Free	Anticancer	Synthetic	MCF-7	Breast Cancer	MTT assay	14.0 ± 3.0% cell viability at 150 µM	24-h	Breast	None
7642	37880286	2023	GIGAVLKVLTTGLPALISWIKRKRQQC	MC–FA	27	Linear	L	None	Folic Acid	Free	Anticancer; Antibacterial	Synthetic analogue	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 12.63 µg/mL	24-h	Breast	None
7640	37880286	2023	GIGAVLKVLTTGLPALISWIKRKRQQC	MC–FA	27	Linear	L	None	Folic Acid	Free	Anticancer; Antibacterial	Synthetic analogue	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 66.43 µg/mL	24-h	Cervix	None
7641	37880286	2023	GIGAVLKVLTTGLPALISWIKRKRQQC	MC–FA	27	Linear	L	None	Folic Acid	Free	Anticancer; Antibacterial	Synthetic analogue	C-33A	Cervical Cancer	MTT assay	IC₅₀ = 35.22 µg/ mL	24-h	Cervix	None
7638	37880286	2023	CGIGAVLKVLTTGLPALISWIKRKRQQ	CM–FA	27	Linear	L	None	Amidation	Folic Acid	Anticancer; Antibacterial	Synthetic analogue	C-33A	Cervical Cancer	MTT assay	IC₅₀ = 35.75 µg/mL	24-h	Cervix	None
7639	37880286	2023	CGIGAVLKVLTTGLPALISWIKRKRQQ	CM–FA	27	Linear	L	None	Amidation	Folic Acid	Anticancer; Antibacterial	Synthetic analogue	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 10.38 µg/mL	24-h	Breast	None
7637	37880286	2023	CGIGAVLKVLTTGLPALISWIKRKRQQ	CM–FA	27	Linear	L	None	Amidation	Folic Acid	Anticancer; Antibacterial	Synthetic analogue	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 67.34 µg/mL	24-h	Cervix	None
7636	37880286	2023	GIGAVLKVLTTGLPALISWIKRKRQQC	Mel-C	27	Linear	L	None	Amidation	Free	Anticancer; Antibacterial	Synthetic analogue	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 160.62 µg/mL	24-h	Breast	None
7635	37880286	2023	GIGAVLKVLTTGLPALISWIKRKRQQC	Mel-C	27	Linear	L	None	Amidation	Free	Anticancer; Antibacterial	Synthetic analogue	C-33A	Cervical Cancer	MTT assay	IC₅₀ = 58.63 µg/mL	24-h	Cervix	None
7634	37880286	2023	GIGAVLKVLTTGLPALISWIKRKRQQC	Mel-C	27	Linear	L	None	Amidation	Free	Anticancer; Antibacterial	Synthetic analogue	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 50.72 µg/mL	24-h	Cervix	None
7633	37880286	2023	CGIGAVLKVLTTGLPALISWIKRKRQQ	C-Mel	27	Linear	L	None	Amidation	Free	Anticancer; Antibacterial	Synthetic analogue	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 110.59 µg/mL	24-h	Breast	None
7632	37880286	2023	CGIGAVLKVLTTGLPALISWIKRKRQQ	C-Mel	27	Linear	L	None	Amidation	Free	Anticancer; Antibacterial	Synthetic analogue	C-33A	Cervical Cancer	MTT assay	IC₅₀ = 44.76 µg/mL	24-h	Cervix	None
7631	37880286	2023	CGIGAVLKVLTTGLPALISWIKRKRQQ	C-Mel	27	Linear	L	None	Amidation	Free	Anticancer; Antibacterial	Synthetic analogue	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 64.15 µg/mL	24-h	Cervix	None
7628	36873017	2023	CLKKLLKLLKKLLKLCLEELLHHLEELLHH	LK-LE3	30	Cyclic	L	None	Amidation	Free	Anticancer	Synthetic	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 10.2 µM at pH 6	24-h	Cervix	None
7627	36873017	2023	CLKKLLKLLKKLLKLCLEHLLEHLEHLLEH	LK-LE2	30	Cyclic	L	None	Amidation	Free	Anticancer	Synthetic	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 12.9 µM at pH 6	24-h	Cervix	None
7626	36873017	2023	CLKKLLKLLKKLLKLCLHELLEHLHELLEH	LK-LE1	30	Cyclic(C1-C16)	L	None	Amidation	Free	Anticancer	Synthetic	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 11.3 µM at pH 6	24-h	Cervix	None
7611	37734650	2023	KLKSKLMVVANKIGLLKSLARKFVKSH	NKL-MUT	27	Linear	L	None	Free	Free	Antimicrobial	Trematomus bernacchii	B16-F10	Skin Cancer	luciferase-based ATPlite assay	ATP level = 0.023 ± 0.007 at 40 μM	12-h	Skin	None
7610	37734650	2023	KLKSKLMVVCNKIGLLKSLCRKFVKSH	NKL-WT	27	Linear	L	None	Free	Free	Antimicrobial	Trematomus bernacchii	B16-F10	Skin Cancer	luciferase-based ATPlite assay	ATP level = 0.753 ± 0.254 at 40 μM	12-h	Skin	None
7608	36840453	2023	FLKSLWRGVKAIFNGARQGYKEHKN	AMP-WF3	25	Linear	L	None	Free	Free	Anticancer	Poecilia Mexicana fish	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 50 µM	24-h	Blood	None
7595	36626098	2023	FKCRRWQWRMKKLGAPSITCVRRAF	bLF	25	Linear	L	None	Free	Free	Antimicrobial	Bos Taurus	Jurkat	Blood Cancer	MTT assay	cell viability ~ 17.5% at 20 µM	4-h	Blood	None
7594	36626098	2023	FKCRRWQWRMKKLGAPSITCVRRAF	bLF	25	Linear	L	None	Free	Free	Antimicrobial	Bos Taurus	HepG-2	Liver Cancer	MTT assay	cell viability ~ 21% at 10 µM	24-h	Liver	None
7583	37098530	2023	GIGAVLKVLTTGLPALISWIKRKRQQ	Mellitin	26	Linear	L	None	Amidation	Free	Anticancer	Main component of honey bee venom	K-562	Leukemia Cancer	Sulforhodamine B assay	IC₅₀ = 1.84 ± 0.75 μg/ml	96-h	Blood	None
7580	36830725	2023	CGEMGWVRCKFAKFAKKFAKFAKKFAKFAK	Pep-1-Phor21	30	Linear	L	None	Free	Free	Anticancer	Hybrid peptide PEP1 and Phor 21	PC-3	Prostrate Cancer	AlamarBlue assay	IC₅₀ ≤ 0.6 μM	24-h	Prostate	None
7579	36830725	2023	CGEMGWVRCKFAKFAKKFAKFAKKFAKFAK	Pep-1-Phor21	30	Linear	L	None	Free	Free	Anticancer	Hybrid peptide PEP1 and Phor 21	DU-145	Prostrate Cancer	AlamarBlue assay	IC₅₀ = 2.57 ± 2.02 µM	24-h	Prostate	None
7578	36830725	2023	CGEMGWVRCKFAKFAKKFAKFAKKFAKFAK	Pep-1-Phor21	30	Linear	L	None	Free	Free	Anticancer	Hybrid peptide PEP1 and Phor 21	LNCaP	Liver Cancer	AlamarBlue assay	IC₅₀ = 55.13 ± 13.56 µM	24-h	Liver	None
7573	37580909	2023	QETFSDLWKLLVQRKRQKLMP	mPNC-NLS	21	Linear	L	None	Free	Free	Anticancer	Synthetic	A-549	Lung Cancer	Cytotoxicity assay	IC₅₀ = 45 μM	24-h	Lung	None
7572	37580909	2023	QETFSDLWKLLVQRKRQKLMP	mPNC-NLS	21	Linear	L	None	Free	Free	Anticancer	Synthetic	U-87	Brain Tumor	MTT assay	IC₅₀ = 56.9 μM	24-h	Brain	None
7571	37580909	2023	QETFSDLWKLLVQRKRQKLMP	mPNC-NLS	21	Linear	L	None	Free	Free	Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 44.9 μM	24-h	Lung	None
7568	37483971	2023	THPPTTTTTTTTTTTYTAAPATTT	ATMP1	24	Linear	L	None	Free	Free	Antimicrobial	Anabas testudineus	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 8.25 ± 0.14 μg/ml	48-h	Breast	None
7567	37483971	2023	THPPTTTTTTTTTTTYTAAPATTT	ATMP5	24	Linear	L	None	Free	Free	Anticancer; Antimicrobial	Synthetic Analog of ATMP1	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 64.04 ± 0.021 μg /ml	24-h	Breast	None
7566	None	2023	AWLDKLKSIGKVVGKVAIGVAKNLLNPQ	Raniseptin-3	28	Linear	L	None	Free	Free	Antimicrobial and Antitumor	Boana raniceps	B16-F10	Skin Cancer	MTT assay	IC₅₀ = 6.56 uM	3-h	Skin	None
7565	None	2023	ALLDKLKSLGKVVGKVALGVVQNYLNPRQ	Raniseptin-6	29	Linear	L	None	Free	Free	Antimicrobial and Antitumor	Boana raniceps	B16-F10	Skin Cancer	MTT assay	IC₅₀ = 8.69 uM	3-h	Skin	None
7562	37310533	2023	RIIDRLWLVRRPQKPKFVLVWVL	PMAP-NC	23	Linear	L	None	Free	Free	Antimicrobial	Synthetic Analgog of PMAP-24	A-549	Lung Cancer	MTT assay	IC₅₀ = 7.1 μM	4-h	Lung	None
7561	37310533	2023	RIIDRLWLVRRPQKPKFVLVWVL	PMAP-NC	23	Linear	L	None	Free	Free	Antimicrobial	Synthetic Analgog of PMAP-23	MDA-MB-361	Breast Cancer	MTT assay	IC₅₀ = 6.4 μM	4-h	Breast	None
7558	37764334	2023	ALWKSILKNAGKAVLNEINQIV	14VL23	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Dermaseptin-SS1- Analog	H-460	Lung Cancer	MTT assay	IC₅₀ = 16.4 µM	24-h	Lung	None
7557	37764334	2023	ALWKSILKNAGKAVLNEINQIV	14VL23	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Dermaseptin-SS1- Analog	H-838	Lung Cancer	MTT assay	IC₅₀ = 5.7 µM	24-h	Lung	None
7556	37764334	2023	ALWKKILKNAGKAVLNEINQIVQ	14V5K	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Dermaseptin-SS1- Analog	H-460	Lung Cancer	MTT assay	IC₅₀ = 6.1 µM	24-h	Lung	None
7555	37764334	2023	ALWKKILKNAGKAVLNEINQIVQ	14V5K	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Dermaseptin-SS1- Analog	H-838	Lung Cancer	MTT assay	IC₅₀ = 8.1 µM	24-h	Lung	None
7554	37764334	2023	ALWKSILKNVGKVLNEINQIVQ	L2V	22	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Dermaseptin-SS1- Analog	H-460	Lung Cancer	MTT assay	IC₅₀ = 0.6 µM	24-h	Lung	None
7553	37764334	2023	ALWKSILKNVGKVLNEINQIVQ	L2V	22	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Dermaseptin-SS1- Analog	H-838	Lung Cancer	MTT assay	IC₅₀ = 2.2 µM	24-h	Lung	None
7552	37764334	2023	ALWKSILKNAGKAGLNEINQIVQ	14G	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Dermaseptin-SS1- Analog	H-460	Lung Cancer	MTT assay	IC₅₀ = 31.7 µM	24-h	Lung	None
7551	37764334	2023	ALWKSILKNAGKAGLNEINQIVQ	14G	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Dermaseptin-SS1- Analog	H-838	Lung Cancer	MTT assay	IC₅₀ = 48.7 µM	24-h	Lung	None
7550	37764334	2023	ALWKSILKNAGKAVLNEINQIVQ	14V	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Dermaseptin-SS1- Analog	H-460	Lung Cancer	MTT assay	IC₅₀ = 4.1 µM	24-h	Lung	None
7549	37764334	2023	ALWKSILKNAGKAVLNEINQIVQ	14V	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Dermaseptin-SS1- Analog	H-838	Lung Cancer	MTT assay	IC₅₀ = 7.0 µM	24-h	Lung	None
7548	37764334	2023	ALWKSILKNAGKALNEINQIVQ	L14	22	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Dermaseptin-SS1- Analog	H-460	Lung Cancer	MTT assay	IC₅₀ = 20.1 µM	24-h	Lung	None
7547	37764334	2023	ALWKSILKNAGKALNEINQIVQ	L14	22	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Dermaseptin-SS1- Analog	H-838	Lung Cancer	MTT assay	IC₅₀ = 64.4 µM	24-h	Lung	None
7546	37764334	2023	ALWKSILKNAGKAALNEINQIV	Dermaseptin-SS1	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Brown-belly leaf frog, Phyllomedusa Tarsius	H-460	Lung Cancer	MTT assay	IC₅₀ = 1.3 µM	24-h	Lung	None
7545	37764334	2023	ALWKSILKNAGKAALNEINQIV	Dermaseptin-SS1	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Brown-belly leaf frog, Phyllomedusa Tarsius	H-838	Lung Cancer	MTT assay	IC₅₀ = 7.7 µM	24-h	Lung	None
7515	37228702	2023	FLPLLAGLAANFLPKIICKIARKC	B1AW-K	24	Linear	L	None	Amidation	Free	Antimicrobial and Antitumor	analogue of B1AW	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 3.860 µM	24-h	Brain	None
7514	37228702	2023	FLPLLAGLAANFLPKIICKIARKC	B1AW-K	24	Linear	L	None	Amidation	Free	Antimicrobial and Antitumor	analogue of B1AW	H-838	Lung Cancer	MTT assay	IC₅₀ = 5.15 µM	24-h	Lung	None
7513	37228702	2023	FLPLLAGLAANFLPKIICKIARKC	B1AW-K	24	Linear	L	None	Amidation	Free	Antimicrobial and Antitumor	analogue of B1AW	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 4.283 µM	24-h	Prostate	None
7512	37228702	2023	FLPLLAGLAANFLPQIICKIARKC	B1AW	24	Linear	L	None	Amidation	Free	Antimicrobial and Antitumor	Wuyi torrent frog, Amolops wuyiensis	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 33.56 µM	24-h	Brain	None
7511	37228702	2023	FLPLLAGLAANFLPQIICKIARKC	B1AW	24	Linear	L	None	Amidation	Free	Antimicrobial and Antitumor	Wuyi torrent frog, Amolops wuyiensis	H-838	Lung Cancer	MTT assay	IC₅₀ = 32.15 µM	24-h	Lung	None
7510	37228702	2023	FLPLLAGLAANFLPQIICKIARKC	B1AW	24	Linear	L	None	Amidation	Free	Antimicrobial and Antitumor	Wuyi torrent frog, Amolops wuyiensis	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 33.46 µM	24-h	Prostate	None
7509	37508198	2023	FLGVALKLGKVLGKALLPLASSLLHSQ	Figanin 2BN	27	Linear	L	None	Amidation	Free	Antimicrobial and Antitumor	Giant Gladiator Treefrog (Boana boans)	HT-29	Colon Cancer	MTT assay	LC₅₀ = 14.1 uM	24-h	Colon	None
7508	37508198	2023	FLGVALKLGKVLGKALLPLASSLLHSQ	Figanin 2BN	27	Linear	L	None	Amidation	Free	Antimicrobial and Antitumor	Giant Gladiator Treefrog (Boana boans)	MDA-MB-231	Breast Cancer	MTT assay	LC₅₀ = 8.1 uM	24-h	Breast	None
7507	37508198	2023	FLGVALKLGKVLGKALLPLASSLLHSQ	Figanin 2BN	27	Linear	L	None	Amidation	Free	Antimicrobial and Antitumor	Giant Gladiator Treefrog (Boana boans)	A-549	Lung Cancer	MTT assay	LC₅₀ = 6.7 uM	24-h	Lung	None
7506	37508198	2023	GIFKDTLKKVVAAVLTTVADNIHPK	Picturin 1BN	25	Linaer	L	None	Amidation	Free	Antimicrobial and Antitumor	Giant Gladiator Treefrog (Boana boans)	HT-29	Colon Cancer	MTT assay	LC₅₀ = 84.9 uM	24-h	Colon	None
7505	37508198	2023	GIFKDTLKKVVAAVLTTVADNIHPK	Picturin 1BN	25	Linear	L	None	Amidation	Free	Antimicrobial and Antitumor	Giant Gladiator Treefrog (Boana boans)	MDA-MB-231	Breast Cancer	MTT assay	LC₅₀ = 64.2 uM	24-h	Breast	None
7504	37508198	2023	GIFKDTLKKVVAAVLTTVADNIHPK	Picturin 1BN	25	Linear	L	None	Amidation	Free	Antimicrobial and Antitumor	Giant Gladiator Treefrog (Boana boans)	A-549	Lung Cancer	MTT assay	LC₅₀ = 30.7 µM	24-h	Lung	None
7503	37508198	2023	GLMDMLKKVGKVALTVAKSALLP	Picturin 2BN	23	Linear	L	None	Amidation	Free	Antimicrobial and Antitumor	Giant Gladiator Treefrog (Boana boans)	HT-29	Colon Cancer	MTT assay	LC₅₀ 52.2 uM	24-h	Colon	None
7502	37508198	2023	GLMDMLKKVGKVALTVAKSALLP	Picturin 2BN	23	Linear	L	None	Amidation	Free	Antimicrobial and Antitumor	Giant Gladiator Treefrog (Boana boans)	MDA-MB-231	Breast Cancer	MTT assay	LC₅₀ 26.3 uM	24-h	Breast	None
7501	37508198	2023	GLMDMLKKVGKVALTVAKSALLP	Picturin 2BN	23	Linear	L	None	Amidation	Free	Antimicrobial and Antitumor	Giant Gladiator Treefrog (Boana boans)	A-549	Lung Cancer	MTT assay	LC₅₀ = 23 µM	24-h	Lung	None
7500	37598210	2023	grrrqrrkkrlgpfsidllikslsdnmtdl	M1-20	30	Linear	D	None	Free	Free	Anticancer	Synthetic	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 32.47 µM	36-h	Lung	None
7499	37598210	2023	grrrqrrkkrlgpfsidllikslsdnmtdl	M1-20	30	Linear	D	None	Free	Free	Anticancer	Synthetic	U-2 OS	Bone Cancer	CCK-8 assay	IC₅₀ = 25.65 µM	36-h	Bone	None
7498	37598210	2023	grrrqrrkkrlgpfsidllikslsdnmtdl	M1-20	30	Linear	D	None	Free	Free	Anticancer	Synthetic	HeLa	Cervical Cancer	CCK-8 assay	IC₅₀ = 42.95 µM	36-h	Cervix	None
7497	37598210	2023	grrrqrrkkrlgpfsidllikslsdnmtdl	M1-20	30	Linear	D	None	Free	Free	Anticancer	Synthetic	ZR-75-30	Breast Cancer	CCK-8 assay	IC₅₀ = 23.57 µM	36-h	Breast	None
7496	37598210	2023	grrrqrrkkrlgpfsidllikslsdnmtdl	M1-20	30	Linear	D	None	Free	Free	Anticancer	Synthetic	MCF-7	Breast Cancer	CCK-8 assay	IC₅₀ = 31.05 µM	36-h	Breast	None
7495	37598210	2023	grrrqrrkkrlgpfsidllikslsdnmtdl	M1-20	30	Linear	D	None	Free	Free	Anticancer	Synthetic	MDA-MB-231	Breast Cancer	CCK-8 assay	IC₅₀ = 18.15 µM	36-h	Breast	None
7480	37396945	2023	LSTAADMQGVVTDGMASGLDKDYLKPDD	p28	28	Linear	L	None	Free	Free	Antitumor	Pseudomonas aeruginosa	CT-26	Colorectal Cancer	MTT assay	IC₅₀ ~ 150 μg/ml	24-h	Colon	None
7479	37396945	2023	LSTAADMQGVVTDGMASGLDKDYLKPDD	p28	28	Linear	L	None	Free	Free	Antitumor	Pseudomonas aeruginosa	HT-29	Colon Cancer	MTT assay	IC₅₀ ~ 200 μg/ml	24-h	Colon	None
7421	36410436	2023	RRRRNRTRRNRRRVRGGLTIYFY	FHV-2D5	23	Linear	L	None	Free	Free	Anticancer	STAP-2 PH domain–derived peptide	DU-145	Liver Cancer	CellTiter-Glo assay	Graph figure 1-G	48-h	Liver	None
7420	36410436	2023	TRRQRTRRARRNRGGLTIYFY	HTLV-II-Rex-2D5	21	Linear	L	None	Free	Free	Anticancer	STAP-2 PH domain–derived peptide	DU-145	Liver Cancer	CellTiter-Glo assay	Graph figure 1-G	48-h	Liver	None
7419	36410436	2023	GRKKRRQRRRPPQGGLTIYFY	TAT-2D5	21	Linear	L	None	Free	Free	Anticancer	STAP-2 PH domain–derived peptide	DU-145	Liver Cancer	CellTiter-Glo assay	Graph figure 1-G	48-h	Liver	None
7417	36410436	2023	RRRRRRRRGGVVELRVPTDLTLLPGHLYMM	6E(V116-M135)	30	Linear	L	None	Free	Free	Anticancer	STAP-2 PH domain–derived peptide	DU-145	Liver Cancer	CellTiter-Glo assay	Graph figure 1-D	48-h	Liver	None
7413	36410436	2023	RRRRRRRRGGQGLTIYFYNSNR	2D(Q44-R55)	22	Linear	L	None	Free	Free	Anticancer	STAP-2 PH domain–derived peptide	DU-145	Liver Cancer	CellTiter-Glo assay	Graph figure 1-C	48-h	Liver	None
7412	36410436	2023	RRRRRRRRGGQGLTIYFYNSNRDFQ	2C(Q44-Q58)	25	Linear	L	None	Free	Free	Anticancer	STAP-2 PH domain–derived peptide	DU-145	Liver Cancer	CellTiter-Glo assay	Graph figure 1-C	48-h	Liver	None
7411	36410436	2023	RRRRRRRRGGFWAGLQGLTIYFYNSNRDFQ	2A(F39-Q58)	30	Linear	L	None	Free	Free	Anticancer	STAP-2 PH domain–derived peptide	DU-145	Liver Cancer	CellTiter-Glo assay	Graph figure 1-C	48-h	Liver	None
7410	36410436	2023	RRRRRRRRGGMWKGFILTVVELRVPTDLTL	#6(M108-L127)	30	Linear	L	None	Free	Free	Anticancer	STAP-2 PH domain–derived peptide	MCF-7	Breast Cancer	CellTiter-Glo assay	Graph figure 1-B	48-h	Breast	None
7409	36410436	2023	RRRRRRRRGGMWKGFILTVVELRVPTDLTL	#6(M108-L127)	30	Linear	L	None	Free	Free	Anticancer	STAP-2 PH domain–derived peptide	DU-145	Liver Cancer	CellTiter-Glo assay	Graph figure 1-B	48-h	Liver	None
7408	36410436	2023	RRRRRRRRGGDQEIKFKVETLECREMWKGF	#5(D93-F112)	30	Linear	L	None	Free	Free	Anticancer	STAP-2 PH domain–derived peptide	DU-145	Liver Cancer	CellTiter-Glo assay	Graph figure 1-B	48-h	Liver	None
7407	36410436	2023	RRRRRRRRGGDRDYKKFWAGLQGLTIYFYN	#2(D33-N52)	30	Linear	L	None	Free	Free	Anticancer	STAP-2 PH domain–derived peptide	MCF-7	Breast Cancer	CellTiter-Glo assay	Graph figure 1-B	48-h	Breast	None
7406	36410436	2023	RRRRRRRRGGDRDYKKFWAGLQGLTIYFYN	#2(D33-N52)	30	Linear	L	None	Free	Free	Anticancer	STAP-2 PH domain–derived peptide	DU-145	Liver Cancer	CellTiter-Glo assay	Graph figure 1-B	48-h	Liver	None
7355	35606468	2022	GLLGKILGAGKKVLLGVSGLL	Nigrocin-M1	21	Linear	L	None	Free	Free	Antimicrobial and Antitumor	Synthetic; Analogue of Nigrocin M1	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 24.60 μM	24-h	Breast	None
7354	35606468	2022	GLLGKILGAGKKVLLGVSGLL	Nigrocin-M1	21	Linear	L	None	Free	Free	Antimicrobial and Antitumor	Synthetic; Analogue of Nigrocin M1	U-251-MG	Brain Tumor	MTT assay	IC₅₀ = 25.06 μM	24-h	Brain	None
7352	35606468	2022	GLLGKILGAGKKVLLGVSGLL	Nigrocin-M1	21	Linear	L	None	Free	Free	Antimicrobial and Antitumor	Synthetic; Analogue of Nigrocin M1	H-157	Non-small cell lung cancer	MTT assay	IC₅₀ = 24 μM	24-h	Lung	None
7353	35606468	2022	GLLGKILGAGKKVLLGVSGLL	Nigrocin-M1	21	Linear	L	None	Free	Free	Antimicrobial and Antitumor	Synthetic; Analogue of Nigrocin M1	PC-3	Prostate cancer	MTT assay	IC₅₀ = 31.27 μM	24-h	Prostate	None
7350	35606468	2022	GLLGKILGAGKKVLCGVSGLC	Nigrocin-PN	21	Linear	L	None	Free	Free	Antimicrobial and Antitumor	Pelophylax nigromaculatus	PC-3	Prostate cancer	MTT assay	IC₅₀ = 53.03 μM	24-h	Prostate	None
7351	35606468	2022	GLLGKILGAGKKVLCGVSGLC	Nigrocin-PN	21	Linear	L	None	Free	Free	Antimicrobial and Antitumor	Pelophylax nigromaculatus	U-251-MG	Brain Tumor	MTT assay	IC₅₀ = 73.65 μM	24-h	Brain	None
7349	35606468	2022	GLLGKILGAGKKVLCGVSGLC	Nigrocin-PN	21	Linear	L	None	Free	Free	Antimicrobial and Antitumor	Pelophylax nigromaculatus	H-157	Non-small cell lung cancer	MTT assay	IC₅₀ = 18.04 μM	24-h	Lung	None
7307	35764196	2022	kklalalakkwlalakklalalakk	D-LAK-120-A	25	Linear	D	None	Amidation	Free	Antimicrobial	Synthetic	HCC-827	Lung Adenocarcinoma	MTT assay	IC₅₀ between 4.0 and 5.5 μM	72-h	Lung	None
7306	35764196	2022	kklalalakkwlalakklalalakk	D-LAK-120-A	25	Linear	D	None	Amidation	Free	Antimicrobial	Synthetic	H-1975	Non Small Cell Lung Cancer (NSCLC)	MTT assay	IC₅₀ between 4.0 and 5.5 μM	72-h	Lung	None
7305	35764196	2022	kklalalakkwlalakklalalakk	D-LAK-120-A	25	Linear	D	None	Amidation	Free	Antimicrobial	Synthetic	H-358	Non Small Cell Lung Cancer (NSCLC)	MTT assay	IC₅₀ = 4.00 ± 0.20 μM	72-h	Lung	None
7304	35764196	2022	kklalalakkwlalakklalalakk	D-LAK-120-A	25	Linear	D	None	Amidation	Free	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 5.55 ± 0.13 μM	72-h	Lung	None
7303	36287985	2022	IWSFLIKAATKLLPSLFGGGKKDS	SMP24	24	Linear	L	None	Free	Free	Antimicrobial	Egyptian scorpion Scorpio maurus palmatus	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 5.524 µM	24-h	Liver	None
7302	35878176	2022	IWSFLIKAATKLLPSLFGGGKKDS	SMP24	24	Linear	L	None	Free	Free	Antimicrobial	Egyptian scorpion Scorpio maurus palmatus	H-460	Lung Cancer	MTT assay	IC₅₀ = 7.07 ± 0.81 µM	24-h	Lung	None
7301	35878176	2022	IWSFLIKAATKLLPSLFGGGKKDS	SMP24	24	Linear	L	None	Free	Free	Antimicrobial	Egyptian scorpion Scorpio maurus palmatus	PC-9	Lung Cancer	MTT assay	IC₅₀ = 6.34 ± 0.53 µM	24-h	Lung	None
7300	35878176	2022	IWSFLIKAATKLLPSLFGGGKKDS	SMP24	24	Linear	L	None	Free	Free	Antimicrobial	Egyptian scorpion Scorpio maurus palmatus	H-3122	Lung Cancer	MTT assay	IC₅₀ = 4.64 ± 0.18 µM	24-h	Lung	None
7299	35878176	2022	IWSFLIKAATKLLPSLFGGGKKDS	SMP24	24	Linear	L	None	Free	Free	Antimicrobial	Egyptian scorpion Scorpio maurus palmatus	A-549	Lung Cancer	MTT assay	IC₅₀ = 4.06 ± 0.60 µM	24-h	Lung	None
7276	35601827	2022	IWLTALKFLGKNLGKLAKQQLAKL	LyeTx-I-b	24	Linear	L	None	Amidated	Acetylation	Antimicrobial	Synthetic	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 2.47 µM	48-h	Breast	None
7275	35013881	2022	KLKNFAKGVAQSLLNKASCKLSGQC	Brevinin-2R	25	Linear	L	None	Free	Free	Antimicrobial	Rana ridibunda	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 131.5 μg/ml	24-h	Cervix	None
7274	36465844	2022	GVKFAKRFWRFAKKAFKRFEK	HAZ	21	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 5.44 μM	4-h	Lung	None
7254	35774163	2022	flgvlallgylavrpflpkkkqqk	D-NAF-1	24	Linear	D	None	Free	Free	Anticancer	NAF-1/CISD2	MDA-MB-231	Breast Cancer	Not Available	IC₅₀ = 12.8 ± 0.2 μM	NA	Breast	None
7253	35774163	2022	FLGVLALLGYLAVRPFLPKKKQQK	NAF-1	24	Linear	L	None	Free	Free	Anticancer	NAF-1/CISD2	MDA-MB-231	Breast Cancer	Not Available	IC₅₀ = 18.3 ± 0.4 μM	NA	Breast	None
7250	36672551	2022	GRKKRRQRRRPPQ-X-CWMSPRHLGTC	CIGB-300	25	Cyclic	L	X = Beta- Alanine	Free	Biotinylated	Anticancer	Synthetic	NCI-H-460	Lung Cancer	Crystal Violet assay	IC₅₀ = 30 ± 5.3 µM	48-h	Lung	None
7249	35745643	2022	FKWQFEMLIMKIAKTSGFMFYSSY	BmPLA2	24	Linear	L	None	Free	Free	Anticancer	phospholipase A2 isoform from B. moojeni venom	RD	Rhabdomyosarcoma	MTT assay	60% reduction in cell viability	24-h	Muscle	None
7248	35745643	2022	FKWQFEMLIMKIAKTSGFMFYSSY	BmPLA2	24	Linear	L	None	Free	Free	Anticancer	phospholipase A2 isoform from B. moojeni venom	CaCo-2	Colorectal Cancer	MTT assay	IC₅₀ = 0.6 µM	24-h	Colon	None
7223	35190586	2022	MADSERLSAPGCWAACTNFSRTRK	RB4	24	Linear	L	None	Amidation	Free	Anticancer	Derived from protein PLP2	MCF-7	Breast Cancer	MTT assay	EC₅₀ = 0.724 ± 0.340 mol/L × 10^-3	24-h	Breast	None
7222	35190586	2022	MADSERLSAPGCWAACTNFSRTRK	RB4	24	Linear	L	None	Amidation	Free	Anticancer	Derived from protein PLP2	A-2058	Skin Cancer	MTT assay	EC₅₀ = 0.744 ± 0.208 mol/L × 10^-3	24-h	Skin	None
7221	35190586	2022	MADSERLSAPGCWAACTNFSRTRK	RB4	24	Linear	L	None	Amidation	Free	Anticancer	Derived from protein PLP2	U-87	Brain Tumor	MTT assay	EC₅₀ = 0.427 ± 0.053 mol/L × 10^-3	24-h	Brain	None
7220	35190586	2022	MADSERLSAPGCWAACTNFSRTRK	RB4	24	Linear	L	None	Amidation	Free	Anticancer	Derived from protein PLP2	HeLa	Cervical Cancer	MTT assay	EC₅₀ = 0.525 ± 0.160 mol/L × 10^-3	24-h	Cervix	None
7219	35190586	2022	MADSERLSAPGCWAACTNFSRTRK	RB4	24	Linear	L	None	Amidation	Free	Anticancer	Derived from protein PLP2	B16-F10-Nex 2	Skin Cancer	MTT assay	EC₅₀ = 0.263 ± 0.585 mol/L × 10^-3	24-h	Skin	None
7218	36005521	2022	GWGSFFKKAAHVGKHVGKAALTHYL	Ple-a	25	Linear	L	None	Amidation	Free	Antimicrobial	C-terminal-amidated derivative of Pleurocidin	WiDr	Colon Cancer	MTT assay	IC₅₀ = 197.3 μM	24-h	Colon	None
7217	36005521	2022	GWGSFFKKAAHVGKHVGKAALTHYL	Ple-a	25	Linear	L	None	Amidation	Free	Antimicrobial	C-terminal-amidated derivative of Pleurocidin	AGS	Stomach Cancer	MTT assay	IC₅₀ = 29.8 μM	24-h	Stomach	None
7216	36005521	2022	GWGSFFKKAAHVGKHVGKAALTHYL	Ple-a	25	Linear	L	None	Amidation	Free	Antimicrobial	C-terminal-amidated derivative of Pleurocidin	A-549	Lung Cancer	MTT assay	IC₅₀ = 42.1 μM	24-h	Lung	None
7215	36005521	2022	GWGSFFKKAAHVGKHVGKAALTHYL	Ple-a	25	Linear	L	None	Amidation	Free	Antimicrobial	C-terminal-amidated derivative of Pleurocidin	Hep3B	Liver Cancer	MTT assay	IC₅₀ = 77.5 μM	24-h	Liver	None
7214	36005521	2022	GWGSFFKKAAHVGKHVGKAALTHYL	Ple-a	25	Linear	L	None	Amidation	Free	Antimicrobial	C-terminal-amidated derivative of Pleurocidin	Huh-7	Liver Cancer	MTT assay	IC₅₀ = 60 μM	24-h	Liver	None
7213	36005521	2022	GWGSFFKKAAHVGKHVGKAALTHYL	Ple-a	25	Linear	L	None	Amidation	Free	Antimicrobial	C-terminal-amidated derivative of Pleurocidin	J5	Liver Cancer	MTT assay	IC₅₀ = 11 μM	24-h	Liver	None
7212	36005521	2022	GWGSFFKKAAHVGKHVGKAALTHYL	Ple	25	Linear	L	None	Free	Free	Antimicrobial	Pleuronectes americanus	AGS	Stomach Cancer	MTT assay	IC₅₀ = 186.5 μM	24-h	Stomach	None
7211	36005521	2022	GWGSFFKKAAHVGKHVGKAALTHYL	Ple	25	Linear	L	None	Free	Free	Antimicrobial	Pleuronectes americanus	A-549	Lung Cancer	MTT assay	IC₅₀ = 300.8 μM	24-h	Lung	None
7210	36005521	2022	GWGSFFKKAAHVGKHVGKAALTHYL	Ple	25	Linear	L	None	Free	Free	Antimicrobial	Pleuronectes americanus	Hep3B	Liver Cancer	MTT assay	IC₅₀ = 340.9 μM	24-h	Liver	None
7209	36005521	2022	GWGSFFKKAAHVGKHVGKAALTHYL	Ple	25	Linear	L	None	Free	Free	Antimicrobial	Pleuronectes americanus	J5	Liver Cancer	MTT assay	IC₅₀ = 54.9 μM	24-h	Liver	None
7195	35053455	2022	MDRWLVKWKKKRKIRRRRRRRRRRR	ATX-101	25	Linear	L	None	Free	Acetylation	Antitumor and Cell Penetrating	Synthetic	SNB-19	Brain Tumor	CCK-8 assay	IC₅₀ = 12.0 ± 0.6 μM	72-h	Brain	None
7194	35053455	2022	MDRWLVKWKKKRKIRRRRRRRRRRR	ATX-101	25	Linear	L	None	Free	Acetylation	Antitumor and Cell Penetrating	Synthetic	SF-268	Brain Tumor	CCK-8 assay	IC₅₀ = 4.8 ± 0.1 μM	72-h	Brain	None
7193	35053455	2022	MDRWLVKWKKKRKIRRRRRRRRRRR	ATX-101	25	Linear	L	None	Free	Acetylation	Antitumor and Cell Penetrating	Synthetic	U-138	Brain Tumor	CCK-8 assay	IC₅₀ = 7.5 ± 0.3 μM	72-h	Brain	None
7192	35053455	2022	MDRWLVKWKKKRKIRRRRRRRRRRR	ATX-101	25	Linear	L	None	Free	Acetylation	Antitumor and Cell Penetrating	Synthetic	LN229	Brain Tumor	CCK-8 assay	IC₅₀ = 4.7 ± 0.2 μM	72-h	Brain	None
7191	35053455	2022	MDRWLVKWKKKRKIRRRRRRRRRRR	ATX-101	25	Linear	L	None	Free	Acetylation	Antitumor and Cell Penetrating	Synthetic	SW-1783	Brain Tumor	CCK-8 assay	IC₅₀ = 4.8 ± 0.2 μM	72-h	Brain	None
7190	35053455	2022	MDRWLVKWKKKRKIRRRRRRRRRRR	ATX-101	25	Linear	L	None	Free	Acetylation	Antitumor and Cell Penetrating	Synthetic	D54	Brain Tumor	CCK-8 assay	IC₅₀ = 8.4 ± 0.1 μM	72-h	Brain	None
7189	35053455	2022	MDRWLVKWKKKRKIRRRRRRRRRRR	ATX-101	25	Linear	L	None	Free	Acetylation	Antitumor and Cell Penetrating	Synthetic	U-118	Brain Tumor	CCK-8 assay	IC₅₀ = 6.8 ± 0.2 μM	72-h	Brain	None
7188	35053455	2022	MDRWLVKWKKKRKIRRRRRRRRRRR	ATX-101	25	Linear	L	None	Free	Acetylation	Antitumor and Cell Penetrating	Synthetic	U-373	Brain Tumor	CCK-8 assay	IC₅₀ = 5.0 ± 0.2 μM	72-h	Brain	None
7187	35053455	2022	MDRWLVKWKKKRKIRRRRRRRRRRR	ATX-101	25	Linear	L	None	Free	Acetylation	Antitumor and Cell Penetrating	Synthetic	T98G	Brain Tumor	CCK-8 assay	IC₅₀ = 7.1 ± 0.2 μM	96-h	Brain	None
7186	35053455	2022	MDRWLVKWKKKRKIRRRRRRRRRRR	ATX-101	25	Linear	L	None	Free	Acetylation	Antitumor and Cell Penetrating	Synthetic	A-172	Brain Tumor	CCK-8 assay	IC₅₀ = 6.4 ± 0.4 μM	96-h	Brain	None
7185	35053455	2022	MDRWLVKWKKKRKIRRRRRRRRRRR	ATX-101	25	Linear	L	None	Free	Acetylation	Antitumor and Cell Penetrating	Synthetic	U-251	Brain Tumor	CCK-8 assay	IC₅₀ = 4.9 ± 0.3 μM	96-h	Brain	None
7184	35053455	2022	MDRWLVKWKKKRKIRRRRRRRRRRR	ATX-101	25	Linear	L	None	Free	Acetylation	Antitumor and Cell Penetrating	Synthetic	U87-MG	Brain Tumor	CCK-8 assay	IC₅₀ = 4.3 ± 0.3 μM	96-h	Brain	None
7183	35660629	2022	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Free	Antimicrobial	skin mucous secretions of winter flounder	SCC-9	Oral Cancer	CCK-8 assay	IC₅₀ = 45 μg/ml	24-h	Tongue	None
7182	35660629	2022	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Free	Antimicrobial	skin mucous secretions of winter flounder	CAL-27	Oral Cancer	CCK-8 assay	IC₅₀ = 45 μg/ml	24-h	Tongue	None
7089	35740895	2022	FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF	Jeff-[G10a]₂-SHa	26	Linear	Mix	Jeffamine linker	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	MNT-1	Skin Cancer	Resazurin dye assay	IC₅₀ = 57.03 ± 6.09 µM	48-h	Skin	US_10550155_B2
7088	35740895	2022	FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF	Jeff-[G10a]₂-SHa	26	Linear	Mix	Jeffamine linker	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	PC-3	Prostate Cancer	Resazurin dye assay	IC₅₀ = 57.99 ± 5.04 µM	48-h	Prostate	US_10550155_B2
7086	35740895	2022	FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF	Jeff-[G10a]₂-SHa	26	Linear	Mix	Jeffamine linker	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	A-2780	Ovarian Cancer	Resazurin dye assay	IC₅₀ = 33.92 ± 5.90 µM	48-h	Ovary	US_10550155_B2
7087	35740895	2022	FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF	Jeff-[G10a]₂-SHa	26	Linear	Mix	Jeffamine linker	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	MiaPaCa.2	Pancreatic Cancer	Resazurin dye assay	IC₅₀ = 57.45 ± 6.03 µM	48-h	Pancreas	US_10550155_B2
7084	35740895	2022	FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF	Jeff-[G10a]₂-SHa	26	Linear	Mix	Jeffamine linker	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	MCF-7	Breast Cancer	Resazurin dye assay	IC₅₀ = 35.71 ± 8.50 µM	48-h	Breast	US_10550155_B2
7085	35740895	2022	FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF	Jeff-[G10a]₂-SHa	26	Linear	Mix	Jeffamine linker	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	A-549	Lung Cancer	Resazurin dye assay	IC₅₀ = 70.71 ± 5.39 µM	48-h	Lung	US_10550155_B2
7076	35740895	2022	FLSGIVGMLaKLFKFLKaLMFLSGIVG	[G10a]₂-SHa	27	Linear	Mix	None	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	MNT-1	Skin Cancer	Resazurin dye assay	IC₅₀ = 4.72 ± 0.36 µM	48-h	Skin	US_10550155_B2
7075	35740895	2022	FLSGIVGMLaKLFKFLKaLMFLSGIVG	[G10a]₂-SHa	27	Linear	Mix	None	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	PC-3	Prostate Cancer	Resazurin dye assay	IC₅₀ = 6.31 ± 0.66 µM	48-h	Prostate	US_10550155_B2
7074	35740895	2022	FLSGIVGMLaKLFKFLKaLMFLSGIVG	[G10a]₂-SHa	27	Linear	Mix	None	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	MiaPaCa.2	Pancreatic Cancer	Resazurin dye assay	IC₅₀ = 8.71 ± 0.35 µM	48-h	Pancreas	US_10550155_B2
7073	35740895	2022	FLSGIVGMLaKLFKFLKaLMFLSGIVG	[G10a]₂-SHa	27	Linear	Mix	None	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	A-2780	Ovarian Cancer	Resazurin dye assay	IC₅₀ = 4.42 ± 0.06 µM	48-h	Ovary	US_10550155_B2
7072	35740895	2022	FLSGIVGMLaKLFKFLKaLMFLSGIVG	[G10a]₂-SHa	27	Linear	Mix	None	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	A-549	Lung Cancer	Resazurin dye assay	IC₅₀ = 3.79 ± 1.61 µM	48-h	Lung	US_10550155_B2
7071	35740895	2022	FLSGIVGMLaKLFKFLKaLMFLSGIVG	[G10a]₂-SHa	27	Linear	Mix	None	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	HepG-2	Liver Cancer	Resazurin dye assay	IC₅₀ = 14.31 ± 1.37 µM	48-h	Liver	US_10550155_B2
7070	35740895	2022	FLSGIVGMLaKLFKFLKaLMFLSGIVG	[G10a]₂-SHa	27	Linear	Mix	None	Amidation	Free	Antimicrobial and Anticancer	Analog of temporin SHa	MCF-7	Breast Cancer	Resazurin dye assay	IC₅₀ = 5.69 ± 1.46 µM	48-h	Breast	US_10550155_B2
6904	33916789	2021	FFPLIAGLAARFLPKIFCSITKRC	Brevinin-1RL1	24	Cyclic(C18-C24)	L	None	Free	Free	Antimicrobial	Rana limnocharis	B16-F10	Skin Cancer	MTS assay	IC₅₀ = 6.65 ± 0.33 μM	48-h	Skin	None
6903	33916789	2021	FFPLIAGLAARFLPKIFCSITKRC	Brevinin-1RL1	24	Cyclic(C18-C24)	L	None	Free	Free	Antimicrobial	Rana limnocharis	SMMC-7721	Liver Cancer	MTS assay	IC₅₀ = 6.87 ± 0.51 μM	48-h	Liver	None
6902	33916789	2021	FFPLIAGLAARFLPKIFCSITKRC	Brevinin-1RL1	24	Cyclic(C18-C24)	L	None	Free	Free	Antimicrobial	Rana limnocharis	A-549	Lung Cancer	MTS assay	IC₅₀ = 5.81 ± 0.23 μM	48-h	Lung	None
6901	33916789	2021	FFPLIAGLAARFLPKIFCSITKRC	Brevinin-1RL1	24	Cyclic(C18-C24)	L	None	Free	Free	Antimicrobial	Rana limnocharis	SW-480	Blood Cancer	MTS assay	IC₅₀ = 10.37 ± 0.40 μM	48-h	Blood	None
6900	33916789	2021	FFPLIAGLAARFLPKIFCSITKRC	Brevinin-1RL1	24	Cyclic(C18-C24)	L	None	Free	Free	Antimicrobial	Rana limnocharis	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ = 5.44 ± 0.33 μM	48-h	Breast	None
6899	33916789	2021	FFPLIAGLAARFLPKIFCSITKRC	Brevinin-1RL1	24	Cyclic(C18-C24)	L	None	Free	Free	Antimicrobial	Rana limnocharis	HCT-116	Colon Cancer	MTS assay	IC₅₀ = 5.87 ± 0.15 μM	48-h	Colon	None
6885	34135370	2021	FIHHIFRGIVHAGRSIGRFLTG	Piscidin 3	22	Linear	L	Cu2+ bound	Free	Free	Anticancer	Morone chrysops x Morone saxatilis	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 1.97 µM	24-h	Cervix	None
6884	34135370	2021	FIHHIFRGIVHAGRSIGRFLTG	Piscidin 3	22	Linear	L	None	Free	Free	Anticancer	Morone chrysops x Morone saxatilis	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 18.1 µM	24-h	Cervix	None
6883	34135370	2021	FIHHIFRGIVHAGRSIGRFLTG	Piscidin 3	22	Linear	L	Cu2+ bound	Free	Free	Anticancer	Morone chrysops x Morone saxatilis	A-549	Lung Cancer	MTT assay	IC₅₀ = 2.99 µM	24-h	Lung	None
6882	34135370	2021	FIHHIFRGIVHAGRSIGRFLTG	Piscidin 3	22	Linear	L	None	Free	Free	Anticancer	Morone chrysops x Morone saxatilis	A-549	Lung Cancer	MTT assay	IC₅₀ = 21.6 µM	24-h	Lung	None
6881	34135370	2021	FIHHIFRGIVHAGRSIGRFLTG	Piscidin 3	22	Linear	L	Cu2+ bound	Free	Free	Anticancer	Morone chrysops x Morone saxatilis	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 5.25 µM	24-h	Breast	None
6880	34135370	2021	FIHHIFRGIVHAGRSIGRFLTG	Piscidin 3	22	Linear	L	None	Free	Free	Anticancer	Morone chrysops x Morone saxatilis	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 17.5 µM	24-h	Breast	None
6879	34135370	2021	FIHHIFRGIVHAGRSIGRFLTG	Piscidin 3	22	Linear	L	Cu2+ bound	Free	Free	Anticancer	Morone chrysops x Morone saxatilis	HT-1080	Fibrosarcoma	MTT assay	IC₅₀ = 5.52 µM	24-h	Not Available	None
6878	34135370	2021	FIHHIFRGIVHAGRSIGRFLTG	Piscidin 3	22	Linear	L	None	Free	Free	Anticancer	Morone chrysops x Morone saxatilis	HT-1080	Fibrosarcoma	MTT assay	IC₅₀ = 26.01 µM	24-h	Not Available	None
6877	34135370	2021	FFHHIFRGIVHVGKTIHRLVTG	Piscidin 1, Moronecidin	22	Linear	L	Cu2+ bound	Free	Free	Anticancer	Morone saxatilis	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 2.17 µM	24-h	Cervix	None
6876	34135370	2021	FFHHIFRGIVHVGKTIHRLVTG	Piscidin 1, Moronecidin	22	Linear	L	None	Free	Free	Anticancer	Morone saxatilis	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 2.22 µM	24-h	Cervix	None
6875	34135370	2021	FFHHIFRGIVHVGKTIHRLVTG	Piscidin 1, Moronecidin	22	Linear	L	Cu2+ bound	Free	Free	Anticancer	Morone saxatilis	A-549	Lung Cancer	MTT assay	IC₅₀ = 2.15 µM	24-h	Lung	None
6874	34135370	2021	FFHHIFRGIVHVGKTIHRLVTG	Piscidin 1, Moronecidin	22	Linear	L	None	Free	Free	Anticancer	Morone saxatilis	A-549	Lung Cancer	MTT assay	IC₅₀ = 4.2 µM	24-h	Lung	None
6873	34135370	2021	FFHHIFRGIVHVGKTIHRLVTG	Piscidin 1, Moronecidin	22	Linear	L	Cu2+ bound	Free	Free	Anticancer	Morone saxatilis	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 3.92 µM	24-h	Breast	None
6872	34135370	2021	FFHHIFRGIVHVGKTIHRLVTG	Piscidin 1, Moronecidin	22	Linear	L	None	Free	Free	Anticancer	Morone saxatilis	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 5.83 µM	24-h	Breast	None
6871	34135370	2021	FFHHIFRGIVHVGKTIHRLVTG	Piscidin 1, Moronecidin	22	Linear	L	Cu2+ bound	Free	Free	Anticancer	Morone saxatilis	HT-1080	Fibrosarcoma	MTT assay	IC₅₀ = 5.31 µM	24-h	Not Available	None
6870	34135370	2021	FFHHIFRGIVHVGKTIHRLVTG	Piscidin 1, Moronecidin	22	Linear	L	None	Free	Free	Anticancer	Morone saxatilis	HT-1080	Fibrosarcoma	MTT assay	IC₅₀ = 5.58 µM	24-h	Not Available	None
6861	33677023	2021	GKLRLIKKLWVKKWKKKGWKA	Pep	21	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 2 µM	24-h	Breast	None
6860	33677023	2021	GKLRLIKKLWVKKWKKKGWKA	Pep	21	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 4 µM	24-h	Lung	None
6857	33690977	2021	zffygwyggmekllrggrgerppr	NMTP-5	24	Linear	D	Z = C₁₀H₇CH₂C(O), M, 4-(Trifluoromethyl)-D-phenylalanine	Free	Free	Anticancer	Not Available	SK-HEP-1	Liver Cancer	MTT assay	IC₅₀ = 53.84 ± 4.35 µM	48-h	Liver	None
6809	34309373	2021	Pal-RDVFTKGYGFGL-GRK(Dansylglycine)KRRQRRRPQ	Pal-N-Ter-TAT	24	Linear	L	Dansylglycine = fluorescent amino acid residue located in the side chain of lysine	TAT	Palmitic acid	Anticancer	Analogue of N-terminal fragment of the VDAC1 protein	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 27.26 μM	24-h	Breast	None
6808	34309373	2021	Pal-RDVFTKGYGFGL-GRK(Dansylglycine)KRRQRRRPQ	Pal-N-Ter-TAT	24	Linear	L	Dansylglycine = fluorescent amino acid residue located in the side chain of lysine	TAT	Palmitic acid	Anticancer	Analogue of N-terminal fragment of the VDAC1 protein	A-549	Lung Cancer	MTT assay	IC₅₀ = 44.98 μM	24-h	Lung	None
6807	34309373	2021	Pal-RDVFTKGYGFGL-GRK(Dansylglycine)KRRQRRRPQ	Pal-N-Ter-TAT	24	Linear	L	Dansylglycine = fluorescent amino acid residue located in the side chain of lysine	TAT	Palmitic acid	Anticancer	Analogue of N-terminal fragment of the VDAC1 protein	A-375	Skin Cancer	MTT assay	IC₅₀ = 36.67(Supplementary material)/15.2 ± 0.7 μM(Published paper)	24-h	Skin	None
6801	34848729	2021	TGIATSGLATFTLHTGSLAPAT	AtMP2	22	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Anabastestudineus skin mucus fraction 2	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 6.97 ± 0.24 μg/ml	48-h	Breast	None
6800	34848729	2021	TGIATSGLATFTLHTGSLAPAT	AtMP2	22	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Anabastestudineus skin mucus fraction 2	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 5.89 ± 0.14 μg/ml	48-h	Breast	None
6799	34848729	2021	THPPTTTTTTTTTTTTTAAPATTT	AtMP1	24	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Anabastestudineus skin mucus fraction 2	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 9.35 ± 0.25 μg/ml	48-h	Breast	None
6798	34848729	2021	THPPTTTTTTTTTTTTTAAPATTT	AtMP1	24	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Anabastestudineus skin mucus fraction 2	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 8.25 ± 0.14 μg/ml	48-h	Breast	None
6785	33562681	2021	FIHHIIGGLFSAGKAIHRLIRRRRR	TP4	25	Linear	L	None	Free	Free	Antimicrobial	Oreochromis niloticus	Aska-SS	Synovial Sarcoma	MTS assay	IC₅₀ = 32.41 μg/mL	NA	Muscle	None
6784	33562681	2021	FIHHIIGGLFSAGKAIHRLIRRRRR	TP4	25	Linear	L	None	Free	Free	Antimicrobial	Oreochromis niloticus	SW982	Synovial Sarcoma	MTS assay	IC₅₀ = 29.20 μg/mL	NA	Muscle	None
6778	34461456	2021	gigavlkvlttglpaliswikrkrqqc	D-melittin	27	Linear	D	None	Free	Free	Anticancer	Synthetic	MDA-MB-435 DOX-R	Breast Cancer	MTS assay	IC₅₀ = 3.4 µM	24-h	Breast	None
6777	34461456	2021	gigavlkvlttglpaliswikrkrqqc	D-melittin	27	Linear	D	None	Free	Free	Anticancer	Synthetic	MDA-MB-435 WT	Breast Cancer	MTS assay	IC₅₀ = 3.5 µM	24-h	Breast	None
6776	34461456	2021	gigavlkvlttglpaliswikrkrqqc	D-melittin	27	Linear	D	None	Free	Free	Anticancer	Synthetic	CT-26	Colorectal Cancer	MTS assay	IC₅₀ = 2.2 µM	24-h	Colon	None
6775	34461456	2021	gigavlkvlttglpaliswikrkrqqc	D-melittin	27	Linear	D	None	Free	Free	Anticancer	Synthetic	A-549	Lung Cancer	MTS assay	IC₅₀ = 4.5 µM	24-h	Lung	None
6730	34309373	2021	RDVFTKGYGFGL-GRK(Dansylglycine)KRRQRRRPQ	N-Ter-TAT	24	Linear	L	Dansylglycine = fluorescent amino acid residue located in the side chain of lysine	TAT	Free	Anticancer	Synthetic	A-375	Skin Cancer	MTT assay	IC₅₀ > 50.0 μM	24-h	Skin	None
6728	33582221	2021	ALWKDLLKNVGIAAGKAALNKVTDMVNQ	Dermaseptin-TO	28	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa tomopterna	PC-3	Prostate Cancer	MTT assay	Graph Figure-7	24-h	Prostate	None
6727	33582221	2021	ALWKDLLKNVGIAAGKAALNKVTDMVNQ	Dermaseptin-TO	28	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa tomopterna	H-157	Lung Cancer	MTT assay	Graph Figure-7	24-h	Lung	None
6726	33582221	2021	ALWKDLLKNVGIAAGKAALNKVTDMVNQ	Dermaseptin-TO	28	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa tomopterna	U251-MG	Brain Tumor	MTT assay	Graph Figure-7	24-h	Brain	None
6725	34572719	2021	IWLTALKFLGKNLGKLAKQQLAKL	LyeTxI-b	24	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	MDA-MB-231	Breast Cancer	MTT assay	IC₅₀ = 5.77 ± 0.83 µM	48-h	Breast	None
6724	34572719	2021	IWLTALKFLGKNLGKLAKQQLAKL	LyeTxI-b	24	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 7.34 ± 3.09 µM	48-h	Breast	None
6723	34572719	2021	IWLTALKFLGKNLGKLAKQQLAKL	LyeTxI-b	24	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	4T1	Breast Cancer	MTT assay	IC₅₀ = 6.5 ± 5.30 µM	48-h	Breast	None
6722	34236134	2021	FKCRRWQWRMKKLGAPSITCVRRAF	Bovine Lactoferricin (LfcinB)	25	Linear	L	None	Free	Free	Antimicrobial	Bovine Milk	MDA-MB-231	Breast Cancer	Annexin V-FITC assay	~80% cell death at 200 µg/ml	48-h	Breast	None
6721	34236134	2021	FKCRRWQWRMKKLGAPSITCVRRAF	Bovine Lactoferricin (LfcinB)	25	Linear	L	None	Free	Free	Antimicrobial	Bovine Milk	MCF-7	Breast Cancer	Annexin V-FITC assay	~50% cell death at 300 µg/ml	48-h	Breast	None
6720	34236134	2021	FKCRRWQWRMKKLGAPSITCVRRAF	Bovine Lactoferricin (LfcinB)	25	Linear	L	None	Free	Free	Antimicrobial	Bovine Milk	SK-BR-3	Breast Cancer	Annexin V-FITC assay	~80% cell death at 100 µg/ml	48-h	Breast	None
6719	34236134	2021	FKCRRWQWRMKKLGAPSITCVRRAF	Bovine Lactoferricin (LfcinB)	25	Linear	L	None	Free	Free	Antimicrobial	Bovine Milk	MDA-MB-468	Breast Cancer	Annexin V-FITC assay	~60% cell death at 300 µg/ml	48-h	Breast	None
6718	34564615	2021	FlPLIASLAGNVVPKIFCKITKRC	B1OS-D-L	24	Linear	Mix	None	Free	Free	Antimicrobial	B-1OS	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 3.721 µM	24-h	Colon	None
6717	34564615	2021	FlPLIASLAGNVVPKIFCKITKRC	B1OS-D-L	24	Linear	Mix	None	Free	Free	Antimicrobial	B-1OS	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 3.17 µM	24-h	Breast	None
6716	34564615	2021	FlPLIASLAGNVVPKIFCKITKRC	B1OS-D-L	24	Linear	Mix	None	Free	Free	Antimicrobial	B-1OS	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 3.492 µM	24-h	Brain	None
6715	34564615	2021	FlPLIASLAGNVVPKIFCKITKRC	B1OS-D-L	24	Linear	Mix	None	Free	Free	Antimicrobial	B-1OS	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 2.629 µM	24-h	Prostate	None
6714	34564615	2021	FlPLIASLAGNVVPKIFCKITKRC	B1OS-D-L	24	Linear	Mix	None	Free	Free	Antimicrobial	B-1OS	H-838	Lung Cancer	MTT assay	IC₅₀ = 2.553 µM	24-h	Lung	None
6713	34564615	2021	FLPLIASLAGNVVPKIFCKITKRC	B1OS-L	24	Linear	L	None	Free	Free	Antimicrobial	B-1OS	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 11.03 µM	24-h	Colon	None
6712	34564615	2021	FLPLIASLAGNVVPKIFCKITKRC	B1OS-L	24	Linear	L	None	Free	Free	Antimicrobial	B-1OS	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 8.883 µM	24-h	Breast	None
6711	34564615	2021	FLPLIASLAGNVVPKIFCKITKRC	B1OS-L	24	Linear	L	None	Free	Free	Antimicrobial	B-1OS	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 8.629 µM	24-h	Brain	None
6710	34564615	2021	FLPLIASLAGNVVPKIFCKITKRC	B1OS-L	24	Linear	L	None	Free	Free	Antimicrobial	B-1OS	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 5.473 µM	24-h	Prostate	None
6709	34564615	2021	FLPLIASLAGNVVPKIFCKITKRC	B1OS-L	24	Linear	L	None	Free	Free	Antimicrobial	B-1OS	H-838	Lung Cancer	MTT assay	IC₅₀ = 3.976 µM	24-h	Lung	None
6708	34564615	2021	FPLIASLAGNVVPKIFCKITKRC	B1OS	23	Linear	L	None	Free	Free	Antimicrobial	Odorrana schmackeri	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 33.69 µM	24-h	Colon	None
6707	34564615	2021	FPLIASLAGNVVPKIFCKITKRC	B1OS	23	Linear	L	None	Free	Free	Antimicrobial	Odorrana schmackeri	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 112 µM	24-h	Breast	None
6706	34564615	2021	FPLIASLAGNVVPKIFCKITKRC	B1OS	23	Linear	L	None	Free	Free	Antimicrobial	Odorrana schmackeri	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 233.0 µM	24-h	Brain	None
6705	34564615	2021	FPLIASLAGNVVPKIFCKITKRC	B1OS	23	Linear	L	None	Free	Free	Antimicrobial	Odorrana schmackeri	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 95.94 µM	24-h	Prostate	None
6704	34564615	2021	FPLIASLAGNVVPKIFCKITKRC	B1OS	23	Linear	L	None	Free	Free	Antimicrobial	Odorrana schmackeri	H-838	Lung Cancer	MTT assay	IC₅₀ = 36.84 µM	24-h	Lung	None
6703	32812694	2021	FALGAVTKVLYKLFCLITRKC	Brevinin-1HY	21	Linear	L	None	Free	Free	Antimicrobial	Analogue of Brevinin-1H	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 3.583 µM	24-h	Colon	None
6702	32812694	2021	FALGAVTKVLYKLFCLITRKC	Brevinin-1HY	21	Linear	L	None	Free	Free	Antimicrobial	Analogue of Brevinin-1H	H-157	Lung Cancer	MTT assay	IC₅₀ = 2.811 µM	24-h	Lung	None
6701	32812694	2021	FALGAVTKVLYKLFCLITRKC	Brevinin-1HY	21	Linear	L	None	Free	Free	Antimicrobial	Analogue of Brevinin-1H	MDA-MB-435S	Breast Cancer	MTT assay	IC₅₀ = 2.243 µM	24-h	Breast	None
6700	32812694	2021	FALGAVTKVLYKLFCLITRKC	Brevinin-1HY	21	Linear	L	None	Free	Free	Antimicrobial	Analogue of Brevinin-1H	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 5.425 µM	24-h	Prostate	None
6699	32812694	2021	FALGAVTCLIRTKCKVLPKLF	Brevinin-1Ha	21	Linear	L	None	Free	Free	Antimicrobial	Analogue of Brevinin-1H	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 342.8 µM	24-h	Colon	None
6698	32812694	2021	FALGAVTCLIRTKCKVLPKLF	Brevinin-1Ha	21	Linear	L	None	Free	Free	Antimicrobial	Analogue of Brevinin-1H	H-157	Lung Cancer	MTT assay	IC₅₀ = 278.9 µM	24-h	Lung	None
6697	32812694	2021	FALGAVTCLIRTKCKVLPKLF	Brevinin-1Ha	21	Linear	L	None	Free	Free	Antimicrobial	Analogue of Brevinin-1H	MDA-MB-435S	Breast Cancer	MTT assay	IC₅₀ = 214.7 µM	24-h	Breast	None
6696	32812694	2021	FALGAVTCLIRTKCKVLPKLF	Brevinin-1Ha	21	Linear	L	None	Free	Free	Antimicrobial	Analogue of Brevinin-1H	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 186.9 µM	24-h	Prostate	None
6695	32812694	2021	FALGAVTKVLPKLFCLITRKC	Brevinin-1H	21	Linear	L	None	Free	Free	Antimicrobial	Amolops hainanensis	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 2.599 µM	24-h	Colon	None
6694	32812694	2021	FALGAVTKVLPKLFCLITRKC	Brevinin-1H	21	Linear	L	None	Free	Free	Antimicrobial	Amolops hainanensis	H-157	Lung Cancer	MTT assay	IC₅₀ = 3.37 µM	24-h	Lung	None
6693	32812694	2021	FALGAVTKVLPKLFCLITRKC	Brevinin-1H	21	Linear	L	None	Free	Free	Antimicrobial	Amolops hainanensis	MDA-MB-435S	Breast Cancer	MTT assay	IC₅₀ = 3.47 µM	24-h	Breast	None
6692	32812694	2021	FALGAVTKVLPKLFCLITRKC	Brevinin-1H	21	Linear	L	None	Free	Free	Antimicrobial	Amolops hainanensis	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 5.87 µM	24-h	Prostate	None
6679	34943741	2021	WLWKKIKNVAKAAGKAAKGAL	t-DPH1-6KW	21	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of t-DPH1	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 1499 μM	24-h	Brain	None
6678	34943741	2021	WLWKKIKNVAKAAGKAAKGAL	t-DPH1-6KW	21	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of t-DPH1	H-157	Lung Cancer	MTT assay	IC₅₀ = 427.3 μM	24-h	Lung	None
6677	34943741	2021	WLWKKIKNVAKAAGKAAKGAL	t-DPH1-6KW	21	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of t-DPH1	H-838	Lung Cancer	MTT assay	IC₅₀ = 180.8 μM	24-h	Lung	None
6676	34943741	2021	WLWKKIKNVAKAAGKAAKGAL	t-DPH1-6KW	21	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of t-DPH1	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 118.4 μM	24-h	Prostate	None
6675	34943741	2021	GLWKKIKNVAKAAGKAAKGAL	t-DPH1-6K	21	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of t-DPH1	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 593.7 μM	24-h	Brain	None
6674	34943741	2021	GLWKKIKNVAKAAGKAAKGAL	t-DPH1-6K	21	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of t-DPH1	H-157	Lung Cancer	MTT assay	IC₅₀ = 88.28 μM	24-h	Lung	None
6673	34943741	2021	GLWKKIKNVAKAAGKAAKGAL	t-DPH1-6K	21	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of t-DPH1	H-838	Lung Cancer	MTT assay	IC₅₀ = 186.1 μM	24-h	Lung	None
6672	34943741	2021	GLWKKIKNVAKAAGKAAKGAL	t-DPH1-6K	21	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of t-DPH1	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 55.65 μM	24-h	Prostate	None
6671	34943741	2021	GLWKKIKNVAKAAGKAALGAL	t-DPH1-5K	21	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of t-DPH1	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 2.679 μM	24-h	Brain	None
6670	34943741	2021	GLWKKIKNVAKAAGKAALGAL	t-DPH1-5K	21	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of t-DPH1	H-157	Lung Cancer	MTT assay	IC₅₀ = 1.546 μM	24-h	Lung	None
6669	34943741	2021	GLWKKIKNVAKAAGKAALGAL	t-DPH1-5K	21	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of t-DPH1	H-838	Lung Cancer	MTT assay	IC₅₀ = 1.796 μM	24-h	Lung	None
6668	34943741	2021	GLWKKIKNVAKAAGKAALGAL	t-DPH1-5K	21	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of t-DPH1	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 2.605 μM	24-h	Prostate	None
6667	34943741	2021	GLWKKIKNVAAAAGKAALGAL	t-DPH1-K4	21	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of t-DPH1	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 32.18 μM	24-h	Brain	None
6666	34943741	2021	GLWKKIKNVAAAAGKAALGAL	t-DPH1-K4	21	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of t-DPH1	H-157	Lung Cancer	MTT assay	IC₅₀ = 6.143 μM	24-h	Lung	None
6665	34943741	2021	GLWKKIKNVAAAAGKAALGAL	t-DPH1-K4	21	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of t-DPH1	H-838	Lung Cancer	MTT assay	IC₅₀ = 10.11 μM	24-h	Lung	None
6664	34943741	2021	GLWKKIKNVAAAAGKAALGAL	t-DPH1-K4	21	Linear	L	None	Amidation	Free	Antimicrobial	Analogue of t-DPH1	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 18.99 μM	24-h	Prostate	None
6663	34943741	2021	GLWSKIKNVAAAAGKAALGAL	t-DPH1	21	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa hypochondrialis	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 34.25 μM	24-h	Brain	None
6662	34943741	2021	GLWSKIKNVAAAAGKAALGAL	t-DPH1	21	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa hypochondrialis	H-157	Lung Cancer	MTT assay	IC₅₀ = 10.20 μM	24-h	Lung	None
6661	34943741	2021	GLWSKIKNVAAAAGKAALGAL	t-DPH1	21	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa hypochondrialis	H-838	Lung Cancer	MTT assay	IC₅₀ = 23.51 μM	24-h	Lung	None
6660	34943741	2021	GLWSKIKNVAAAAGKAALGAL	t-DPH1	21	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa hypochondrialis	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 14.67 μM	24-h	Prostate	None
6582	None	2020	klaklakklaklakGGRKKRRQRRR	D(KLAKLAK)2-TAT	25	Linear	Mix	None	Amidation	Acetylation	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 5.3 μM	24-h	Lung	None
6556	32443921	2020	FLGAILKIGHALAKTVLPMVTNAFKPKQ	Figainin 2	28	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Boana raniceps	MCF-7	Breast Cancer	MTT assay	IC₅₀= 15.3 µM	24-h	Breast	None
6555	32443921	2020	FLGAILKIGHALAKTVLPMVTNAFKPKQ	Figainin 2	28	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Boana raniceps	B16-F10	Skin Cancer	MTT assay	IC₅₀ = 12.8 µM	24-h	Skin	None
6551	32498425	2020	IWLTALKFLGKNLGKHLAKQQLSKL	LVTX-8	25	Linear	L	None	Amidation	Acetylation	Anticancer	Lycosa vittata	H-460	Lung Cancer	CCK-8 assay	IC₅₀ = 19 μM	24-h	Lung	None
6550	32498425	2020	IWLTALKFLGKNLGKHLAKQQLSKL	LVTX-8	25	Linear	L	None	Amidation	Acetylation	Anticancer	Lycosa vittata	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 8 μM	24-h	Lung	None
6546	32256172	2020	KAIGLVIPEIDGKLDGGAQRV	NMANF2	21	Linear	L	None	Free	Free	Anticancer	Staphylococcus hominis strain MANF2	HT-29	Colon Cancer	MTT assay	IC₅₀ = 48.9 µg/mL	NA	Colon	None
6545	32256172	2020	KAIGLVIPEIDGKLDGGAQRV	NMANF2	21	Linear	L	None	Free	Free	Anticancer	Staphylococcus hominis strain MANF2	A-549	Lung Cancer	MTT assay	IC₅₀ = 46.6 µg/mL	NA	Lung	None
6544	34508563	2020	FLGALFKVASKLVPAAICSISKKC	Brevinin-1HL	24	Linear	L	None	Free	Free	Antimicrobial	Hylarana latouchii	NCI-H23	Lung Cancer	MTT assay	IC₅₀ = 8.52 ± 1.02 μM	24-h	Lung	None
6527	32151609	2020	PWRIRIRRRRIRIRWPPWRIRIRR	R-DIM-LF11-334-LF11-334	24	Linear	L	None	Amidation	Free	Anticancer	Synthetic	WM164	Skin Cancer	MTS assay	LC₅₀ = 3.6 ± 0.7 μM	24-h	Skin	EP_2943215_B1
6526	32151609	2020	PWRIRIRRRRIRIRWPPWRIRIRR	R-DIM-LF11-334-LF11-334	24	Linear	L	None	Amidation	Free	Anticancer	Synthetic	SBcl2	Skin Cancer	MTS assay	LC₅₀ < 1 ± 0.1 μM	24-h	Skin	EP_2943215_B1
6525	32151609	2020	PWRIRIRRRRIRIRWPPWRIRIRR	R-DIM-LF11-334-LF11-334	24	Linear	L	None	Amidation	Free	Anticancer	Synthetic	A-375	Skin Cancer	MTS assay	LC₅₀ < 1 ± 0.1 μM	24-h	Skin	EP_2943215_B1
6512	32151609	2020	FQWQRNIRKVRPRVKRINRQWQF	R-DIM-P-LF11	23	Linear	L	None	Amidation	Free	Anticancer	Synthetic	WM164	Skin Cancer	MTS assay	LC₅₀ = 20.9 ± 3.9 μM	24-h	Skin	EP_2943215_B1
6511	32151609	2020	FQWQRNIRKVRPRVKRINRQWQF	R-DIM-P-LF11	23	Linear	L	None	Amidation	Free	Anticancer	Synthetic	SBcl2	Skin Cancer	MTS assay	LC₅₀ = 10.7 ± 0.2 μM	24-h	Skin	EP_2943215_B1
6510	32151609	2020	FQWQRNIRKVRPRVKRINRQWQF	R-DIM-P-LF11	23	Linear	L	None	Amidation	Free	Anticancer	Synthetic	A-375	Skin Cancer	MTS assay	LC₅₀ = 125.0 ± 16.8 μM	24-h	Skin	EP_2943215_B1
6505	32462055	2020	Aha-LRRLRRRLLRDWLKAFYDKVAEKLKEAF	AEM-28–2	28	Linear	L	Aha= α-aminohenoic acid	Amidation	Acetylation	Anti-inflammatory and Anticancer	Synthetic	OV-2008	Ovarian Cancer	MTS assay	~40% cell viability at 10 μg/mL	24-h	Ovary	None
6506	32462055	2020	Aha-LRRLRRRLLRDWLKAFYDKVAEKLKEAF	AEM-28–2	28	Linear	L	Aha= α-aminohenoic acid	Amidation	Acetylation	Anti-inflammatory and Anticancer	Synthetic	SK-OV-3	Ovarian Cancer	MTS assay	~30% cell viability at 10 μg/mL	24-h	Ovary	None
6507	32462055	2020	Aha-LRRLRRRLLRDWLKAFYDKVAEKLKEAF	AEM-28–2	28	Linear	L	Aha= α-aminohenoic acid	Amidation	Acetylation	Anti-inflammatory and Anticancer	Synthetic	CaCo-2	Colon Cancer	MTS assay	~60% cell viability at 10 μg/mL	24-h	Colon	None
6503	32462055	2020	Aha-LRRLRRRLLRDWLKAFYDKVAEKLKEAF	AEM-28–2	28	Linear	L	Aha= α-aminohenoic acid	Amidation	Acetylation	Anti-inflammatory and Anticancer	Synthetic	CT-26	Colorectal Cancer	MTS assay	~30% cell viability at 10 μg/mL	24-h	Colon	None
6504	32462055	2020	Aha-LRRLRRRLLRDWLKAFYDKVAEKLKEAF	AEM-28–2	28	Linear	L	Aha= α-aminohenoic acid	Amidation	Acetylation	Anti-inflammatory and Anticancer	Synthetic	ID8	Colon Cancer	MTS assay	~20% cell viability at 10 μg/mL	24-h	Colon	None
6501	32462055	2020	LRKLRKRLLRDWLKAFYDKVAEKLKEAF	AEM-28	28	Linear	L	None	Free	Free	Anti-inflammatory and Anticancer	Synthetic	CaCo-2	Colon Cancer	MTS assay	~70% cell viability at 10 μg/mL	24-h	Colon	None
6500	32462055	2020	LRKLRKRLLRDWLKAFYDKVAEKLKEAF	AEM-28	28	Linear	L	None	Free	Free	Anti-inflammatory and Anticancer	Synthetic	SK-OV-3	Ovarian Cancer	MTS assay	~50% cell viability at 10 μg/mL	24-h	Ovary	None
6499	32462055	2020	LRKLRKRLLRDWLKAFYDKVAEKLKEAF	AEM-28	28	Linear	L	None	Free	Free	Anti-inflammatory and Anticancer	Synthetic	OV-2008	Ovarian Cancer	MTS assay	~60% cell viability at 10 μg/mL	24-h	Ovary	None
6498	32462055	2020	LRKLRKRLLRDWLKAFYDKVAEKLKEAF	AEM-28	28	Linear	L	None	Free	Free	Anti-inflammatory and Anticancer	Synthetic	ID8	Colon Cancer	MTS assay	~60% cell viability at 10 μg/mL	24-h	Colon	None
6497	32462055	2020	LRKLRKRLLRDWLKAFYDKVAEKLKEAF	AEM-28	28	Linear	L	None	Free	Free	Anti-inflammatory and Anticancer	Synthetic	CT-26	Colorectal Cancer	MTS assay	~20% cell viability at 10 μg/mL	24-h	Colon	None
6496	32126228	2020	GALFLGFLGAAGSTMGAWSQPKKKRKV	MPG	27	Linear	L	None	Cysteamidation	Acetylation	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 15.8 μM	24-h	Blood	None
6491	32126228	2020	GIGRWLHSARRFGRAFVGEIMNS	MagaininF5W-Arg	23	Linear	L	None	Free	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 16.8 μM	24-h	Blood	None
6490	32126228	2020	GIGKWLHSAKKFGKAFVGEIMNS	MagaininF5W-Lys	23	Linear	L	None	Free	Free	Antimicrobial	Synthetic	Jurkat	Blood Cancer	MTT assay	IC₅₀ = 16.8 μM	24-h	Blood	None
6451	32582642	2020	ALWKDMLKGIGKLAGKAALGAVKTLV	Dermaseptin-PP	26	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa palliata	H-157	Lung Cancer	LDH leakage assay	80% LDH release at 10−4 M	24-h	Lung	None
6450	32582642	2020	ALWKDMLKGIGKLAGKAALGAVKTLV	Dermaseptin-PP	26	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa palliata	U-251	Brain Tumor	MTT assay	IC₅₀ = 2.47 μM	24-h	Brain	None
6449	32582642	2020	ALWKDMLKGIGKLAGKAALGAVKTLV	Dermaseptin-PP	26	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa palliata	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 4.15 μM	24-h	Prostate	None
6448	32582642	2020	ALWKDMLKGIGKLAGKAALGAVKTLV	Dermaseptin-PP	26	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa palliata	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 2.92 μM	24-h	Breast	None
6447	32582642	2020	ALWKDMLKGIGKLAGKAALGAVKTLV	Dermaseptin-PP	26	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa palliata	H-157	Lung Cancer	MTT assay	IC₅₀ = 1.55 μM	24-h	Lung	None
6408	32347293	2020	FLGALFKVASKLVPAAICSISKKC	Brevinin-1GHd	24	Linear	L	None	Free	Free	Antimicrobial	Hylarana guentheri	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 9.854 µM	24-h	Prostate	None
6407	32347293	2020	FLGALFKVASKLVPAAICSISKKC	Brevinin-1GHd	24	Linear	L	None	Free	Free	Antimicrobial	Hylarana guentheri	MDA-MB-435S	Skin Cancer	MTT assay	IC₅₀ = 1.197 µM	24-h	Skin	None
6406	32347293	2020	FLGALFKVASKLVPAAICSISKKC	Brevinin-1GHd	24	Linear	L	None	Free	Free	Antimicrobial	Hylarana guentheri	U-251-MG	Brain Tumor	MTT assay	IC₅₀ = 7.985 µM	24-h	Brain	None
6405	32347293	2020	FLGALFKVASKLVPAAICSISKKC	Brevinin-1GHd	24	Linear	L	None	Free	Free	Antimicrobial	Hylarana guentheri	NCI-H-157	Lung Cancer	MTT assay	IC₅₀ = 2.987 µM	24-h	Lung	None
6261	31276399	2019	RGWFRAMRSIARFIARERLRGHL	R-Lycosin I derivative 8b	23	Linear	L	None	Free	3′-Aminopropyl Beta-D-Galactopyranoside	Anticancer	Monosaccharide Analogue of Anticancer Peptide R-Lycosin-I	PC-3	Prostate Cancer	CCK-8 assay	IC₅₀ = 4.9 ± 0.2 µM	24-h	Prostate	None
6259	31276399	2019	RGWFRAMRSIARFIARERLRGHL	R-Lycosin I derivative 8b	23	Linear	L	None	Free	3′-Aminopropyl Beta-D-Galactopyranoside	Anticancer	Monosaccharide Analogue of Anticancer Peptide R-Lycosin-I	H-1437	Lung Cancer	CCK-8 assay	IC₅₀ = 5.3 ± 0.2 µM	24-h	Lung	None
6260	31276399	2019	RGWFRAMRSIARFIARERLRGHL	R-Lycosin I derivative 8b	23	Linear	L	None	Free	3′-Aminopropyl Beta-D-Galactopyranoside	Anticancer	Monosaccharide Analogue of Anticancer Peptide R-Lycosin-I	HGC-27	Gastric Cancer	CCK-8 assay	IC₅₀ = 5.3 ± 0.2 µM	24-h	Not Available	None
6257	31276399	2019	RGWFRAMRSIARFIARERLRGHL	R-Lycosin I derivative 8b	23	Linear	L	None	Free	3′-Aminopropyl Beta-D-Galactopyranoside	Anticancer	Monosaccharide Analogue of Anticancer Peptide R-Lycosin-I	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 7.0 ± 0.3 µM	24-h	Lung	None
6258	31276399	2019	RGWFRAMRSIARFIARERLRGHL	R-Lycosin I derivative 8b	23	Linear	L	None	Free	3′-Aminopropyl Beta-D-Galactopyranoside	Anticancer	Monosaccharide Analogue of Anticancer Peptide R-Lycosin-I	H-460	Lung Cancer	CCK-8 assay	IC₅₀ = 4.9 ± 0.9 µM	24-h	Lung	None
6255	31276399	2019	RGWFRAMRSIARFIARERLRGHL	R-Lycosin I derivative 8a	23	Linear	L	None	Free	3′-Aminopropyl-D-glucopyranoside	Anticancer	Monosaccharide Analogue of Anticancer Peptide R-Lycosin-I	PC-3	Prostate Cancer	CCK-8 assay	IC₅₀ = 6.9 ± 0.4 µM	24-h	Prostate	None
6256	31276399	2019	RGWFRAMRSIARFIARERLRGHL	R-Lycosin I derivative 8b	23	Linear	L	None	Free	3′-Aminopropyl Beta-D-Galactopyranoside	Anticancer	Monosaccharide Analogue of Anticancer Peptide R-Lycosin-I	MDA-MB-231	Breast Cancer	CCK-8 assay	IC₅₀ = 6.0 ± 0.2 µM	24-h	Breast	None
6254	31276399	2019	RGWFRAMRSIARFIARERLRGHL	R-Lycosin I derivative 8a	23	Linear	L	None	Free	3′-Aminopropyl-D-glucopyranoside	Anticancer	Monosaccharide Analogue of Anticancer Peptide R-Lycosin-I	HGC-27	Gastric Cancer	CCK-8 assay	IC₅₀ = 12.6 ± 0.6 µM	24-h	Not Available	None
6253	31276399	2019	RGWFRAMRSIARFIARERLRGHL	R-Lycosin I derivative 8a	23	Linear	L	None	Free	3′-Aminopropyl-D-glucopyranoside	Anticancer	Monosaccharide Analogue of Anticancer Peptide R-Lycosin-I	H-1437	Lung Cancer	CCK-8 assay	IC₅₀ = 13.0 ± 0.2 µM	24-h	Lung	None
6252	31276399	2019	RGWFRAMRSIARFIARERLRGHL	R-Lycosin I derivative 8a	23	Linear	L	None	Free	3′-Aminopropyl-D-glucopyranoside	Anticancer	Monosaccharide Analogue of Anticancer Peptide R-Lycosin-I	H-460	Lung Cancer	CCK-8 assay	IC₅₀ = 8.5 ± 0.4 µM	24-h	Lung	None
6250	31276399	2019	RGWFRAMRSIARFIARERLRGHL	R-Lycosin I derivative 8a	23	Linear	L	None	Free	3′-Aminopropyl-D-glucopyranoside	Anticancer	Monosaccharide Analogue of Anticancer Peptide R-Lycosin-I	MDA-MB-231	Breast Cancer	CCK-8 assay	IC₅₀ = 10.1 ± 0.2 µM	24-h	Breast	None
6251	31276399	2019	RGWFRAMRSIARFIARERLRGHL	R-Lycosin I derivative 8a	23	Linear	L	None	Free	3′-Aminopropyl-D-glucopyranoside	Anticancer	Monosaccharide Analogue of Anticancer Peptide R-Lycosin-I	A-549	Lung Cancer	CCK-8 assay	IC₅₀ = 9.6 ± 0.3 µM	24-h	Lung	None
6227	31161686	2019	GIXXWLHSAXXFGXXFVXXIZNS	8Dap	23	Linear	L	X = 2,3-Diaminopropionic Acid , Z = norleucine	Amidation	Free	Anticancer	Synthetic	PANC-1	Pancreatic Cancer	WST-1 assay	EC₅₀ = 61.4±0.7 μM	24-h	Pancreas	None
6226	31161686	2019	GIKXWLHSAXXFGXKFVXXIZNS	6Dap	23	Linear	L	X = 2,3-Diaminopropionic Acid , Z = norleucine	Amidation	Free	Anticancer	Synthetic	PANC-1	Pancreatic Cancer	WST-1 assay	EC₅₀ = 55.0±1.8 μM	24-h	Pancreas	None
6225	31161686	2019	GIKXWLHSAXKFGXKFVKXIZNS	4Dap	23	Linear	L	X = 2,3-Diaminopropionic Acid , Z = norleucine	Amidation	Free	Anticancer	Synthetic	PANC-1	Pancreatic Cancer	WST-1 assay	EC₅₀ = 35.7±0.7 μM	24-h	Pancreas	None
6224	31161686	2019	GIKXWLHSAKKFGXKFVKKIZNS	2Dap	23	Linear	L	X = 2,3-Diaminopropionic Acid , Z = norleucine	Amidation	Free	Anticancer	Synthetic	PANC-1	Pancreatic Cancer	WST-1 assay	EC₅₀ = 14.7±0.6 μM	24-h	Pancreas	None
6223	31161686	2019	GIKKWLHSAKKFGKKFVKKIZNS	0Dap	23	Linear	L	Z = norleucine	Amidation	Free	Anticancer	Synthetic	PANC-1	Pancreatic Cancer	WST-1 assay	EC₅₀ = 9.1±0.3 μM	24-h	Pancreas	None
6207	None	2019	CQYSVNPKIKRFELYFKGRMW	LPSBD-0	21	Linear	L	None	Free	Free	Anticancer	Synthetic	THP-1	Leukemia Cancer	Not Available	Not Available	24-h	Blood	None
6206	None	2019	IWSFLIKAATKLLPSLFGGGKKDS	SMP24	24	Linear	L	None	Free	Free	Antimicrobial	Scorpio maurus palmatus	KG-1a	Leukemia Cancer	LDH leakage assay	Fig 2	NA	Blood	None
6205	None	2019	IWSFLIKAATKLLPSLFGGGKKDS	SMP24	24	Linear	L	None	Free	Free	Antimicrobial	Scorpio maurus palmatus	CCRF-CEM	Leukemia Cancer	LDH leakage assay	Fig 2	NA	Blood	None
6204	None	2019	IWSFLIKAATKLLPSLFGGGKKDS	SMP24	24	Linear	L	None	Free	Free	Antimicrobial	Scorpio maurus palmatus	KG-1a	Leukemia Cancer	CellTiter-Glo assay	LC₅₀ = 16 ± 1.3 µg/mL	24-h	Blood	None
6203	None	2019	IWSFLIKAATKLLPSLFGGGKKDS	SMP24	24	Linear	L	None	Free	Free	Antimicrobial	Scorpio maurus palmatus	CCRF-CEM	Leukemia Cancer	CellTiter-Glo assay	LC₅₀ = 16 ± 0.9 µg/mL	24-h	Blood	None
6198	31252047	2019	SRSSRAGLQFPVGRIHRLLRK	Fi-Histin_1-21	21	Linear	L	None	Amidation	Acetylation	Antimicrobial	Fenneropenaeus indicus	Hep-2	Liver Cancer	XTT assay	IC₅₀ = 31.274 ± 24.531 μM	24-h	Liver	None
6197	31252047	2019	SRSSRAGLQFPVGRIHRLLRK	Fi-Histin_1-21	21	Linear	L	None	Amidation	Acetylation	Antimicrobial	Fenneropenaeus indicus	NCI-H-460	Lung Cancer	XTT assay	IC₅₀ = 22.670 ± 13.939 μM	24-h	Lung	None
6196	30377840	2019	MTVVLLLIVLPLLGGVHSSGIL	TC22	22	Linear	L	None	Free	Free	Anticancer	Tribolium castaneum	MCF-7	Breast Cancer	MTT assay	Fig 4a	24-h	Breast	None
6195	30377840	2019	MTVVLLLIVLPLLGGVHSSGIL	TC22	22	Linear	L	None	Free	Free	Anticancer	Tribolium castaneum	HeLa	Cervical Cancer	MTT assay	Fig 4a	24-h	Cervix	None
6194	30449002	2019	IWLTALKFLGKNLGKLAKQQLAKL	LyeTx-I-b	24	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	SH-SY5Y	Brain Tumor	MTT/Resazurin dye assay	IC₅₀ = 93.80 ± 2.17 µM	48-h	Brain	None
6193	30449002	2019	IWLTALKFLGKNLGKLAKQQLAKL	LyeTx-I-b	24	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	U-373-MG	Brain Tumor	MTT/Resazurin dye assay	IC₅₀ = 20.94 ± 5.18 µM	48-h	Brain	None
6192	30449002	2019	IWLTALKFLGKNLGKLAKQQLAKL	LyeTx-I-b	24	Linear	L	None	Amidation	Acetylation	Antimicrobial	Synthetic	U-87-MG	Brain Tumor	MTT/Resazurin dye assay	IC₅₀ = 29.20 ± 7.96 µM	48-h	Brain	None
6190	30717309	2019	FIHHIIGGLFSAGKAIHRLIRRRRR	TP4	25	Linear	L	None	Free	Free	Antimicrobial	Oreochromis niloticus	U-251	Brain Tumor	MTS/PMS assay	LD₅₀ = 20 μg/mL	24-h	Brain	None
6189	30717309	2019	FIHHIIGGLFSAGKAIHRLIRRRRR	TP4	25	Linear	L	None	Free	Free	Antimicrobial	Oreochromis niloticus	U87-MG	Brain Tumor	MTS/PMS assay	LD₅₀ = 20 μg/mL	24-h	Brain	None
6187	31633400	2019	FALGAVTKLLPSLLCMITRKC	HN-1	21	Linear	L	None	Free	Free	Host Defense	Amolops hainanensis	PC-3	Prostate Cancer	MTT assay	Not Available	12-h	Prostate	None
6188	31633400	2019	FALGAVTKLLPSLLCMITRKC	HN-1	21	Linear	L	None	Free	Free	Host Defense	Amolops hainanensis	4T1	Breast Cancer	MTT assay	Not Available	12-h	Breast	None
6186	31633400	2019	FALGAVTKLLPSLLCMITRKC	HN-1	21	Linear	L	None	Free	Free	Host Defense	Amolops hainanensis	MDA-MB-453	Breast Cancer	MTT assay	Not Available	12-h	Breast	None
6185	31633400	2019	FALGAVTKLLPSLLCMITRKC	HN-1	21	Linear	L	None	Free	Free	Host Defense	Amolops hainanensis	SGC-7901	Stomach Cancer	MTT assay	Not Available	12-h	Stomach	None
6184	31633400	2019	FALGAVTKLLPSLLCMITRKC	HN-1	21	Linear	L	None	Free	Free	Host Defense	Amolops hainanensis	A-549	Lung Cancer	MTT assay	Not Available	12-h	Lung	None
6183	31633400	2019	FALGAVTKLLPSLLCMITRKC	HN-1	21	Linear	L	None	Free	Free	Host Defense	Amolops hainanensis	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 6.9 μM	12-h	Breast	None
6181	31226350	2019	GRFKRFRKKFKKLFKKLSPVIPLLHL	BMAP-27	27	Linear	L	None	Amidation	Free	Antimicrobial	Cathelicidin	MDA-MB-361	Breast Cancer	MTT assay	IC₅₀ = 4.2 μM	48-h	Breast	None
6182	31226350	2019	GRFKRFRKKFKKLFKKLSPVIPLLHL	BMAP-27	27	Linear	L	None	Amidation	Free	Antimicrobial	Cathelicidin	A-549	Lung Cancer	MTT assay	IC₅₀ = 5.3 μM	48-h	Lung	None
6159	30885438	2019	IKLSPETKDNLKKVLKGAIKGAIAVAKMV	Hymenochirin - 1B	29	Linear	L	None	Amidation	Free	Host Defense Peptide	Hymenochirus boettgeri	HepG-2	Liver Cancer	MTT assay	30% cell viability at 20 μM	24-h	Liver	None
6158	30885438	2019	IKLSPETKDNLKKVLKGAIKGAIAVAKMV	Hymenochirin - 1B	29	Linear	L	None	Amidation	Free	Host Defense Peptide	Hymenochirus boettgeri	NCI-H-460	Lung Cancer	MTT assay	10% cell viability at 50 μM	24-h	Lung	None
6157	30885438	2019	IKLSPETKDNLKKVLKGAIKGAIAVAKMV	Hymenochirin - 1B	29	Linear	L	None	Amidation	Free	Host Defense Peptide	Hymenochirus boettgeri	A-549	Lung Cancer	MTT assay	40% cell viability at 10 μM	24-h	Lung	None
6156	30885438	2019	IKLSPETKDNLKKVLKGAIKGAIAVAKMV	Hymenochirin - 1B	29	Linear	L	None	Amidation	Free	Host Defense Peptide	Hymenochirus boettgeri	NCI-H-1299	Lung Cancer	MTT assay	20% cell viability at 10 μM	24-h	Lung	None
6103	31426323	2019	ALWKTLLKHVGKAAGKAALNAVTDMVNQ	Dermaseptin-PS4	28	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa sauvagii	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 0.67 µM	24-h	Breast	None
6102	31426323	2019	ALWKTLLKHVGKAAGKAALNAVTDMVNQ	Dermaseptin-PS4	28	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa sauvagii	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 0.44 μM	24-h	Prostate	None
6101	31426323	2019	ALWKTLLKHVGKAAGKAALNAVTDMVNQ	Dermaseptin-PS4	28	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa sauvagii	H-157	Lung Cancer	MTT assay	IC₅₀ = 0.19 μM	24-h	Lung	None
6100	31426323	2019	ALWKTLLKHVGKAAGKAALNAVTDMVNQ	Dermaseptin-PS4	28	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa sauvagii	MDA-MB-435S	Breast Cancer	MTT assay	IC₅₀ = 0.11 μM	24-h	Breast	None
6099	31426323	2019	ALWKTLLKHVGKAAGKAALNAVTDMVNQ	Dermaseptin-PS4	28	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa sauvagii	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 57.66 nM	24-h	Brain	None
6098	30789695	2019	IKLSPETKDNLKKVLKGAIKGAIAVAKMV	H-0	29	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Hymenochirus boettgeri	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 8.07 ± 0.21 μM	48-h	Liver	None
6097	30789695	2019	IKLSPETKDNLKKVLKGAIKGAIAVAKMV	H-0	29	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Hymenochirus boettgeri	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 12.76 ± 0.43 μM	48-h	Colon	None
6095	30789695	2019	IKLSPS₅TKDS₅LKKVLKGAIKGAIAVAKMV	H-2	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 1.60 ± 0.24 μM	48-h	Liver	None
6096	30789695	2019	IKLSPETKDNLKKVLKGAIKGAIAVAKMV	H-0	29	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Hymenochirus boettgeri	A-549	Lung Cancer	MTT assay	IC₅₀ = 15.22 ± 0.21 μM	48-h	Lung	None
6094	30789695	2019	IKLSPS₅TKDS₅LKKVLKGAIKGAIAVAKMV	H-2	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 3.54 ± 0.72 μM	48-h	Colon	None
6093	30789695	2019	IKLSPS₅TKDS₅LKKVLKGAIKGAIAVAKMV	H-2	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 4.26 ± 0.52 μM	48-h	Lung	None
6091	30789695	2019	IKLSPETKDNLKKVLKGS₅IKGS₅IAVAKMV	H-5	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 4.16 ± 0.21 μM	48-h	Colon	None
6092	30789695	2019	IKLSPETKDNLKKVLKGS₅IKGS₅IAVAKMV	H-5	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 2.82 ± 0.23 μM	48-h	Liver	None
6090	30789695	2019	IKLSPETKDNLKKVLKGS₅IKGS₅IAVAKMV	H-5	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 7.35 ± 0.22 μM	48-h	Lung	None
6089	30789695	2019	IKLSPS₅TKDS₅LKKVLKGS₅IKGS₅IAVAKMV	H-10	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 1.50 ± 0.21 μM	48-h	Liver	None
6088	30789695	2019	IKLSPS₅TKDS₅LKKVLKGS₅IKGS₅IAVAKMV	H-10	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 3.51 ± 0.37 μM	48-h	Colon	None
6087	30789695	2019	IKLSPS₅TKDS₅LKKVLKGS₅IKGS₅IAVAKMV	H-10	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 3.59 ± 0.12 μM	48-h	Lung	None
6086	30789695	2019	IKLSKKTKKNLKKVLKGAIKGAIAVAKMV	H-14	29	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 4.54 ± 0.25 μM	48-h	Liver	None
6085	30789695	2019	IKLSKKTKKNLKKVLKGAIKGAIAVAKMV	H-14	29	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 1.841 ± 0.34 μM	48-h	Colon	None
6084	30789695	2019	IKLSKKTKKNLKKVLKGAIKGAIAVAKMV	H-14	29	Linear	L	None	Amidation	Free	Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 0.98 ± 0.11 μM	48-h	Lung	None
6082	30789695	2019	IKLSKS₅TKDS₅LKKVLKGAIKGAIAVAKMV	H-15	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 2.95 ± 0.25 μM	48-h	Colon	None
6083	30789695	2019	IKLSKS₅TKDS₅LKKVLKGAIKGAIAVAKMV	H-15	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 2.20 ± 0.27 μM	48-h	Liver	None
6081	30789695	2019	IKLSKS₅TKDS₅LKKVLKGAIKGAIAVAKMV	H-15	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 2.26 ± 0.24 μM	48-h	Lung	None
6079	30789695	2019	IKLSPS₅TKKS₅LKKVLKGAIKGAIAVAKMV	H-16	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 2.65 ± 0.35 μM	48-h	Colon	None
6080	30789695	2019	IKLSPS₅TKKS₅LKKVLKGAIKGAIAVAKMV	H-16	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 3.14 ± 0.46 μM	48-h	Liver	None
6078	30789695	2019	IKLSPS₅TKKS₅LKKVLKGAIKGAIAVAKMV	H-16	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 1.85 ± 0.31 μM	48-h	Lung	None
6076	30789695	2019	IKLSKS₅TKKS₅LKKVLKGAIKGAIAVAKMV	H-17	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 1.49 ± 0.45 μM	48-h	Colon	None
6077	30789695	2019	IKLSKS₅TKKS₅LKKVLKGAIKGAIAVAKMV	H-17	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 1.64 ± 0.47 μM	48-h	Liver	None
6074	30789695	2019	IKLSKKTKKNLKKVLKGS₅IKGS₅IAVAKMV	H-18	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 1.61 ± 0.21 μM	48-h	Liver	None
6075	30789695	2019	IKLSKS₅TKKS₅LKKVLKGAIKGAIAVAKMV	H-17	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 0.96 ± 0.33 μM	48-h	Lung	None
6072	30789695	2019	IKLSKKTKKNLKKVLKGS₅IKGS₅IAVAKMV	H-18	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 0.89 ± 0.21 μM	48-h	Lung	None
6073	30789695	2019	IKLSKKTKKNLKKVLKGS₅IKGS₅IAVAKMV	H-18	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 1.11 ± 0.21 μM	48-h	Colon	None
6071	30789695	2019	IKLSKETKKNLKKVLKGS₅IKGS₅IAVAKMV	H-19	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 1.64 ± 0.36 μM	48-h	Liver	None
6069	30789695	2019	IKLSKETKKNLKKVLKGS₅IKGS₅IAVAKMV	H-19	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 1.00 ± 0.36 μM	48-h	Lung	None
6070	30789695	2019	IKLSKETKKNLKKVLKGS₅IKGS₅IAVAKMV	H-19	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 1.78 ± 0.35 μM	48-h	Colon	None
6068	30789695	2019	IKLSPS₅TKKS₅LKKVLKGS₅IKGS₅IAVAKMV	H-20	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 4.93 ± 0.53 μM	48-h	Liver	None
6067	30789695	2019	IKLSPS₅TKKS₅LKKVLKGS₅IKGS₅IAVAKMV	H-20	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 2.63 ± 0.35 μM	48-h	Colon	None
6066	30789695	2019	IKLSPS₅TKKS₅LKKVLKGS₅IKGS₅IAVAKMV	H-20	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 2.10 ± 0.32 μM	48-h	Lung	None
6065	30789695	2019	IKLSKS₅TKKS₅LKKVLKGS₅IKGS₅IAVAKMV	H-21	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 1.50 ± 0.28 μM	48-h	Liver	None
6063	30789695	2019	IKLSKS₅TKKS₅LKKVLKGS₅IKGS₅IAVAKMV	H-21	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 3.26 ± 0.36 μM	48-h	Lung	None
6064	30789695	2019	IKLSKS₅TKKS₅LKKVLKGS₅IKGS₅IAVAKMV	H-21	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 3.05 ± 0.21 μM	48-h	Colon	None
6062	30789695	2019	IKLSKKTKKNLKKVLKGS₅IKGS₅IAVAKMV	H-57	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 2.13 ± 0.07 μM	48-h	Liver	None
6061	30789695	2019	IKLSKKTKKNLKKVLKGS₅IKGS₅IAVAKMV	H-57	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 1.29 ± 0.08 μM	48-h	Colon	None
6060	30789695	2019	IKLSKKTKKNLKKVLKGS₅IKGS₅IAVAKMV	H-57	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 0.62 ± 0.12 μM	48-h	Lung	None
6058	30789695	2019	IKLSKKTKKNLKKVLKGS₅IKGS₅IAVAKMV	H-58	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 1.29 ± 0.08 μM	48-h	Colon	None
6059	30789695	2019	IKLSKKTKKNLKKVLKGS₅IKGS₅IAVAKMV	H-58	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 2.13 ± 0.07 μM	48-h	Liver	None
6057	30789695	2019	IKLSKKTKKNLKKVLKGS₅IKGS₅IAVAKMV	H-58	29	Cyclic	L	S₅ = (S)-N-Fmoc-2-(4′-pentenyl)alanine	Amidation	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 0.62 ± 0.12 μM	48-h	Lung	None
6056	30789695	2019	IKLSKETKDNLKKVLKGAIKGAIAVAKMV	[P5K]Hymenochirin-1B	29	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 4.28 ± 0.38 μM	48-h	Liver	None
6055	30789695	2019	IKLSKETKDNLKKVLKGAIKGAIAVAKMV	[P5K]Hymenochirin-1B	29	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 8.09 ± 0.40 μM	48-h	Colon	None
6054	30789695	2019	IKLSKETKDNLKKVLKGAIKGAIAVAKMV	[P5K]Hymenochirin-1B	29	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 2.35 ± 0.31 μM	48-h	Lung	None
6053	30789695	2019	IKLSPETKKNLKKVLKGAIKGAIAVAKMV	[D9K]Hymenochirin-1B	29	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 4.96 ± 0.43 μM	48-h	Liver	None
6052	30789695	2019	IKLSPETKKNLKKVLKGAIKGAIAVAKMV	[D9K]Hymenochirin-1B	29	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 6.50 ± 0.32 μM	48-h	Colon	None
6051	30789695	2019	IKLSPETKKNLKKVLKGAIKGAIAVAKMV	[D9K]Hymenochirin-1B	29	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 1.82 ± 0.23 μM	48-h	Lung	None
6050	30789695	2019	IKLSKETKKNLKKVLKGAIKGAIAVAKMV	[P5K,D9K]Hymenochirin-1B	29	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 2.46 ± 0.32 μM	48-h	Liver	None
6049	30789695	2019	IKLSKETKKNLKKVLKGAIKGAIAVAKMV	[P5K,D9K]Hymenochirin-1B	29	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	HCT-116	Colon Cancer	MTT assay	IC₅₀ = 4.93 ± 0.51 μM	48-h	Colon	None
6048	30789695	2019	IKLSKETKKNLKKVLKGAIKGAIAVAKMV	[P5K,D9K]Hymenochirin-1B	29	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 1.17 ± 0.23 μM	48-h	Lung	None
6047	31635388	2019	GLWSKIKKAAKTAGKAALGFVNKMV	K8, 23-DPT9	25	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	PANC-1	Pancreatic Cancer	MTT assay	IC₅₀ = 11.17 µM	24-h	Pancreas	None
6046	31635388	2019	GLWSKIKKAAKTAGKAALGFVNKMV	K8, 23-DPT9	25	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 9.97 µM	24-h	Prostate	None
6045	31635388	2019	GLWSKIKKAAKTAGKAALGFVNKMV	K8, 23-DPT9	25	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	H-157	Lung Cancer	MTT assay	IC₅₀ = 9.88 µM	24-h	Lung	None
6044	31635388	2019	GLWSKIKKAAKTAGKAALGFVNKMV	K8, 23-DPT9	25	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 18.51 µM	24-h	Brain	None
6043	31635388	2019	GLWSKIKKAAKTAGKAALGFVNKMV	K8, 23-DPT9	25	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 8.64 µM	24-h	Breast	None
6042	31635388	2019	GLWSKIKDAAKTAGKAALGFVNEMV	Dermaseptin-PT9	25	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa tarsius	PANC-1	Pancreatic Cancer	MTT assay	IC₅₀ = 28.95 µM	24-h	Pancreas	None
6041	31635388	2019	GLWSKIKDAAKTAGKAALGFVNEMV	Dermaseptin-PT9	25	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa tarsius	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 21.78 µM	24-h	Prostate	None
6040	31635388	2019	GLWSKIKDAAKTAGKAALGFVNEMV	Dermaseptin-PT9	25	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa tarsius	H-157	Lung Cancer	MTT assay	IC₅₀ = 25.51 µM	24-h	Lung	None
6039	31635388	2019	GLWSKIKDAAKTAGKAALGFVNEMV	Dermaseptin-PT9	25	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa tarsius	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 49.51 µM	24-h	Brain	None
6038	31635388	2019	GLWSKIKDAAKTAGKAALGFVNEMV	Dermaseptin-PT9	25	Linear	L	None	Amidation	Free	Antimicrobial	Phyllomedusa tarsius	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 7.44 µM	24-h	Breast	None
6026	29043494	2018	KILRGVCKKIMRpFLRRISKDILTGKK	NK-pro	27	Linear	Mix	None	Amidated	Free	Antimicrobial	Synthetic analog of NK-2	HL-60	Leukemia Cancer	MTT assay	IC₅₀ = 26.1 μM	24-h	Blood	None
6025	29043494	2018	KILRGVCKKIMRpFLRRISKDILTGKK	NK-pro	27	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analog of NK-2	T-24	Bladder Cancer	MTT assay	IC₅₀ = 33.0 μM	24-h	Bladder	None
6024	29043494	2018	KILRGVCKKIMRpFLRRISKDILTGKK	NK-pro	27	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analog of NK-2	EJ	Bladder Cancer	MTT assay	IC₅₀ = 23.3 μM	24-h	Bladder	None
6023	29043494	2018	KILRGVCKKIMRpFLRRISKDILTGKK	NK-pro	27	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analog of NK-2	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 9.3 μM	24-h	Prostate	None
6022	29043494	2018	KILpGVCKKIMRpFLRRISKDILTGKK	NK-dpro	27	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analog of NK-2	HL-60	Leukemia Cancer	MTT assay	IC₅₀ = 48.4 μM	24-h	Blood	None
6021	29043494	2018	KILpGVCKKIMRpFLRRISKDILTGKK	NK-dpro	27	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analog of NK-2	T-24	Bladder Cancer	MTT assay	IC₅₀ = 39.6 μM	24-h	Bladder	None
6020	29043494	2018	KILpGVCKKIMRpFLRRISKDILTGKK	NK-dpro	27	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analog of NK-2	EJ	Bladder Cancer	MTT assay	IC₅₀ = 28.7 μM	24-h	Bladder	None
6019	29043494	2018	KILpGVCKKIMRpFLRRISKDILTGKK	NK-dpro	27	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analog of NK-2	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 9.6 μM	24-h	Prostate	None
6018	30183307	2018	RGWFRAMRSIARFIARERLREHL	R-C16	23	Linear	L	None	Amidation	Fatty acid :C16H31O	Anticancer	R-Lycosin-I	A-549	Lung Cancer	CCK-8 assay	IC₅₀ ~ 5 µM	24-h	Lung	None
5984	29667478	2018	ytrdlvygdparpgiqgtgtf	D-FP21-PEG-PEI/pGRO-α	21	Linear	D	conjugated to polyethylenimine (PEI) and methoxy polyethylene glycol (mPEG)	Free	Free	Anti-caner, anti-proliferative, anti-tumor	Synthetic	HO-8910	Ovarian Cancer	CCK-8 assay	IC₅₀ = 21.6 μg/mL	24-h	Ovary	None
5983	29667478	2018	YTRDLVYGDPARPGIQGTGTF	L-FP21-PEG-PEI/pGRO-α	21	Linear	L	conjugated to polyethylenimine (PEI) and methoxy polyethylene glycol (mPEG)	Free	Free	Anti-caner, anti-proliferative, anti-tumor	Synthetic	HO-8910	Ovarian Cancer	CCK-8 assay	IC₅₀ = 23.4 μg/mL	24-h	Ovary	None
5974	29757646	2018	GIPCGESCVWIPCISSAIGCSCKNKVCYRN	CyO4	30	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial,Cytotoxic	Viola odorata	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ = 9.8 μM	24-h	Breast	None
5973	29757646	2018	GIPCAESCVFIPCVTAILGCSCKDVCYN	Poca B	28	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial,Cytotoxic	Pombalia calceolaria	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ = 2.7 μM	24-h	Breast	None
5972	29757646	2018	GLPCAESCVFIPCTITAILGCSCRDRVCYD	Poca A	30	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial,Cytotoxic	Pombalia calceolaria	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ = 1.8 μM	24-h	Breast	None
5971	29301308	2018	FIHHIIGGLFSAGKAIHRLIRRRRR	MSP-4	25	Linear	L	None	Free	Free	Antimicrobial	Oreochromis niloticus	MG-63	Bone Cancer	MTT assay	Cell viability = 26.78 ± 1.75% at 10 µM	24-h	Bone	None
5970	30123940	2018	Ahx-(KAVPIAQKE)GG(KRRRRRRRRE)	SmacN7-Arg8 fused peptide P7	22	Cyclic	L	Ahx = aminohexanoic acid; Lactam Bridge between K2 and E10 and between K13 and E22	Amidation	Free	Anticancer	Synthetic	U-266	Skin Cancer	Cell Titer Blue Cell Viability assay	Cell viability < 50% at 50 μM	48-h	Skin	None
5963	29800725	2018	GIGAVLKKLTTGLKALISWIKRKRQQ	MEL-Pep	26	Linear	L	None	Amidation	Free	Anticancer	Synthetic analog of Melittin	BEL-7402/5-FU	Liver Cancer	CCK-8 assay	IC₅₀ = 4.36 μM	24-h	Liver	None
5943	29993185	2018	NDADKDEMQSVYRGKANDDNSRGSKTNHRF	Peptide10 Gonearrestide	30	Linear	L	None	Free	Free	Anticancer	Androctonus mauritanicus	U-251	Brain tumor	MTT assay	Not Available	24-h	Brain	None
5942	29993185	2018	NDADKDEMQSVYRGKANDDNSRGSKTNHRF	Peptide10 Gonearrestide	30	Linear	L	None	Free	Free	Anticancer	Androctonus mauritanicus	Dks8	Colon Cancer	MTT assay	Not Available	24-h	Colon	None
5941	29993185	2018	NDADKDEMQSVYRGKANDDNSRGSKTNHRF	Peptide10 Gonearrestide	30	Linear	L	None	Free	Free	Anticancer	Androctonus mauritanicus	HKe-3	Colon Cancer	MTT assay	Not Available	24-h	Colon	None
5940	29993185	2018	NDADKDEMQSVYRGKANDDNSRGSKTNHRF	Peptide10 Gonearrestide	30	Linear	L	None	Free	Free	Anticancer	Androctonus mauritanicus	DLD-1	Colon Cancer	MTT assay	Not Available	24-h	Colon	None
5939	29993185	2018	NDADKDEMQSVYRGKANDDNSRGSKTNHRF	Peptide10 Gonearrestide	30	Linear	L	None	Free	Free	Anticancer	Androctonus mauritanicus	HCT-116	Colon Cancer	MTT assay	Not Available	24-h	Colon	None
5918	30279210	2018	GIMDTVKNAAKNLAGQLLDKLK	R2PLx-22	22	Linear	L	None	Free	Free	Antimicrobial	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 109.30 µM	24-h	Breast	None
5917	30279210	2018	GIMDTVKNAAKNLAGQLLDKLK	R2PLx-22	22	Linear	L	None	Free	Free	Antimicrobial	Synthetic Analogue of Ranatuerin-2PLx	U-251-MG	Brain Tumor	MTT assay	IC₅₀ = 104.10 µM	24-h	Brain	None
5916	30279210	2018	GIMDTVKNAAKNLAGQLLDKLK	R2PLx-22	22	Linear	L	None	Free	Free	Antimicrobial	Synthetic Analogue of Ranatuerin-2PLx	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 283.90 µM	24-h	Prostate	None
5914	30279210	2018	GIMDTVKNAAKNLAGQLLDKLK	R2PLx-22	22	Linear	L	None	Free	Free	Antimicrobial	Synthetic Analogue of Ranatuerin-2PLx	H-157	Lung Cancer	MTT assay	IC₅₀ = 843.40 µM	24-h	Lung	None
5915	30279210	2018	GIMDTVKNAAKNLAGQLLDKLK	R2PLx-22	22	Linear	L	None	Free	Free	Antimicrobial	Synthetic Analogue of Ranatuerin-2PLx	MDA-MB-435S	Skin Cancer	MTT assay	IC₅₀ = 872.70 µM	24-h	Skin	None
5913	30279210	2018	GIMDTVKNAAKNLAGQLLDKLKCKITAC	Ranatuerin-2PLx	28	Linear	L	None	Free	Free	Antimicrobial	Rana palustris	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 20.19 µM	24-h	Breast	None
5912	30279210	2018	GIMDTVKNAAKNLAGQLLDKLKCKITAC	Ranatuerin-2PLx	28	Linear	L	None	Free	Free	Antimicrobial	Rana palustris	U-251-MG	Brain Tumor	MTT assay	IC₅₀ = 16.14 µM	24-h	Brain	None
5911	30279210	2018	GIMDTVKNAAKNLAGQLLDKLKCKITAC	Ranatuerin-2PLx	28	Linear	L	None	Free	Free	Antimicrobial	Rana palustris	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 5.79 µM	24-h	Prostate	None
5910	30279210	2018	GIMDTVKNAAKNLAGQLLDKLKCKITAC	Ranatuerin-2PLx	28	Linear	L	None	Free	Free	Antimicrobial	Rana palustris	MDA-MB-435S	Skin Cancer	MTT assay	IC₅₀ = 15.44 µM	24-h	Skin	None
5909	30279210	2018	GIMDTVKNAAKNLAGQLLDKLKCKITAC	Ranatuerin-2PLx	28	Linear	L	None	Free	Free	Antimicrobial	Rana palustris	H-157	Lung Cancer	MTT assay	IC₅₀ = 5.90 µM	24-h	Lung	None
5908	30279210	2018	GIMDTVKNAAKNLAGQLLDKLKCSITAC	S-24-R2PLx	28	Linear	L	None	Free	Free	Antimicrobial	Synthetic Analogue of Ranatuerin-2PLx	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 316.90 µM	24-h	Breast	None
5907	30279210	2018	GIMDTVKNAAKNLAGQLLDKLKCSITAC	S-24-R2PLx	28	Linear	L	None	Free	Free	Antimicrobial	Synthetic Analogue of Ranatuerin-2PLx	U-251-MG	Brain Tumor	MTT assay	IC₅₀ = 278.30 µM	24-h	Brain	None
5906	30279210	2018	GIMDTVKNAAKNLAGQLLDKLKCSITAC	S-24-R2PLx	28	Linear	L	None	Free	Free	Antimicrobial	Synthetic Analogue of Ranatuerin-2PLx	MDA-MB-435S	Skin Cancer	MTT assay	IC₅₀ = 179.00 µM	24-h	Skin	None
5905	30279210	2018	GIMDTVKNAAKNLAGQLLDKLKCSITAC	S-24-R2PLx	28	Linear	L	None	Free	Free	Antimicrobial	Synthetic Analogue of Ranatuerin-2PLx	H-157	Lung Cancer	MTT assay	IC₅₀ = 58.18 µM	24-h	Lung	None
5904	30279210	2018	GIMDTVKNAAKNLAGQLLDKLKCSITAC	S-24-R2PLx	28	Linear	L	None	Free	Free	Antimicrobial	Synthetic Analogue of Ranatuerin-2PLx	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 792.60 µM	24-h	Prostate	None
5885	30026168	2018	FLSGIVGMLaKLFLFKQYAELW	[G10a]SHa-BCTP	22	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	NCI-H-460	Lung Cancer	MTT assay	IC₅₀ >100 µM	24-h	Lung	None
5884	30026168	2018	FLSGIVGMLaKLFLFKQYAELW	[G10a]SHa-BCTP	22	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	HeLa	Cervical Cancer	MTT assay	IC₅₀ >100 µM	24-h	Cervix	None
5883	30026168	2018	FLSGIVGMLaKLFLFKQYAELW	[G10a]SHa-BCTP	22	Linear	Mix	None	Amidation	Free	Antimicrobial	Synthetic analogue of Temporin-1SHa	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 26.85 ± 1.85 µM	24-h	Breast	None
5876	29904274	2018	RKKRRQRRRLNLKALLAVAKKIL	tMP-C	23	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	U-251-MG	Brain tumor	MTT assay	IC₅₀ = 3.36 μM	24-h	Brain	None
5877	29904274	2018	RKKRRQRRRLNLKALLAVAKKIL	tMP-C	23	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 3.70 μM	24-h	Breast	None
5874	29904274	2018	RKKRRQRRRLNLKALLAVAKKIL	tMP-C	23	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	MDA-MB-435S	Skin Cancer	MTT assay	IC₅₀ = 3.86 μM	24-h	Skin	None
5875	29904274	2018	RKKRRQRRRLNLKALLAVAKKIL	tMP-C	23	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 3.86 μM	24-h	Prostate	None
5873	29904274	2018	RKKRRQRRRLNLKALLAVAKKIL	tMP-C	23	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	H-157	Lung Cancer	MTT assay	IC₅₀ = 2.79 μM	24-h	Lung	None
5861	30087268	2018	ALWKDILKNLLKAALNEINQIVQ	L10, 11-DPS3	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of Dermaseptin-PS3	H-157	Lung Cancer	MTT assay	IC₅₀ = 0.12 μM	Not Available	Lung	None
5862	30087268	2018	ALWKDILKNLLKAALNEINQIVQ	L10, 11-DPS3	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of Dermaseptin-PS3	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 1.85 μM	Not Available	Prostate	None
5859	30087268	2018	ALWKKILKNAGKAALNKINQIVQ	K5, 17-DPS3	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of Dermaseptin-PS3	H-157	Lung Cancer	MTT assay	IC₅₀ = 18.20 μM	Not Available	Lung	None
5860	30087268	2018	ALWKKILKNAGKAALNKINQIVQ	K5, 17-DPS3	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Analogue of Dermaseptin-PS3	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 18.20 μM	Not Available	Prostate	None
5857	30087268	2018	ALWKDILKNAGKAALNEINQIVQ	Dermaseptin-PS3	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Phyllomedusa sauvagii	H-157	Lung Cancer	MTT assay	IC₅₀ = 15.67 μM	Not Available	Lung	None
5858	30087268	2018	ALWKDILKNAGKAALNEINQIVQ	Dermaseptin-PS3	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Phyllomedusa sauvagii	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 18.20 μM	Not Available	Prostate	None
5855	30258724	2018	GRKKRRQRRRGALWKSLLKNVGKA	DP-2	24	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	H-157	Lung Cancer	MTT assay	IC₅₀ = 3.21 μM	24-h	Lung	None
5856	30258724	2018	GRKKRRQRRRGALWKSLLKNVGKA	DP-2	24	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 6.75 μM	24-h	Prostate	None
5854	30258724	2018	ALWKSLLKNVGKAAGKAALNAVTDMVNQ	DRS-DU-1	28	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Callimedusa (Phyllomedusa) duellmani	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 21.6 μM	24-h	Prostate	None
5852	29191658	2018	FLPIVAKLLSGLLGRKKRRQRRR	temporin-PEb	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of Temporin-PE	MDA-MB-435S	Skin Cancer	MTT assay	IC₅₀ = 3.483 μM	Not Available	Skin	None
5853	30258724	2018	ALWKSLLKNVGKAAGKAALNAVTDMVNQ	DRS-DU-1	28	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Callimedusa (Phyllomedusa) duellmani	H-157	Lung Cancer	MTT assay	IC₅₀ = 8.43 μM	24-h	Lung	None
5850	29191658	2018	FLPIVAKLLSGLLGRKKRRQRRR	temporin-PEb	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of Temporin-PE	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 3.087 μM	Not Available	Brain	None
5851	29191658	2018	FLPIVAKLLSGLLGRKKRRQRRR	temporin-PEb	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of Temporin-PE	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 3.051 μM	Not Available	Prostate	None
5849	29191658	2018	FLPIVAKLLSGLLGRKKRRQRRR	temporin-PEb	23	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Synthetic analog of Temporin-PE	NCI-H-157	Lung Cancer	MTT assay	IC₅₀ = 3.464 μM	Not Available	Lung	None
5840	28636781	2018	GIGGALLSAGKSALKGLAKGLAEHFAN	BLP-7	27	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientali	A-375	Skin Cancer	MTT assay	Cell Viability < 20% at 10 μM	48-h	Skin	None
5839	28636781	2018	GIGGALLSAGKSALKGLAKGLAEHFAN	BLP-7	27	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientali	A-549	Lung Cancer	MTT assay	Cell Viability ~ 20% at 2.5 μM	48-h	Lung	None
5838	28636781	2018	GIGGALLSAGKSALKGLAKGLAEHFAN	BLP-7	27	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientali	PC-3	Prostate Cancer	MTT assay	Cell Viability ~ 20% at 2.5 μM	48-h	Prostate	None
5837	28636781	2018	GIGGALLSAGKSALKGLAKGLAEHFAN	BLP-7	27	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientali	Huh-7	Liver Cancer	MTT assay	IC₅₀ = 1.81 μM	48-h	Liver	None
5836	28636781	2018	GIGGALLSAGKSALKGLAKGLAEHFAN	BLP-7	27	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientali	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 2.83 μM	48-h	Liver	None
5835	28636781	2018	GIGGALLSAGKSALKGLAKGLAEHFAN	BLP-7	27	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientali	SK-HEP-1	Liver Cancer	MTT assay	IC₅₀ = 0.61 μM	48-h	Liver	None
5828	30622471	2018	GRFKRFRKKLKRLWHKVGPFVGPILHY	ChMAP-28	27	Linear	L	None	Free	Free	Antimicrobial	leucocytes of the goat Capra hircus	B16-F10	Skin Cancer	MTT assay	IC₅₀ = 4.82 ± 1.01 μM	48-h	Skin	None
5827	30622471	2018	GRFKRFRKKLKRLWHKVGPFVGPILHY	ChMAP-28	27	Linear	L	None	Free	Free	Antimicrobial	leucocytes of the goat Capra hircus	SK-BR-3	Breast Cancer	MTT assay	IC₅₀ = 5.63 ± 1.05 μM	48-h	Breast	None
5826	30622471	2018	GRFKRFRKKLKRLWHKVGPFVGPILHY	ChMAP-28	27	Linear	L	None	Free	Free	Antimicrobial	leucocytes of the goat Capra hircus	HEK-293T	Renal Cancer	MTT assay	IC₅₀ = 5.09 ± 0.40 μM	48-h	Renal	None
5825	30622471	2018	GRFKRFRKKLKRLWHKVGPFVGPILHY	ChMAP-28	27	Linear	L	None	Free	Free	Antimicrobial	leucocytes of the goat Capra hircus	A-431	Skin Cancer	MTT assay	IC₅₀ = 6.49 ± 0.09 μM	48-h	Skin	None
5824	30622471	2018	GRFKRFRKKLKRLWHKVGPFVGPILHY	ChMAP-29	27	Linear	L	None	Free	Free	Antimicrobial	leucocytes of the goat Capra hircus	HL-60	Leukemia Cancer	LDH leakage assay	~60% LDH Release at 2.5 μM	1-h	Blood	None
5823	30622471	2018	GRFKRFRKKLKRLWHKVGPFVGPILHY	ChMAP-28	27	Linear	L	None	Free	Free	Antimicrobial	leucocytes of the goat Capra hircus	HL-60	Leukemia Cancer	MTT assay	IC₅₀ = 3.39 ± 0.15 μM	48-h	Blood	None
5808	29098406	2018	GIGSAILSAGKSIIKGLAKGLAEHF	Bombinin-BO1	25	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientalis	Huh-7	Liver Cancer	MTT assay	IC₅₀ = 3.91 μM	48-h	Liver	None
5807	29098406	2018	GIGSAILSAGKSIIKGLAKGLAEHF	Bombinin-BO1	25	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientalis	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 3.75 μM	48-h	Liver	None
5806	29098406	2018	GIGSAILSAGKSIIKGLAKGLAEHF	Bombinin-BO1	25	Linear	L	None	Amidation	Free	Antimicrobial	Bombina orientalis	SK-HEP-1	Liver Cancer	MTT assay	IC₅₀ = 0.76 μM	48-h	Liver	None
5720	29263923	2017	GGRSFFLLRRIQGCRFRNTVDD	E5	22	Linear	L	None	Free	Free	Anticancer	Synthetic	4T1	Breast Cancer	CCK-8 assay	49% cell viability at 100 μM	24-h	Breast	None
5713	None	2017	VLLVTLTRLHQRGVIYEKWRHFSGRKYR	VLL-28	28	Linear	L	None	Free	Acetylation	Antibacterial and Anticancer	Sulfolobus islandicus	HEK-293T	Renal Cancer	MTT assay	IC₅₀ = 10 μM	72-h	Renal	None
5705	29280948	2017	KWKSFLKTfKSaKKTvLHTALKAISS	F9D/A12D/V16D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	BxPC-3	Pancreatic Cancer	MTT assay	IC₅₀ = 125.0 ± 1.8 μM	24-h	Pancreas	None
5704	29280948	2017	KWKSFLKTfKSaKKTvLHTALKAISS	F9D/A12D/V16D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	HPAC	Pancreatic Cancer	MTT assay	IC₅₀ = 95.6 ± 1.8 μM	24-h	Pancreas	None
5703	29280948	2017	KWKSFLKTfKSaKKTvLHTALKAISS	F9D/A12D/V16D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	MIA PaCa-2	Pancreatic Cancer	MTT assay	IC₅₀ = 57.9 ± 2.8 μM	24-h	Pancreas	None
5702	29280948	2017	KWKSFLKTfKSaKKTvLHTALKAISS	F9D/A12D/V16D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 125.0 ± 3.4 μM	24-h	Cervix	None
5701	29280948	2017	KWKSFLKTFKSaKKTvLHTALKAISS	A12D/V16D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	BxPC-3	Pancreatic Cancer	MTT assay	IC₅₀ = 125.0 ± 5.9 μM	24-h	Pancreas	None
5700	29280948	2017	KWKSFLKTFKSaKKTvLHTALKAISS	A12D/V16D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	HPAC	Pancreatic Cancer	MTT assay	IC₅₀ = 41.4 ± 1.4 μM	24-h	Pancreas	None
5699	29280948	2017	KWKSFLKTFKSaKKTvLHTALKAISS	A12D/V16D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	MIA PaCa-2	Pancreatic Cancer	MTT assay	IC₅₀ = 46.2 ± 3.0 μM	24-h	Pancreas	None
5698	29280948	2017	KWKSFLKTFKSaKKTvLHTALKAISS	A12D/V16D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 60.1 ± 1.2 μM	24-h	Cervix	None
5697	29280948	2017	KWKSFLKTfKSaKKTVLHTALKAISS	F9D/A12D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	BxPC-3	Pancreatic Cancer	MTT assay	IC₅₀ = 125.0 ± 3.7 μM	24-h	Pancreas	None
5696	29280948	2017	KWKSFLKTfKSaKKTVLHTALKAISS	F9D/A12D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	HPAC	Pancreatic Cancer	MTT assay	IC₅₀ = 42.4 ± 3.0 μM	24-h	Pancreas	None
5695	29280948	2017	KWKSFLKTfKSaKKTVLHTALKAISS	F9D/A12D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	MIA PaCa-2	Pancreatic Cancer	MTT assay	IC₅₀ = 38.8 ± 2.9 μM	24-h	Pancreas	None
5694	29280948	2017	KWKSFLKTfKSaKKTVLHTALKAISS	F9D/A12D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 59.8 ± 0.5 μM	24-h	Cervix	None
5693	29280948	2017	KWKSFLKTFKSaKKTVLHTALKAISS	A12D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	BxPC-3	Pancreatic Cancer	MTT assay	IC₅₀ = 45.1 ± 1.0 μM	24-h	Pancreas	None
5692	29280948	2017	KWKSFLKTFKSaKKTVLHTALKAISS	A12D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	HPAC	Pancreatic Cancer	MTT assay	IC₅₀ = 15.5 ± 1.7 μM	24-h	Pancreas	None
5691	29280948	2017	KWKSFLKTFKSaKKTVLHTALKAISS	A12D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	MIA PaCa-2	Pancreatic Cancer	MTT assay	IC₅₀ = 29.9 ± 4.8 μM	24-h	Pancreas	None
5690	29280948	2017	KWKSFLKTFKSaKKTVLHTALKAISS	A12D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 28.8 ± 0.8 μM	24-h	Cervix	None
5689	29280948	2017	KWKSFLKTFKsAKktVLHTALKAISS	S11D/K14D/T15D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	BxPC-3	Pancreatic Cancer	MTT assay	IC₅₀ = 45.5 ± 5.6 μM	24-h	Pancreas	None
5688	29280948	2017	KWKSFLKTFKsAKktVLHTALKAISS	S11D/K14D/T15D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	HPAC	Pancreatic Cancer	MTT assay	IC₅₀ = 54.2 ± 1.2 μM	24-h	Pancreas	None
5687	29280948	2017	KWKSFLKTFKsAKktVLHTALKAISS	S11D/K14D/T15D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	MIA PaCa-2	Pancreatic Cancer	MTT assay	IC₅₀ = 56.8 ± 3.3 μM	24-h	Pancreas	None
5686	29280948	2017	KWKSFLKTFKsAKktVLHTALKAISS	S11D/K14D/T15D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 41.1 ± 0.5 μM	24-h	Cervix	None
5685	29280948	2017	KWKSFLKTFKSAKktVLHTALKAISS	K14D/T15D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	BxPC-3	Pancreatic Cancer	MTT assay	IC₅₀ = 24.1 ± 5.5 μM	24-h	Pancreas	None
5684	29280948	2017	KWKSFLKTFKSAKktVLHTALKAISS	K14D/T15D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	HPAC	Pancreatic Cancer	MTT assay	IC₅₀ = 22.5 ± 0.5 μM	24-h	Pancreas	None
5683	29280948	2017	KWKSFLKTFKSAKktVLHTALKAISS	K14D/T15D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	MIA PaCa-2	Pancreatic Cancer	MTT assay	IC₅₀ = 47.1 ± 5.3 μM	24-h	Pancreas	None
5682	29280948	2017	KWKSFLKTFKSAKktVLHTALKAISS	K14D/T15D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 31.6 ± 2.1 μM	24-h	Cervix	None
5681	29280948	2017	KWKSFLKTFKsAKkTVLHTALKAISS	S11D/K14D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	BxPC-3	Pancreatic Cancer	MTT assay	IC₅₀ = 22.4 ± 2.3 μM	24-h	Pancreas	None
5680	29280948	2017	KWKSFLKTFKsAKkTVLHTALKAISS	S11D/K14D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	HPAC	Pancreatic Cancer	MTT assay	IC₅₀ = 25.5 ± 0.5 μM	24-h	Pancreas	None
5679	29280948	2017	KWKSFLKTFKsAKkTVLHTALKAISS	S11D/K14D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	MIA PaCa-2	Pancreatic Cancer	MTT assay	IC₅₀ = 41.3 ± 2.6 μM	24-h	Pancreas	None
5678	29280948	2017	KWKSFLKTFKsAKkTVLHTALKAISS	S11D/K14D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 30.6 ± 0.5 μM	24-h	Cervix	None
5677	29280948	2017	KWKSFLKTFKSAKkTVLHTALKAISS	K14D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	BxPC-3	Pancreatic Cancer	MTT assay	IC₅₀ = 20.0 ± 0.8 μM	24-h	Pancreas	None
5676	29280948	2017	KWKSFLKTFKSAKkTVLHTALKAISS	K14D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	HPAC	Pancreatic Cancer	MTT assay	IC₅₀ = 7.2 ± 5.2 μM	24-h	Pancreas	None
5675	29280948	2017	KWKSFLKTFKSAKkTVLHTALKAISS	K14D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	MIA PaCa-2	Pancreatic Cancer	MTT assay	IC₅₀ = 17.9 ± 2.3 μM	24-h	Pancreas	None
5674	29280948	2017	KWKSFLKTFKSAKkTVLHTALKAISS	K14D	26	Linear	Mix	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic Analogue of V13K	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 15.6 ± 4.1 μM	24-h	Cervix	None
5673	29280948	2017	KWKSFLKTFKSAKKTVLHTALKAISS	V13K	26	Linear	L	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	BxPC-3	Pancreatic Cancer	MTT assay	IC₅₀ = 12.5 ± 1.2 μM	24-h	Pancreas	None
5672	29280948	2017	KWKSFLKTFKSAKKTVLHTALKAISS	V13K	26	Linear	L	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	HPAC	Pancreatic Cancer	MTT assay	IC₅₀ = 7.6 ± 4.0 μM	24-h	Pancreas	None
5671	29280948	2017	KWKSFLKTFKSAKKTVLHTALKAISS	V13K	26	Linear	L	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	MIA PaCa-2	Pancreatic Cancer	MTT assay	IC₅₀ = 24.8 ± 0.6 μM	24-h	Pancreas	None
5670	29280948	2017	KWKSFLKTFKSAKKTVLHTALKAISS	V13K	26	Linear	L	None	Amidation	Acetylation	Antimicrobial and Anticancer	Synthetic	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 16 ± 0.5 μM	24-h	Cervix	None
5593	None	2017	CKLKNFAKGVAQSLLNKASKLSGQC	BR-C	25	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 75.44 μg/ml	24-h	Lung	None
5592	None	2017	CKLKNFAKGVAQSLLNKASKLSGQC	BR-C	25	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 45.72 μg/ml	24-h	Breast	None
5590	None	2017	KlKNFAKGVAQSllNKASCKlSGQC	BR-D	25	Linear	Mix	None	Free	Free	Antimicrobial	Synthetic	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 67.52 μg/ml	24-h	Breast	None
5591	None	2017	KlKNFAKGVAQSllNKASCKlSGQC	BR-D	25	Linear	Mix	None	Free	Free	Antimicrobial	Synthetic	A-549	Lung Cancer	MTT assay	IC₅₀ = 94.74 μg/ml	24-h	Lung	None
5589	29064402	2017	ALWKEVLKNAGKAALNEINNLV	Dermaseptin-PH	22	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Pithecopus (Phyllomedusa) hypochondrialis	PC-3	Prostate Cancer	MTT assay	IC₅₀ = 11.8 μM	Not Available	Prostate	None
5588	29064402	2017	ALWKEVLKNAGKAALNEINNLV	Dermaseptin-PH	22	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Pithecopus (Phyllomedusa) hypochondrialis	MDA-MB-435S	Breast Cancer	MTT assay	IC₅₀ = 9.94 μM	Not Available	Breast	None
5587	29064402	2017	ALWKEVLKNAGKAALNEINNLV	Dermaseptin-PH	22	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Pithecopus (Phyllomedusa) hypochondrialis	U251-MG	Brain Tumor	MTT assay	IC₅₀ = 2.36 μM	Not Available	Brain	None
5586	29064402	2017	ALWKEVLKNAGKAALNEINNLV	Dermaseptin-PH	22	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Pithecopus (Phyllomedusa) hypochondrialis	H-157	Lung Cancer	MTT assay	IC₅₀ = 2.01 μM	Not Available	Lung	None
5585	29064402	2017	ALWKEVLKNAGKAALNEINNLV	Dermaseptin-PH	22	Linear	L	None	Amidation	Free	Antimicrobial and Anticancer	Pithecopus (Phyllomedusa) hypochondrialis	MCF-7	Breast Cancer	MTT assay	IC₅₀ = 0.69 μM	Not Available	Breast	None
5301	27248170	2016	FIHHIIGGLFSAGKAIHRLIRRRRR	TP4	25	Linear	L	None	Free	Free	Antimicrobial	Oreochromis niloticus	MDA-MB-231	Breast Cancer	LDH leakage assay	LDH activity = 1.5mU/mL at 10 μg/mL	3-h	Breast	None
5300	27248170	2016	FIHHIIGGLFSAGKAIHRLIRRRRR	TP4	25	Linear	L	None	Free	Free	Antimicrobial	Oreochromis niloticus	MCF-7	Breast Cancer	MTS assay	IC₅₀ = 5.03 μM	6-h	Breast	None
5299	27248170	2016	FIHHIIGGLFSAGKAIHRLIRRRRR	TP4	25	Linear	L	None	Free	Free	Antimicrobial	Oreochromis niloticus	MDA-MB-453	Breast Cancer	MTS assay	IC₅₀ = 5.03 μM	6-h	Breast	None
5298	27248170	2016	FIHHIIGGLFSAGKAIHRLIRRRRR	TP4	25	Linear	L	None	Free	Free	Antimicrobial	Oreochromis niloticus	MDA-MB-231	Breast Cancer	MTS assay	IC₅₀ = 5.03 μM	6-h	Breast	None
5270	None	2015	CQYSVNPKIKRFELYFKGRMW	LPSBD-0	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Hep3B	Liver Cancer	Cell Proliferation assay	~40% cell survival at 60 µg/ml	24-h	Liver	None
5269	None	2015	CQYSVNPKIKRFELYFKGRMW	LPSBD-0	21	Linear	L	None	Free	Free	Anticancer	Synthetic	A-549	Lung Cancer	Cell Proliferation assay	~20% cell survival at 60 µg/ml	24-h	Lung	None
5214	25447543	2015	ACYCRIPACIAGERRYGTCIYQGRLWAFCC	Human neutrophil peptide-1 (HNP-1)	30	Cyclic(C2-C30, C4-C19,C9-C29)	L	None	Free	Free	Antimicrobial	Homo sapiens	PC-3	Prostate Cancer	Cytotoxicity assay (LIVE/DEAD® Viability/Cytotoxicity Assay Kit (L-3224))	IC₅₀ = 2.2 ± 0.3 μM	4h	Prostate	None
5182	26322745	2015	GLPTCGETCFKGKCYTPGCSCSYPICKKD	Cyclotide mela-6	29	Cyclic	L	None	Cyclized	Cyclized	Antibacterial and Anticancer	Melicytus latifolius	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 11.42 ±1.00 µM	Not Available	Cervix	None
5181	26322745	2015	GLPTCGETCFKGKCYTPGCSCSYPICKKD	Cyclotide mela-6	29	Cyclic	L	None	Cyclized	Cyclized	Antibacterial and Anticancer	Melicytus latifolius	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 1.58 ±0.48 µM	Not Available	Skin	None
5180	26399495	2015	GIPCGESCVFIPCLTSAIGCSCKSKVCYRN	Mra30	30	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial and Anticancer	Viola tricolor, Melicytus ramiflorus, Viola philippica	BGC-823	Gastric Cancer	Resazurin dye assay	IC₅₀ = 1.75 ±0.05 µM	Not Available	Stomach	None
5179	26399495	2015	GIPCGESCVFIPCLTSAIGCSCKSKVCYRN	Mra30	30	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial and Anticancer	Viola tricolor, Melicytus ramiflorus, Viola philippica	HeLa	Cervical Cancer	Resazurin dye assay	IC₅₀ = 15.5 ±0.06 µM	Not Available	Cervix	None
5178	26399495	2015	GIPCGESCVFIPCLTSAIGCSCKSKVCYRN	Mra30	30	Cyclic	L	None	Cyclized	Cyclized	Antimicrobial and Anticancer	Viola tricolor, Melicytus ramiflorus, Viola philippica	MM96L	Skin Cancer	Resazurin dye assay	IC₅₀ = 4.91 ±0.04 µM	Not Available	Skin	None
5177	26322745	2015	GKPICGETCFKGKCYTPGCTCSYPICKKD	Mela3	29	Cyclic	L	None	Cyclized	Cyclized	Antibacterial and Anticancer	Melicytus latifolius	HeLa	Cervical Cancer	Resazurin dye assay	CC₅₀ = 18.73 ±1.82 µM	Not Available	Cervix	None
5176	26322745	2015	GKPICGETCFKGKCYTPGCTCSYPICKKD	Mela3	29	Cyclic	L	None	Cyclized	Cyclized	Antibacterial and Anticancer	Melicytus latifolius	MM96L	Skin Cancer	Resazurin dye assay	CC₅₀ = 2.04 ±0.26 µM	Not Available	Skin	None
5162	26751970	2015	GLPLCGETCVGGTCNTPGCSCGWPVCVRN	Vigno 5	29	Cyclic(C5-C19,C9-C21,C14-C21)	L	None	Free	Free	Anticancer	Viola ignobilis	HeLa	Cervical Cancer	MTT assay	24% cell viability at 7.5 μM	24-h	Cervix	None
5152	26064310	2015	GTSCGETCVLLPCLSSVLGCTCQNKRCYKD	DC3	30	Cyclic	L	None	Cyclized	Cyclized	Anticancer	Hedyotis diffusa	DU-145	Liver Cancer	CCK-8 assay	IC₅₀ = 0.55 μM	72-h	Liver	None
5151	26064310	2015	GTSCGETCVLLPCLSSVLGCTCQNKRCYKD	DC3	30	Cyclic	L	None	Cyclized	Cyclized	Anticancer	Hedyotis diffusa	PC-3	Prostate Cancer	CCK-8 assay	IC₅₀ = 0.76 μM	72-h	Prostate	None
5150	26064310	2015	GTSCGETCVLLPCLSSVLGCTCQNKRCYKD	DC3	30	Cyclic	L	None	Cyclized	Cyclized	Anticancer	Hedyotis diffusa	LNCaP	Prostate Cancer	CCK-8 assay	IC₅₀ = 0.21 μM	72-h	Prostate	None
5139	26405806	2015	FKKLKKLFSKLWNWKRKKRRQRRR	HPRP-A1-TAT	24	Linear	L	None	Amidation	Acetylation	Anticancer	Synthetic	HeLa	Cervical Cancer	MTT assay	IC₅₀ = 1.8 ± 0.02 μM	24-h	Cervix	None
5138	26405806	2015	FKKLKKLFSKLWNWKRKKRRQRRR	HPRP-A1-TAT	24	Linear	L	None	Amidation	Acetylation	Anticancer	Synthetic	B-16	Skin Cancer	MTT assay	IC₅₀ = 3.9 ± 0.02 μM	24-h	Skin	None
5137	26405806	2015	FKKLKKLFSKLWNWKRKKRRQRRR	HPRP-A1-TAT	24	Linear	L	None	Amidation	Acetylation	Anticancer	Synthetic	HepG-2	Liver Cancer	MTT assay	IC₅₀ = 5.8 ± 0.36 μM	24-h	Liver	None
5136	26405806	2015	FKKLKKLFSKLWNWKRKKRRQRRR	HPRP-A1-TAT	24	Linear	L	None	Amidation	Acetylation	Anticancer	Synthetic	SGC-7901	Gastric cancer	MTT assay	IC₅₀ = 4.8 ± 0.08 μM	24-h	Stomach	None
5128	26239537	2015	FWQRRIRRWRRFWQRRIRRWRR	DIM-LF11-318	22	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	SBcl2	Skin Cancer	MTS assay	LC₅₀ = 9.4 ± 0.5 μM	24-h	Skin	None
5127	26239537	2015	FWQRRIRRWRRFWQRRIRRWRR	DIM-LF11-318	22	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	A-375	Skin Cancer	MTS assay	LC₅₀ = 9.3 ± 0.8 μM	24-h	Skin	None
5126	26239537	2015	FWQRRIRRWRRFWQRRIRRWRR	DIM-LF11-318	22	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	A-375	Skin Cancer	PI uptake assay	LC₅₀ = 3.8 ± 0.5 μM	8-h	Skin	None
5125	26239537	2015	PFWRRRIRIRRRRIRIRRRWFP	R-DIM-LF11-337	22	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	SBcl2	Skin Cancer	MTS assay	LC₅₀ = 5.0 ± 0.4 μM	24-h	Skin	None
5124	26239537	2015	PFWRRRIRIRRRRIRIRRRWFP	R-DIM-LF11-337	22	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	A-375	Skin Cancer	MTS assay	LC₅₀ = 12.3 ± 1.3 μM	24-h	Skin	None
5123	26239537	2015	PFWRRRIRIRRRRIRIRRRWFP	R-DIM-LF11-337	22	Linear	L	None	Amidation	Free	Host Defence Peptide	Synthetic	A-375	Skin Cancer	PI uptake assay	LC₅₀ = 3.5 ± 0.4 μM	8-h	Skin	None
5093	25312253	2014	GGRSFFLLRRIQGCRFRNTVDD	E5	22	Linear	L	None	Free	Free	Anticancer	Synthetic	U-937	Leukemia Cancer	FITC-Annexin V/PI double staining and flow cytometry assay	>20% apoptosis rate at 80 μM	24-h	Blood	None
5092	25312253	2014	GGRSFFLLRRIQGCRFRNTVDD	E5	22	Linear	L	None	Free	Free	Anticancer	Synthetic	HL-60	Leukemia Cancer	FITC-Annexin V/PI double staining and flow cytometry assay	>20% apoptosis rate at 80 μM	24-h	Blood	None
5091	25312253	2014	GGRSFFLLRRIQGCRFRNTVDD	E5	22	Linear	L	None	Free	Free	Anticancer	Synthetic	NB-4	Leukemia Cancer	FITC-Annexin V/PI double staining and flow cytometry assay	60% apoptosis rate at 80 μM	24-h	Blood	None
5054	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC107	Colorectal Cancer	Cell Viability assay	Cell viability >70% at 12.5μM approx	24-h	Colon	None
5053	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC107	Colorectal Cancer	Cell Viability assay	Cell viability >65% at 12.5μM approx	24-h	Colon	None
5052	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC107	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 12.5μM approx	24-h	Colon	None
5051	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC32	Colorectal Cancer	Cell Viability assay	Cell viability >85% at 12.5μM approx	24-h	Colon	None
5050	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC32	Colorectal Cancer	Cell Viability assay	Cell viability >80% at 12.5μM approx	24-h	Colon	None
5049	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC32	Colorectal Cancer	Cell Viability assay	Cell viability >55% at 12.5μM approx	24-h	Colon	None
5048	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC113	Colorectal Cancer	Cell Viability assay	Cell viability >70% at 12.5μM approx	24-h	Colon	None
5047	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC113	Colorectal Cancer	Cell Viability assay	Cell viability >65% at 12.5μM approx	24-h	Colon	None
5046	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC113	Colorectal Cancer	Cell Viability assay	Cell viability >80% at 12.5μM approx	24-h	Colon	None
5045	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC60	Colorectal Cancer	Cell Viability assay	Cell viability >70% at 12.5μM approx	24-h	Colon	None
5044	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC60	Colorectal Cancer	Cell Viability assay	Cell viability >60% at 12.5μM approx	24-h	Colon	None
5043	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC60	Colorectal Cancer	Cell Viability assay	Cell viability >70% at 12.5μM approx	24-h	Colon	None
5042	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC40	Colorectal Cancer	Cell Viability assay	Cell viability >85% at 12.5μM approx	24-h	Colon	None
5041	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC40	Colorectal Cancer	Cell Viability assay	Cell viability >80% at 12.5μM approx	24-h	Colon	None
5040	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC40	Colorectal Cancer	Cell Viability assay	Cell viability >45% at 12.5μM approx	24-h	Colon	None
5039	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC24	Colorectal Cancer	Cell Viability assay	Cell viability >70% at 12.5μM approx	24-h	Colon	None
5038	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC24	Colorectal Cancer	Cell Viability assay	Cell viability >55% at 12.5μM approx	24-h	Colon	None
5037	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC24	Colorectal Cancer	Cell Viability assay	Cell viability >55% at 12.5μM approx	24-h	Colon	None
5036	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC18	Colorectal Cancer	Cell Viability assay	Cell viability >75% at 12.5μM approx	24-h	Colon	None
5035	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC18	Colorectal Cancer	Cell Viability assay	Cell viability >55% at 12.5μM approx	24-h	Colon	None
5034	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC18	Colorectal Cancer	Cell Viability assay	Cell viability >55% at 12.5μM approx	24-h	Colon	None
5033	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HCT-116	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 12.5μM approx	24-h	Colon	None
5032	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HCT-116	Colorectal Cancer	Cell Viability assay	Cell viability >40% at 12.5μM approx	24-h	Colon	None
5031	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HCT-116	Colorectal Cancer	Cell Viability assay	Cell viability >40% at 12.5μM approx	24-h	Colon	None
5030	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC32	Colorectal Cancer	Cell Viability assay	Cell viability =50% at 12.5μM approx.	1-h	Colon	None
5029	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC32	Colorectal Cancer	Cell Viability assay	Cell viability =50% at 12.5μM approx.	1-h	Colon	None
5028	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC32	Colorectal Cancer	Cell Viability assay	Cell viability >60% at 25μM approx	1-h	Colon	None
5027	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC60	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 25μM approx	1-h	Colon	None
5026	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC60	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 25μM approx	1-h	Colon	None
5025	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC60	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 25μM approx	1-h	Colon	None
5024	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC40	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 25μM approx	1-h	Colon	None
5023	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC40	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 25μM approx	1-h	Colon	None
5022	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC40	Colorectal Cancer	Cell Viability assay	Cell viability >60% at 25μM approx	1-h	Colon	None
5021	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC24	Colorectal Cancer	Cell Viability assay	Cell viability >60% at 25μM approx	1-h	Colon	None
5020	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC24	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 25μM approx	1-h	Colon	None
5019	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HROC24	Colorectal Cancer	Cell Viability assay	Cell viability >60% at 25μM approx	1-h	Colon	None
5018	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A-Δ	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HCT-116	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 12.5μM approx.	1-h	Colon	None
5017	24962950	2014	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HCT-116	Colorectal Cancer	Cell Viability assay	Cell viability =50% at 12.5μM approx.	1-h	Colon	None
5016	24962950	2014	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antitumor	NK-2 peptide based derivatives	HCT-116	Colorectal Cancer	Cell Viability assay	Cell viability >50% at 25μM approx	1-h	Colon	None
5011	24661024	2014	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Free	Free	Antimicrobial	Main component of honey bee venom	SCC25	Skin Cancer	Cell Viability assay	102.9 ± 4.1% cell growth inhibition at 1 µM	24-h	Skin	None
5005	24587350	2014	GIGKFLKKAKKFGKAFVKILKK	Pexiganan	22	Linear	L	None	Amidation	Free	Antimicrobial	Analog of magainin 2	OVRCAR-3	Ovarian Cancer	MTT/MTS assay	LC₅₀= 13 at 100 µM	72-h	Ovary	None
5003	24587350	2014	GIGKFLKKAKKFGKAFVKILKK	Pexiganan	22	Linear	L	None	Amidation	Free	Antimicrobial	Analog of magainin 2	LNCaP	Prostate cancer	MTT/MTS assay	LC₅₀= 6 at 100 µM	72-h	Prostate	None
5001	24587350	2014	GIGKFLKKAKKFGKAFVKILKK	Pexiganan	22	Linear	L	None	Amidation	Free	Antimicrobial	Analog of magainin 2	MCF-7	Breast Cancer	MTT/MTS assay	LC₅₀= 8 at 100 µM	72-h	Breast	None
4674	15279899	2004	FRKSKEKIGKEFKRIVQRIKDFLRNLV	HCAP18(109-135)	27	Linear	L	None	Free	Free	Antimicrobial	hCAP18 synthetic peptide	SAS-H1	Oral Cancer	Not Available	Not Available	Not Available	Oral mucosa	None
4673	22885172	2012	GLFGKLIKKFARKAISYAVKKARGKH	ltc2aG11A	26	Linear	L	None	Free	Free	Antimicrobial	Central Asian spider, Lachesana tarabaevi	Prostate tumor cellline	Prostate Cancer	LDH leakage assay	graph fig 8 A	Not Available	Prostate	None
4672	22885172	2012	GLFGKLIKKFGRKAISYAVKKARGKH	Latarcin 2a	26	Linear	L	None	Free	Free	Antimicrobial	Central Asian spider, Lachesana tarabaevi	Breast tumor cellline	Breast Cancer	LDH leakage assay	graph fig 8 A	Not Available	Breast	None
4607	12417587	2003	TRSSRAGLQWPVGRVHRLLRKGGC	BF2d	24	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	HeLa	Cervical Cancer	MTT/MTS assay	at 100 µM 90-100% viablity	6-h	Cervix	None
4605	12417587	2003	TRSSRAGLQWPVGRVHRLLRKGGC	BF2d	24	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	HeLa	Cervical Cancer	MTT/MTS assay	at 10 µM 90-95% viablity	6-h	Cervix	None
4603	12417587	2003	TRSSRAGLQWPVGRVHRLLRKGGC	BF2d	24	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	HeLa	Cervical Cancer	MTT/MTS assay	at 1 µM 90-100% viablity	6-h	Cervix	None
4602	12417587	2003	GIGKFLHSAKKWGKAFVGQIMNC	MG2d	23	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic	HeLa	Cervical Cancer	MTT/MTS assay	at 1 µM 90-100% viablity	6-h	Cervix	None
4592	21403917	2011	TRSSRAGLQFPVGRVHRLLRK	Buforin 2	21	Linear	L	None	Free	Free	Antimicrobial	Bufo Bufo Gargarizans	U-937	Lymphoma Cancer	MTT/MTS assay	IC₅₀ =90-95 µg/ml	Not Available	Blood	None
4575	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MCF-7-TX400	Breast Cancer	MTT/MTS assay	~5% cytotoxic at 50 µM	24-h	Breast	None
4574	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MCF-7-TX400	Breast Cancer	MTT/MTS assay	60-70% cytotoxic at 50 µM	24-h	Breast	None
4571	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MCF-7	Breast Cancer	MTT/MTS assay	70% cytotoxic at 50 µM	24-h	Breast	None
4572	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MCF-7	Breast Cancer	MTT/MTS assay	0% cytotoxic at 50 µM	24-h	Breast	None
4573	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MCF-7-TX400	Breast Cancer	MTT/MTS assay	60-70% cytotoxic at 50 µM	24-h	Breast	None
4567	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	~0% cytotoxic at 10 µM	24-h	Breast	None
4568	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	5-10% cytotoxic at 25 µM	24-h	Breast	None
4569	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	20% cytotoxic at 50 µM	24-h	Breast	None
4570	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MCF-7	Breast Cancer	MTT/MTS assay	70% cytotoxic at 50 µM	24-h	Breast	None
4564	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	5% cytotoxic at 25 µM	24-h	Breast	None
4565	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	10-15% cytotoxic at 50 µM	24-h	Breast	None
4566	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	~0% cytotoxic at 5 µM	24-h	Breast	None
4561	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	15-20% cytotoxic at 50 µM	24-h	Breast	None
4562	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	~5% cytotoxic at 5 µM	24-h	Breast	None
4563	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	~5% cytotoxic at 10 µM	24-h	Breast	None
4559	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	10% cytotoxic at 10 µM	24-h	Breast	None
4560	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	10-15% cytotoxic at 25 µM	24-h	Breast	None
4557	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	10-15% cytotoxic at 50 µM	24-h	Breast	None
4558	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	10% cytotoxic at 5 µM	24-h	Breast	None
4555	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	~0% cytotoxic at 10 µM	24-h	Breast	None
4556	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	10% cytotoxic at 25 µM	24-h	Breast	None
4552	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	10% cytotoxic at 25 µM	24-h	Breast	None
4553	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	10-15% cytotoxic at 50 µM	24-h	Breast	None
4554	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	~0% cytotoxic at 5 µM	24-h	Breast	None
4549	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	80-90% cytotoxic at 25 µM	24-h	Breast	None
4550	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	85-90% cytotoxic at 50 µM	24-h	Breast	None
4551	22023734	2011	GWRTLLKKAEVKTVGKLALKHYL	NRC-13	23	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	~5% cytotoxic at 10 µM	24-h	Breast	None
4546	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	80-90% cytotoxic at 50 µM	24-h	Breast	None
4547	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	30-40% cytotoxic at 5 µM	24-h	Breast	None
4548	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	60-70% cytotoxic at 10 µM	24-h	Breast	None
4544	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	50% cytotoxic at 10 µM	24-h	Breast	None
4545	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	80% cytotoxic at 25 µM	24-h	Breast	None
4543	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	10% cytotoxic at 5 µM	24-h	Breast	None
4540	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	20% cytotoxic at 10 µM	24-h	Breast	None
4541	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	70-80% cytotoxic at 25 µM	24-h	Breast	None
4542	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	80-85% cytotoxic at 50 µM	24-h	Breast	None
4538	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	40-50% cytotoxic at 50 µM	24-h	Breast	None
4539	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	~0% cytotoxic at 5 µM	24-h	Breast	None
4537	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	20% cytotoxic at 25 µM	24-h	Breast	None
4534	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	40-50% cytotoxic at 50 µM	24-h	Breast	None
4535	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	~0% cytotoxic at 5 µM	24-h	Breast	None
4536	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	10% cytotoxic at 10 µM	24-h	Breast	None
4532	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	5% cytotoxic at 10 µM	24-h	Breast	None
4533	22023734	2011	RWGKWFKKATHVGKHVGKAALTAYL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	20-30% cytotoxic at 25 µM	24-h	Breast	None
4530	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	85-90% cytotoxic at 50 µM	24-h	Breast	None
4531	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-07	25	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	~0% cytotoxic at 5 µM	24-h	Breast	None
4528	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	40-50% cytotoxic at 10 µM	24-h	Breast	None
4529	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	80% cytotoxic at 25 µM	24-h	Breast	None
4525	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	60-70% cytotoxic at 25 µM	24-h	Breast	None
4526	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	80-85% cytotoxic at 50 µM	24-h	Breast	None
4527	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	4T1	Breast Cancer	MTT/MTS assay	15-20% cytotoxic at 5 µM	24-h	Breast	None
4524	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	40-50% cytotoxic at 10 µM	24-h	Breast	None
4521	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	70% cytotoxic at 25 µM	24-h	Breast	None
4522	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	80-85% cytotoxic at 50 µM	24-h	Breast	None
4523	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-468	Breast Cancer	MTT/MTS assay	30% cytotoxic at 5 µM	24-h	Breast	None
4520	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	50% cytotoxic at 10 µM	24-h	Breast	None
4518	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	60% cytotoxic at 50 µM	24-h	Breast	None
4519	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	SKBR-3	Breast Cancer	MTT/MTS assay	30% cytotoxic at 5 µM	24-h	Breast	None
4517	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	30-35% cytotoxic at 25 µM	24-h	Breast	None
4515	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	5-10% cytotoxic at 5 µM	24-h	Breast	None
4516	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	T-47D	Breast Cancer	MTT/MTS assay	10% cytotoxic at 10 µM	24-h	Breast	None
4514	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	60% cytotoxic at 50 µM	24-h	Breast	None
4511	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	5% cytotoxic at 5 µM	24-h	Breast	None
4512	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	5% cytotoxic at 10 µM	24-h	Breast	None
4513	22023734	2011	GRRKRKWLRRIGKGVKIIGGAALDHL	NRC-03	26	Linear	L	None	Amidation	Biotinylated	Antimicrobial	Pleurocidin-family	MDA-MB-231	Breast Cancer	MTT/MTS assay	30-35% cytotoxic at 25 µM	24-h	Breast	None
4504	22057278	2011	AAKKWAKAKWAKAKKWAKAA	Z10	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Colon	None
4503	22057278	2011	AAWKWAWAKKWAKAKKWAKAA	Z9	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ =13 µM	Not Available	Colon	None
4501	22057278	2011	KAAKKAWKAAKKAWKAAKKAA	Z7	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ =21 µM	Not Available	Colon	None
4502	22057278	2011	AWKKWAKAWKWAKAKWWAKAA	Z8	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ =23 µM	Not Available	Colon	None
4500	22057278	2011	KWWKKAAKAAKKAAKAAKKWA	Z6	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ =31 µM	Not Available	Colon	None
4499	22057278	2011	KAAKKAWKWAKKAAKWAKKAA	Z5	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ =67 µM	Not Available	Colon	None
4498	22057278	2011	KAAKKAWKAAKKAAKWWKKAA	Z4	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ =173 µM	Not Available	Colon	None
4497	22057278	2011	KAAKKAWKAWKKAAKAAWKKAA	Z3	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Colon	None
4496	22057278	2011	KAAKKWAKAWKKAAKAWKKAA	Z2	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Colon	None
4495	22057278	2011	KAAKKWAKAAKKWAKAWKKAA	Z1	21	Linear	L	None	Free	Free	Anticancer	Synthetic	HT-29	Colon Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Colon	None
4494	22057278	2011	AAKKWAKAKWAKAKKWAKAA	Z10	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Breast	None
4493	22057278	2011	AAWKWAWAKKWAKAKKWAKAA	Z9	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =16 µM	Not Available	Breast	None
4492	22057278	2011	AWKKWAKAWKWAKAKWWAKAA	Z8	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =14 µM	Not Available	Breast	None
4491	22057278	2011	KAAKKAWKAAKKAWKAAKKAA	Z7	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =15 µM	Not Available	Breast	None
4490	22057278	2011	KWWKKAAKAAKKAAKAAKKWA	Z6	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =16 µM	Not Available	Breast	None
4489	22057278	2011	KAAKKAWKWAKKAAKWAKKAA	Z5	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =28 µM	Not Available	Breast	None
4488	22057278	2011	KAAKKAWKAAKKAAKWWKKAA	Z4	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =68 µM	Not Available	Breast	None
4487	22057278	2011	KAAKKAWKAWKKAAKAAWKKAA	Z3	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =128 µM	Not Available	Breast	None
4486	22057278	2011	KAAKKWAKAWKKAAKAWKKAA	Z2	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =173 µM	Not Available	Breast	None
4485	22057278	2011	KAAKKWAKAAKKWAKAWKKAA	Z1	21	Linear	L	None	Free	Free	Anticancer	Synthetic	MT-1	Breast Cancer	MTT/MTS assay	EC₅₀ =186 µM	Not Available	Breast	None
4484	22057278	2011	AAKKWAKAKWAKAKKWAKAA	Z10	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Skin	None
4483	22057278	2011	AAWKWAWAKKWAKAKKWAKAA	Z9	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ =9 µM	Not Available	Skin	None
4482	22057278	2011	AWKKWAKAWKWAKAKWWAKAA	Z8	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ =19 µM	Not Available	Skin	None
4481	22057278	2011	KAAKKAWKAAKKAWKAAKKAA	Z7	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ =15 µM	Not Available	Skin	None
4480	22057278	2011	KWWKKAAKAAKKAAKAAKKWA	Z6	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ =17 µM	Not Available	Skin	None
4479	22057278	2011	KAAKKAWKWAKKAAKWAKKAA	Z5	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ =42 µM	Not Available	Skin	None
4478	22057278	2011	KAAKKAWKAAKKAAKWWKKAA	Z4	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ =155 µM	Not Available	Skin	None
4477	22057278	2011	KAAKKAWKAWKKAAKAAWKKAA	Z3	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Skin	None
4476	22057278	2011	KAAKKWAKAWKKAAKAWKKAA	Z2	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Skin	None
4475	22057278	2011	KAAKKWAKAAKKAAKAWKKAA	Z1	21	Linear	L	None	Free	Free	Anticancer	Synthetic	Meth A	Skin Cancer	MTT/MTS assay	EC₅₀ >211 µM	Not Available	Skin	None
4454	17067680, 18957441	2007	GIKCRFCCGCCTPGICGVCCRF	hepcidin TH1-5	22	Not Available	L	None	Free	Free	Anticancer	Tilapia, Oreochromis mossambicus	Not Available	Colorectal Cancer	Not Available	Not Available	Not Available	Not Available	None
4448	8245827, 18957441	1993	KSSAYSLQMGATAIKQVKKLFKKWGW	Plantaricin A	26	Not Available	L	None	Free	Free	Antibacterial	Lactobacillus plantarumC11, WCFS1, V90	Not Available	Colorectal Cancer	Not Available	Not Available	Not Available	Not Available	None
4437	11713517, 18957441	2001	FFHHIFRGIVHVGKTIHRLVTG	Piscidin 1	22	Not Available	L	None	Free	Free	Antibacterial	Hybrid striped bass (Morone saxatilis x M. chrysops)	Not Available	Breast Cancer	Not Available	Not Available	Not Available	Not Available	None
4436	12581207, 18957441	2003	FFGWLIKGAIHAGKAIHGLIHRRRH	Chrysophsin-1	25	Not Available	L	None	Free	Free	Antibacterial	Red sea bream,Chrysophrys majororPagrus major	Not Available	Breast Cancer	Not Available	Not Available	Not Available	Not Available	None
4433	12804591, 19923233	2003	AIGSILGALAKGLPTLISWIKNR	Prepromelittin-related peptide	23	Not Available	L	None	Free	Free	Antibacterial	Rana tagoi [Tago frog]	Not Available	Fibrosarcoma	Not Available	Not Available	Not Available	Fibrous connective tissue	None
4432	4056036, 18957441	1985	DCYCRIPACIAGERRYGTCIYQGRLWAFCC	HNP-3	30	Not Available	L	None	Free	Free	Anticancer	Homo sapiens	Not Available	Fibrosarcoma	Not Available	Not Available	Not Available	Fibrous connective tissue	None
4431	4056036, 18957441	1985	CYCRIPACIAGERRYGTCIYQGRLWAFCC	HNP-2	29	Not Available	L	None	Free	Free	Anticancer	Homo sapiens	Not Available	Fibrosarcoma	Not Available	Not Available	Not Available	Fibrous connective tissue	None
4430	4056036, 18957441	1985	ACYCRIPACIAGERRYGTCIYQGRLWAFCC	HNP-1	30	Not Available	L	None	Free	Free	Anticancer	Homo sapiens	Not Available	Fibrosarcoma	Not Available	Not Available	Not Available	Fibrous connective tissue	None
4428	9548831, 18957441	1998	GLPVCGETCVGGTCNTPGCSCSWPVCTRN	Varv peptide A	29	Not Available	L	None	Free	Free	Anticancer	Viola arvensis,Viola odorata, Viola tricolor, Viola baoshanensis, Viola yedoensis, and Viola biflora	Not Available	Fibrosarcoma	Not Available	Not Available	Not Available	Fibrous connective tissue	None
4427	21434649, 18957441	2011	GLPVCGETCFGGTCNTPGCTCDPWPVCTRN	Vaby D	30	Not Available	L	None	Free	Free	Anticancer	African, the Ethiopian highlands, Viola abyssinica	Not Available	Fibrosarcoma	Not Available	Not Available	Not Available	Fibrous connective tissue	None
4426	21434649, 18957441	2011	GLPVCGETCAGGTCNTPGCSCSWPICTRN	Vaby A	29	Not Available	L	None	Free	Free	Anticancer	African, the Ethiopian highlands, Viola abyssinica	Not Available	Fibrosarcoma	Not Available	Not Available	Not Available	Fibrous connective tissue	None
4425	10601876, 18957441	2000	GLLSVLGSVAKHVLPHVVPVIAEKL	Caerin 1.10	25	Not Available	L	None	Free	Free	Anticancer	Magnificent treefrog Litoria splendida, Australia	Not Available	Lung Cancer	Not Available	Not Available	Not Available	Not Available	None
4424	9266696, 18957441	1997	GLLSVLGSVAKHVLPHVVPVIAEHL	Caerin 1.1	25	Not Available	L	None	Free	Free	Anticancer	Australian green tree frogLitoria splendida; Litoria rothii	Not Available	Lung Cancer	Not Available	Not Available	Not Available	Not Available	None
4422	18191970, 18957441	2008	GIPCAESCVWIPCTVTALIGCGCSNKVCYN	Vibi E	30	Not Available	L	None	Free	Free	Anticancer	Alpine violetViola biflora	Not Available	Leukemia Cancer	Not Available	Not Available	Not Available	Not Available	None
4421	10075760, 18957441	1999	GVPICGETCTLGTCYTAGCSCSWPVCTRN	Varv peptide F	29	Not Available	L	None	Free	Free	Anticancer	Viola arvensis	Not Available	Leukemia Cancer	Not Available	Not Available	Not Available	Not Available	None
4416	22771617, 18957441	2012	GLLGLLGSVVSHVVPAIVGHF	Maculatin 1.3	21	Not Available	L	None	Free	Free	Anticancer	Blue-thighed frog,Litoria chloris, Australia	Not Available	Skin Cancer	Not Available	Not Available	Not Available	Not Available	None
4415	22771617, 18957441	2012	GLLGLLGSVVSHVLPAITQHL	Maculatin 1.4	21	Not Available	L	None	Free	Free	Anticancer	Blue-thighed frog,Litoria chloris, Australia	Not Available	Skin Cancer	Not Available	Not Available	Not Available	Not Available	None
4413	9230483, 18957441	1997	GLFSVLGAVAKHVLPHVVPVIAEK	Caerin 1.6	24	Not Available	L	None	Free	Free	Anticancer	Blue-thighed frog,Litoria chloris, Australia	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4412	9230483, 18957441	1997	GLFKVLGSVAKHLLPHVVPVIAEK	Caerin 1.8	24	Not Available	L	None	Free	Free	Anticancer	Blue-thighed frog,Litoria chloris, Australia	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4411	9230483, 18957441	1997	GLFKVLGSVAKHLLPHVAPVIAEK	Caerin 1.7	24	Not Available	L	None	Free	Free	Anticancer	Orange-thighed frog,Litoria xanthomera, Australia	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4410	9516047, 18957441	1998	GLFGVLGSIAKHVLPHVVPVIAEK	Caerin 1.9	24	Not Available	L	None	Free	Free	Anticancer	Litoria chloris, Australia	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4401	11835991, 18957441	2002	GIGTKILGGVKTALKGALKELASTYAN	Maximin 1	27	Not Available	L	None	Free	Free	Anticancer	Bombina maxima	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4400	11835991, 18957441	2002	GIGGVLLSAGKAALKGLAKVLAEKYAN	Maximin 4	27	Not Available	L	None	Free	Free	Anticancer	Bombina maxima	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4399	11835991, 18957441	2002	GIGGKILSGLKTALKGAAKELASTYLH	Maximin 3	27	Not Available	L	None	Free	Free	Antibacterial	Bombina maxima	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4398	11835991, 18957441	2002	ILGPVISTIGGVLGGLLKNL	Maximin H1	27	Not Available	L	None	Free	Free	Antibacterial	Bombina maxima	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4397	20575512, 18957441	2010	GIACGESCVFLGCFIPGCSCKSKVCYFN	Psyle A	28	Not Available	L	None	Free	Free	Antibacterial	Psychotria leptothyrsa	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4395	20575512, 18957441	2010	KLCGETCFKFKCYTPGCSCSYPFCK	Psyle C	25	Not Available	L	None	Free	Free	Antibacterial	Psychotria leptothyrsa	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4394	8910461, 18957441	1996	GGLRSLGRKILRAWKKYGPIIVPIIRIG	BMAP-28	28	Not Available	L	None	Free	Free	Antibacterial	CowBos taurus	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4393	8910461, 18957441	1996	GRFKRFRKKFKKLFKKLSPVIPLLHLG	BMAP-27	27	Not Available	L	None	Free	Free	Antibacterial	CowBos taurus	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4392	9620615, 18957441	1998	GLLQTIKEKLESLESLAKGIVSGIQA	Maculatin 3.1	26	Not Available	L	None	Free	Free	Anticancer	Litoria genimaculate, Litoria eucnemis, Australia	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4391	9620615, 18957441	1998	GLFVGVLAKVAAHVVPAIAEHF	Maculatin 1.1	22	Not Available	L	None	Free	Free	Antibacterial	Litoria genimaculate, Litoria eucnemis, Australia	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4390	9620615, 18957441	1998	GLFVGLAKVAAHNNPAIAEHFQA	Maculatin 1.2	23	Not Available	L	None	Free	Free	Antibacterial	Litoria genimaculate, Litoria eucnemis, Australia	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4384	21596752, 18957441	2011	GEFLKCGESCVQGECYTPGCSCDWPICKKN	Cliotide T2	30	Not Available	L	None	Free	Free	Antibacterial	Clitoria ternatea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4383	21596752, 18957441	2011	GIPCGESCVFIPCITAAIGCSCKSKVCYRN	Cliotide T4	30	Not Available	L	None	Free	Free	Antibacterial	Clitoria ternatea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4382	21596752, 18957441	2011	GIPCGESCVFIPCITGAIGCSCKSKVCYRN	Cliotide T1	30	Not Available	L	None	Free	Free	Antibacterial	Clitoria ternatea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4381	21596752, 18957441	2011	GLPTCGETCTLGTCYVPDCSCSWPICMKN	Cliotide T3	29	Not Available	L	None	Free	Free	Antibacterial	Clitoria ternatea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4380	10600388, 18957441	1999	GIPCGESCVWIPCISSAIGCSCKSKVCYRN	Cycloviolacin O2	30	Not Available	L	None	Free	Free	Antibacterial	Viola odorata	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4378	21723349, 18957441	2011	GLPVCGETCVGGTCNTPGCGCSWPVCTRN	Viba17	29	Not Available	L	None	Free	Free	Antibacterial	Viola philippica	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4377	21723349, 18957441	2011	GLPVCGETCVGGTCNTPGCACSWPVCTRN	Viba 15	29	Not Available	L	None	Free	Free	Antibacterial	Viola philippica	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4376	21723349, 18957441	2011	GIPCGESCVFIPCLTSAIDCSCKSKVCYRN	Mram 8	30	Not Available	L	None	Free	Free	Antibacterial	Viola philippica	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4371	22467870, 18957441	2012	GEYCGESCYLIPCFTPGCYCVSRQCVNKN	Chassatide C10	29	Not Available	L	None	Free	Free	Antibacterial	Chassalia chartacea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4370	22467870, 18957441	2012	GDACGETCFTGICFTAGCSCNPWPTCTRN	Chassatide C4	29	Not Available	L	None	Free	Free	Antibacterial	Chassalia chartacea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4369	22467870, 18957441	2012	GASCGETCFTGICFTAGCSCNPWPTCTRN	Chassatide C4	29	Not Available	L	None	Free	Free	Antibacterial	Chassalia chartacea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4368	22467870, 18957441	2012	IPCGESCVWIPCISGMFGCSCKDKVCYS	ChaC11	29	Not Available	L	None	Free	Free	Antibacterial	Chassalia chartacea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4367	22467870, 18957441	2012	AIPCGESCVWIPCISTVIGCSCSNKVCYR	Chassatide C8	29	Not Available	L	None	Free	Free	Antibacterial	Chassalia chartacea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4366	22467870, 18957441	2012	IPCGESCVWIPCITAIAGCSCKNKVCYT	ChaC7	29	Not Available	L	None	Free	Free	Antibacterial	Chassalia chartacea	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4364	16713189, 18957441	2006	FLPILASLAAKFGPKLFCLVTKKC	Brevinin-1BYa	24	Not Available	L	None	Free	Free	Antibacterial	Rana boylii, North America	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4362	19254736, 18957441	2009	GLMDTIKGVAKTVAASWLDKLKCKITGC	Ranatuerin-2Ya	28	Not Available	L	None	Free	Free	Antibacterial	North America, leopard frog, Lithobates yavapaiensis	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4361	19254736, 18957441	2009	FLPVIAGVAANFLPKLFCAISKKC	Brevinin-1BLa	24	Not Available	L	None	Free	Free	Antibacterial	North America, leopard frog, Lithobates blairi	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4360	19254736, 18957441	2009	FLPIIAGVAAKVLPKIFCAISKKC	Brevinin-1BLa	24	Not Available	L	None	Free	Free	Antibacterial	North America, leopard frog, Lithobates blairi	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4359	19254736, 18957441	2009	FLPIIAGIAAKFLPKIFCTISKKC	Brevinin-1BLa	24	Not Available	L	None	Free	Free	Antibacterial	North America, leopard frog, Lithobates blairi	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4358	19254736, 18957441	2009	FLPIIAGAAAKVVQKIFCAISKKC	Brevinin-1BLa	24	Not Available	L	None	Free	Free	Antibacterial	North America, leopard frog, Lithobates blairi	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4357	19254736, 18957441	2009	FLPIIAGAAAKVVEKIFCAISKKC	Brevinin-1BLa	24	Not Available	L	None	Free	Free	Antibacterial	North America, leopard frog, Lithobates blairi	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4356	19254736, 18957441	2009	FLPAIVGAAAKFLPKIFCAISKKC	Brevinin-1BLa	24	Not Available	L	None	Free	Free	Antibacterial	North America, leopard frog, Lithobates blairi	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	None
4354	None	2009	GRVPYPRGGLLkLLKklLKKLlKL	Sema3A(aa371-377) -nLytic	24	Linear	Mix	None	Free	Free	Anticancer	Synthetic Peptide	SU.86.86	Pancreatic Cancer	WST-1 assay	IC₅₀= 8.0 µM	48-h	Pancreatic	WO_2010_064207_A2
4353	None	2009	GRVPYPRGGLLkLLKklLKKLlKL	Sema3A(aa371-377) -nLytic	24	Linear	Mix	None	Free	Free	Anticancer	Synthetic Peptide	Pane- 1	Breast Cancer	WST-1 assay	IC₅₀= 14.1 µM	48-h	Breast	WO_2010_064207_A2
4352	None	2009	GRVPYPRGGLLkLLKklLKKLlKL	Sema3A(aa371-377) -nLytic	24	Linear	Mix	None	Free	Free	Anticancer	Synthetic Peptide	CFPAC-I	Pancreatic Cancer	WST-1 assay	IC₅₀= 9.2 µM	48-h	Pancreatic	WO_2010_064207_A2
4351	None	2009	GRVPYPRGGLLkLLKklLKKLlKL	Sema3A(aa371-377) -nLytic	24	Linear	Mix	None	Free	Free	Anticancer	Synthetic Peptide	BxPC-3	Pancreatic Cancer	WST-1 assay	IC₅₀= 14.7 µM	48-h	Pancreatic	WO_2010_064207_A2
4262	16568093	2006	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	IMR5	Tumor	MTT/MTS assay	2% apoptosis at 50 µM	8-h	Not Available	None
4261	16568093	2006	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	IMR5	Tumor	MTT/MTS assay	1% apoptosis at 20 µM	8-h	Not Available	None
4260	16568093	2006	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	IMR5	Tumor	MTT/MTS assay	0% apoptosis at 10 µM	8-h	Not Available	None
4259	16568093	2006	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	NGP	Tumor	MTT/MTS assay	3% apoptosis at 50 µM	8-h	Not Available	None
4258	16568093	2006	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	NGP	Tumor	MTT/MTS assay	2% apoptosis at 20 µM	8-h	Not Available	None
4257	16568093	2006	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	NGP	Tumor	MTT/MTS assay	1% apoptosis at 10 µM	8-h	Not Available	None
4256	16568093	2006	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	NB69	Brain Tumor	MTT/MTS assay	5% apoptosis at 50 µM	8-h	Brain	None
4255	16568093	2006	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	NB69	Brain Tumor	MTT/MTS assay	1% apoptosis at 20 µM	8-h	Brain	None
4254	16568093	2006	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	NB69	Brain Tumor	MTT/MTS assay	2% apoptosis at 10 µM	8-h	Brain	None
4253	16568093	2006	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	SK-N-AS	Brain Tumor	MTT/MTS assay	3% apoptosis at 50 µM	8-h	Brain	None
4252	16568093	2006	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	SK-N-AS	Brain Tumor	MTT/MTS assay	2% apoptosis at 20 µM	8-h	Brain	None
4251	16568093	2006	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	SK-N-AS	Brain Tumor	MTT/MTS assay	1% apoptosis at 10 µM	8-h	Brain	None
4250	16568093	2006	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	IMR5	Tumor	MTT/MTS assay	55% apoptosis at 50 µM	8-h	Not Available	None
4249	16568093	2006	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	IMR5	Tumor	MTT/MTS assay	35% apoptosis at 20 µM	8-h	Not Available	None
4248	16568093	2006	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	IMR5	Tumor	MTT/MTS assay	23% apoptosis at 10 µM	8-h	Not Available	None
4247	16568093	2006	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	NGP	Tumor	MTT/MTS assay	79% apoptosis at 50 µM	8-h	Not Available	None
4246	16568093	2006	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	NGP	Tumor	MTT/MTS assay	46% apoptosis at 20 µM	8-h	Not Available	None
4245	16568093	2006	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	NGP	Tumor	MTT/MTS assay	43% apoptosis at 10 µM	8-h	Not Available	None
4244	16568093	2006	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	NB69	Brain Tumor	MTT/MTS assay	68% apoptosis at 50 µM	8-h	Brain	None
4243	16568093	2006	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	NB69	Brain Tumor	MTT/MTS assay	66% apoptosis at 20 µM	8-h	Brain	None
4242	16568093	2006	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	NB69	Brain Tumor	MTT/MTS assay	25% apoptosis at 10 µM	8-h	Brain	None
4241	16568093	2006	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	SK-N-AS	Brain Tumor	MTT/MTS assay	65% apoptosis at 50 µM	8-h	Brain	None
4240	16568093	2006	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	SK-N-AS	Brain Tumor	MTT/MTS assay	45% apoptosis at 20 µM	8-h	Brain	None
4239	16568093	2006	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	Linear	Mix	None	Free	Free	Antitumor	Synthetic Peptide	SK-N-AS	Brain Tumor	MTT/MTS assay	8% apoptosis at 10 µM	8-h	Brain	None
4207	15867360	2005	LGQSAASAHHAYIVLAIENSFMTASKKK	hP8	28	Linear	L	None	Free	Free	Antiangiogenesis	Human endostatin peptides	BxPC-3	Pancreatic Cancer	Matrigel Assay	No inhibition at 7 mg/kg/d	672-h	Pancreatic	None
4206	15867360	2005	ETWRTEAPSATGQASSLLGGRLLGQ	hP7	25	Linear	L	None	Free	Free	Antiangiogenesis	Human endostatin peptides	BxPC-3	Pancreatic Cancer	Matrigel Assay	No inhibition at 7 mg/kg/d	672-h	Pancreatic	None
4205	15867360	2005	HPTWPQKSVWHGSDPNGRRLTESY	hP6	24	Linear	L	None	Free	Free	Antiangiogenesis	Human endostatin peptides	BxPC-3	Pancreatic Cancer	Matrigel Assay	No inhibition at 7 mg/kg/d	672-h	Pancreatic	None
4204	15867360	2005	GSEGPLKPGARIFSFDGKDVLRHPT	hP5	25	Linear	L	None	Free	Free	Antiangiogenesis	Human endostatin peptides	BxPC-3	Pancreatic Cancer	Matrigel Assay	29% inhibition at 7 mg/kg/d	672-h	Pancreatic	None
4203	15867360	2005	AAVPIVNLKDELLFPSWEALFSGSE	hP4	25	Linear	L	None	Free	Free	Antiangiogenesis	Human endostatin peptides	BxPC-3	Pancreatic Cancer	Matrigel Assay	No inhibition at 7 mg/kg/d	672-h	Pancreatic	None
4202	15867360	2005	TFRAFLSSRLQDLYSIVRRADRAAV	hP3	25	Linear	L	None	Free	Free	Antiangiogenesis	Human endostatin peptides	BxPC-3	Pancreatic Cancer	Matrigel Assay	No inhibition at 7 mg/kg/d	672-h	Pancreatic	None
4201	15867360	2005	MRGIRGADFQAFQQARAVGLAGTFR	hP2	25	Linear	L	None	Free	Free	Antiangiogenesis	Human endostatin peptides	BxPC-3	Pancreatic Cancer	Matrigel Assay	19% inhibition at 7 mg/kg/d	672-h	Pancreatic	None
4200	15867360	2005	HSHRDFQPVLHLVALNSPLSGGMRG	hP1	25	Linear	L	None	Free	Free	Antiangiogenesis	Human endostatin peptides	BxPC-3	Pancreatic Cancer	Matrigel Assay	39% inhibition at 7 mg/kg/d	672-h	Pancreatic	None
4198	15467750	2004	GRKKRRQRRRGGWMWVTNLRTD	TAT-Ras-GAP317-326	22	Linear	L	None	Free	Free	Anticancer	Not Available	HeLa	Cervical Cancer	LDH leakage assay	79% apoptosis at 50 µM	16 to 24-h	Cervix	None
4197	15467750	2004	GRKKRRQRRRGGWMWVTNLRTD	TAT-Ras-GAP317-326	22	Linear	L	None	Free	Free	Anticancer	Not Available	HeLa	Cervical Cancer	LDH leakage assay	72% apoptosis at 30 µM	16 to 24-h	Cervix	None
4196	15467750	2004	GRKKRRQRRRGGWMWVTNLRTD	TAT-Ras-GAP317-326	22	Linear	L	None	Free	Free	Anticancer	Not Available	HeLa	Cervical Cancer	LDH leakage assay	47% apoptosis at 20 µM	16 to 24-h	Cervix	None
4195	15467750	2004	GRKKRRQRRRGGWMWVTNLRTD	TAT-Ras-GAP317-326	22	Linear	L	None	Free	Free	Anticancer	Not Available	HeLa	Cervical Cancer	LDH leakage assay	15% apoptosis at 10 µM	16 to 24-h	Cervix	None
3842	20515045	2010	ACDCRGDCFCGGGGIVRRADRAAVP	AP(O)	25	Cyclic(C2-C10,C	L	None	Free	Free	Antitumor	Endostatin derived synthetic peptide	BAE	Tumor	MTT/MTS assay	52% inhibition at 10µg/ml	NA	Not Available	None
3841	20515045	2010	ACDCRGDCFCGGGGIVRRADRAAVP	AP(O)	25	Cyclic(C2-C10,C	L	None	Free	Free	Antitumor	Endostatin derived synthetic peptide	BAE	Tumor	MTT/MTS assay	42% inhibition at 5µg/ml	NA	Not Available	None
3840	20515045	2010	ACDCRGDCFCGGGGIVRRADRAAVP	AP(O)	25	Cyclic(C2-C10,C	L	None	Free	Free	Antitumor	Endostatin derived synthetic peptide	BAE	Tumor	MTT/MTS assay	40% inhibition at 2.5µg/ml	NA	Not Available	None
3839	20515045	2010	ACDCRGDCFCGGGGIVRRADRAAVP	AP	25	Linear	L	None	Free	Free	Antitumor	Endostatin derived synthetic peptide	BAE	Tumor	MTT/MTS assay	75% inhibition at 10µg/ml	NA	Not Available	None
3838	20515045	2010	ACDCRGDCFCGGGGIVRRADRAAVP	AP	25	Linear	L	None	Free	Free	Antitumor	Endostatin derived synthetic peptide	BAE	Tumor	MTT/MTS assay	40% inhibition at 5µg/ml	NA	Not Available	None
3837	20515045	2010	ACDCRGDCFCGGGGIVRRADRAAVP	AP	25	Linear	L	None	Free	Free	Antitumor	Endostatin derived synthetic peptide	BAE	Tumor	MTT/MTS assay	50% inhibition at 2.5µg/ml	NA	Not Available	None
3815	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Anticancer	Natural component of bee venom	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 1.4±0.1 µM	24-h	Skin	None
3813	23893605	2013	KILRGVAKKIMRTFLRRILTGKK	C7A- Δ	23	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 13.1±0.9 µM	24-h	Skin	None
3812	23893605	2013	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21k	27	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 12.3±1.0 µM	24-h	Skin	None
3811	23893605	2013	KILRGVAKKILRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 3.7± 4.3 µM	24-h	Skin	None
3810	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Anticancer	Residue of 39-65 of porcine NK-lysine	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 40 µM (approx)	24-h	Skin	None
3809	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Anticancer	Natural component of bee venom	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 1.8±0.1 µM	4-h	Skin	None
3807	23893605	2013	KILRGVAKKIMRTFLRRILTGKK	C7A- Δ	23	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 9.3±1.5 µM	4-h	Skin	None
3806	23893605	2013	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21k	27	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 8.3±0.5 µM	4-h	Skin	None
3805	23893605	2013	KILRGVAKKILRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 12.1±1.6 µM	4-h	Skin	None
3804	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Anticancer	Residue of 39-65 of porcine NK-lysine	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 50 µM (approx)	4-h	Skin	None
3803	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Anticancer	Natural component of bee venom	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 2.1±0.1 µM	2-h	Skin	None
3801	23893605	2013	KILRGVAKKIMRTFLRRILTGKK	C7A- Δ	23	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 13.8±2.0 µM	2-h	Skin	None
3800	23893605	2013	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21k	27	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 12.3±2.0 µM	2-h	Skin	None
3799	23893605	2013	KILRGVAKKILRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 13.0±1.0 µM	2-h	Skin	None
3798	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Anticancer	Residue of 39-65 of porcine NK-lysine	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 50 µM (approx)	2-h	Skin	None
3797	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Anticancer	Natural component of bee venom	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 3.2±0.1 µM	30-Min	Skin	None
3795	23893605	2013	KILRGVAKKIMRTFLRRILTGKK	C7A- Δ	23	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 7.5±0.4 µM	30-Min	Skin	None
3794	23893605	2013	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21k	27	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 8.4±0.2 µM	30-Min	Skin	None
3793	23893605	2013	KILRGVAKKILRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Anticancer	NK-2 variants	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 10.6±0.4 µM	30-Min	Skin	None
3792	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Anticancer	Residue of 39-65 of porcine NK-lysine	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 70 µM (approx)	30-Min	Skin	None
3791	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Anticancer	Natural component of bee venom	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 1.4±0.1 µM	4-h	Skin	None
3789	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Anticancer	Residue of 39-65 of porcine NK-lysine	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀= 4.3±0.3 µM	4-h	Skin	None
3772	22837667	2012	KWKSFlKTFKSlKKTVlHTllKAISS	Peptide L6D/L12D/L17D/L20D/L21D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 12.88±0.15 µMol/L	1-h	Cervix	None
3771	22837667	2012	KWKSFlKTFKSlKKTVlHTlLKAISS	Peptide L6D/L12D/L17D/L20D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 9.69±0.38 µMol/L	1-h	Cervix	None
3769	22837667	2012	KWKSFLKTFKSlKKTVLHTlLKAISS	Peptide L12D/L20D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 3.14±0.06 µMol/L	1-h	Cervix	None
3770	22837667	2012	KWKSFlKTFKSlKKTVLHTlLKAISS	Peptide L6D/L12D/L20D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 7.80±0.26 µMol/L	1-h	Cervix	None
3767	22837667	2012	KWKSFLKTFKSLKKTVLHTlLKAISS	Peptide L20D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 2.33±0.06 µMol/L	1-h	Cervix	None
3768	22837667	2012	KWKSFlKTFKSlKKTVLHTLLKAISS	Peptide L6D/L12D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 3.01±0.08 µMol/L	1-h	Cervix	None
3766	22837667	2012	KWKSFLKTFKSlKKTVLHTLLKAISS	Peptide L12D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 2.63±0.07 µMol/L	1-h	Cervix	None
3765	22837667	2012	KWKSFlKTFKSLKKTVLHTLLKAISS	Peptide L6D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 2.23±0.10 µMol/L	1-h	Cervix	None
3764	22837667	2012	kWkSFLkTFkSLKkTVLHTLLkAISS	Peptide K1D/K3D/K7D /K10D/K14D/K22D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 18.07±0.48 µMol/L	1-h	Cervix	None
3762	22837667	2012	KWKSFLkTFkSLKkTVLHTLLkAISS	Peptide K7D /K10D/K14D/K22D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 4.79±0.23 µMol/L	1-h	Cervix	None
3763	22837667	2012	KWkSFLkTFkSLKkTVLHTLLkAISS	Peptide K3D/K7D /K10D/K14D/K22D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 20.41±0.64 µMol/L	1-h	Cervix	None
3761	22837667	2012	KWKSFLkTFKSLKkTVLHTLLKAISS	Peptide K7D /K14D/K22D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 4.45±0.19 µMol/L	1-h	Cervix	None
3760	22837667	2012	KWKSFLKTFKSLKkTVLHTLLkAISS	Peptide K14D/K22D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 1.40±0.09 µMol/L	1-h	Cervix	None
3759	22837667	2012	KWKSFLkTFKSLKkTVLHTLLKAISS	Peptide K7D /K14D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 2.06±0.01 µMol/L	1-h	Cervix	None
3758	22837667	2012	KWKSFLKTFKSLKKTVLHTLLkAISS	Peptide K22D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 1.39±0.02 µMol/L	1-h	Cervix	None
3757	22837667	2012	KWKSFLKTFKSLKkTVLHTLLKAISS	Peptide K14D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 1.52±0.05 µMol/L	1-h	Cervix	None
3756	22837667	2012	KWKSFLkTFKSLKKTVLHTLLKAISS	Peptide K7D	26	Linear	Mix	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 1.29±0.03 µMol/L	1-h	Cervix	None
3755	22837667	2012	KWKSFLKTFKSLKKTVLHTLLKAISS	Peptide P	26	Linear	L	None	Amidation	Acetylation	Anticancer	A12L/A20L	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀= 1.71±0.07 µMol/L	1-h	Cervix	None
3718	24176852	2013	YGRKKRRQRRRREADFFWSLCTADMS	KilerFLIP	26	linear	L	None	Free	Free	NA	NA	Jurkat	Blood Cancer	Not Available	NA	NA	Blood	None
3468	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HTB-9	Bladder Cancer	MTT/MTS assay	~30% cytotoxicity at 1 µM	72-h	Bladder	WO_2012042540_A2
3469	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HTB-9	Bladder Cancer	MTT/MTS assay	>40% cytotoxicity at 10 µM	72-h	Bladder	WO_2012042540_A2
3466	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HTB-9	Bladder Cancer	MTT/MTS assay	<20% cytotoxicity at 1 µM	48-h	Bladder	WO_2012042540_A2
3467	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HTB-9	Bladder Cancer	MTT/MTS assay	20% cytotoxicity at 10 µM	48-h	Bladder	WO_2012042540_A2
3464	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HTB-9	Bladder Cancer	MTT/MTS assay	40% cytotoxicity at 1 µM	24-h	Bladder	WO_2012042540_A2
3465	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HTB-9	Bladder Cancer	MTT/MTS assay	~50% cytotoxicity at 10 µM	24-h	Bladder	WO_2012042540_A2
3462	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	72-h	Bladder	WO_2012042540_A2
3463	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	<5% cytotoxicity at 10 µM	72-h	Bladder	WO_2012042540_A2
3460	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	48-h	Bladder	WO2012042540A2
3461	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	<3% cytotoxicity at 10 µM	48-h	Bladder	WO_2012042540_A2
3458	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	<15% cytotoxicity at 1 µM	24-h	Bladder	WO_2012042540_A2
3459	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HTB-9	Bladder Cancer	MTT/MTS assay	~15% cytotoxicity at 10 µM	24-h	Bladder	WO_2012042540_A2
3450	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	CaSki	Cervical Cancer	MTT/MTS assay	~20% cytotoxicity at 1 µM	72-h	Cervix	WO_2012042540_A2
3451	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	CaSki	Cervical Cancer	MTT/MTS assay	~45% cytotoxicity at 10 µM	72-h	Cervix	WO_2012042540_A2
3449	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	CaSki	Cervical Cancer	MTT/MTS assay	~55% cytotoxicity at 10 µM	48-h	Cervix	WO_2012042540_A2
3447	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	CaSki	Cervical Cancer	MTT/MTS assay	~40% cytotoxicity at 10 µM	24-h	Cervix	WO_2012042540_A2
3448	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	CaSki	Cervical Cancer	MTT/MTS assay	~20% cytotoxicity at 1 µM	48-h	Cervix	WO_2012042540_A2
3445	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	>20% cytotoxicity at 10 µM	72-h	Cervix	WO_2012042540_A2
3446	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	CaSki	Cervical Cancer	MTT/MTS assay	~20% cytotoxicity at 1 µM	24-h	Cervix	WO_2012042540_A2
3443	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	>20% cytotoxicity at 10 µM	48-h	Cervix	WO_2012042540_A2
3444	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	~15% cytotoxicity at 1 µM	72-h	Cervix	WO2012042540A2
3441	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	~15% cytotoxicity at 10 µM	24-h	Cervix	WO_2012042540_A2
3442	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	<3% cytotoxicity at 1 µM	48-h	Cervix	WO_2012042540_A2
3440	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	CaSki	Cervical Cancer	MTT/MTS assay	~5% cytotoxicity at 1 µM	24-h	Cervix	WO_2012042540_A2
3433	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	SiHa	Cervical Cancer	MTT/MTS assay	~45% cytotoxicity at 10 µM	72-h	Cervix	WO_2012042540_A2
3432	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	SiHa	Cervical Cancer	MTT/MTS assay	~20% cytotoxicity at 1 µM	72-h	Cervix	WO_2012042540_A2
3431	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	SiHa	Cervical Cancer	MTT/MTS assay	~50% cytotoxicity at 10 µM	48-h	Cervix	WO_2012042540_A2
3430	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	SiHa	Cervical Cancer	MTT/MTS assay	<20% cytotoxicity at 1 µM	48-h	Cervix	WO_2012042540_A2
3429	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	SiHa	Cervical Cancer	MTT/MTS assay	>40% cytotoxicity at 10 µM	24-h	Cervix	WO_2012042540_A2
3428	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	SiHa	Cervical Cancer	MTT/MTS assay	>20% cytotoxicity at 1 µM	24-h	Cervix	WO2012042540A2
3427	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	~40% cytotoxicity at 10 µM	72-h	Cervix	WO_2012042540_A2
3426	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	~20% cytotoxicity at 1 µM	72-h	Cervix	WO_2012042540_A2
3425	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	>20% cytotoxicity at 10 µM	48-h	Cervix	WO_2012042540_A2
3424	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	<3% cytotoxicity at 1 µM	48-h	Cervix	WO_2012042540_A2
3423	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	>10% cytotoxicity at 10 µM	24-h	Cervix	WO_2012042540_A2
3422	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	SiHa	Cervical Cancer	MTT/MTS assay	5% cytotoxicity at 1 µM	24-h	Cervix	WO_2012042540_A2
3415	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HCT-116	Colon Cancer	MTT/MTS assay	~40% cytotoxicity at 10 µM	72-h	Colon	WO_2012042540_A2
3414	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HCT-116	Colon Cancer	MTT/MTS assay	>30% cytotoxicity at 1 µM	72-h	Colon	WO_2012042540_A2
3413	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HCT-116	Colon Cancer	MTT/MTS assay	>20% cytotoxicity at 10 µM	48-h	Colon	WO_2012042540_A2
3412	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HCT-116	Colon Cancer	MTT/MTS assay	<20% cytotoxicity at 1 µM	48-h	Colon	WO2012042540A2
3411	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HCT-116	Colon Cancer	MTT/MTS assay	50% cytotoxicity at 10 µM	24-h	Colon	WO_2012042540_A2
3410	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	HCT-116	Colon Cancer	MTT/MTS assay	>40% cytotoxicity at 1 µM	24-h	Colon	WO_2012042540_A2
3409	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 10 µM	72-h	Colon	WO_2012042540_A2
3408	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	72-h	Colon	WO_2012042540_A2
3407	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 10 µM	48-h	Colon	WO_2012042540_A2
3406	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	~5% cytotoxicity at 1 µM	48-h	Colon	WO_2012042540_A2
3405	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	15% cytotoxicity at 10 µM	24-h	Colon	WO_2012042540_A2
3404	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	HCT-116	Colon Cancer	MTT/MTS assay	<15% cytotoxicity at 1 µM	24-h	Colon	WO2012042540A2
3396	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	UM-UC-3	Bladder Cancer	MTT/MTS assay	>40% cytotoxicity at 1 µM	72-h	Bladder	WO2012042540A2
3397	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	UM-UC-3	Bladder Cancer	MTT/MTS assay	~50% cytotoxicity at 10 µM	72-h	Bladder	WO_2012042540_A2
3395	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	UM-UC-3	Bladder Cancer	MTT/MTS assay	~50% cytotoxicity at 10 µM	48-h	Bladder	WO_2012042540_A2
3394	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	UM-UC-3	Bladder Cancer	MTT/MTS assay	<30% cytotoxicity at 1 µM	48-h	Bladder	WO_2012042540_A2
3393	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	UM-UC-3	Bladder Cancer	MTT/MTS assay	<30% cytotoxicity at 10 µM	24-h	Bladder	WO_2012042540_A2
3392	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	UM-UC-3	Bladder Cancer	MTT/MTS assay	~30% cytotoxicity at 1 µM	24-h	Bladder	WO_2012042540_A2
3391	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	<45% cytotoxicity at 10 µM	72-h	Bladder	WO_2012042540_A2
3390	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	~45% cytotoxicity at 1 µM	72-h	Bladder	WO_2012042540_A2
3389	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	>25% cytotoxicity at 10 µM	48-h	Bladder	WO_2012042540_A2
3388	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	~25% cytotoxicity at 1 µM	48-h	Bladder	WO2012042540A2
3387	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	~25% cytotoxicity at 10 µM	24-h	Bladder	WO_2012042540_A2
3386	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	UM-UC-3	Bladder Cancer	MTT/MTS assay	~25% cytotoxicity at 1 µM	24-h	Bladder	WO_2012042540_A2
3379	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	COLO-205	Colon Cancer	MTT/MTS assay	~20% cytotoxicity at 10 µM	72-h	Colon	WO_2012042540_A2
3378	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	COLO-205	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	72-h	Colon	WO_2012042540_A2
3377	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	COLO-205	Colon Cancer	MTT/MTS assay	~35% cytotoxicity at 10 µM	48-h	Colon	WO_2012042540_A2
3376	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	COLO-205	Colon Cancer	MTT/MTS assay	>20% cytotoxicity at 1 µM	48-h	Colon	WO_2012042540_A2
3375	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	COLO-205	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 10 µM	24-h	Colon	WO_2012042540_A2
3374	None	2012	GQVWEATATVNAIRGSVTPAVSQFNARTAD	MB30	30	Linear	L	None	Free	Free	Anticancer	Derived from the MPT63 secreted protein	COLO-205	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	24-h	Colon	WO_2012042540_A2
3373	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 10 µM	72-h	Colon	WO_2012042540_A2
3372	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	>10% cytotoxicity at 1 µM	72-h	Colon	WO2012042540A2
3371	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	>10% cytotoxicity at 10 µM	48-h	Colon	WO_2012042540_A2
3370	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	10% cytotoxicity at 1 µM	48-h	Colon	WO_2012042540_A2
3369	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	~10% cytotoxicity at 10 µM	24-h	Colon	WO_2012042540_A2
3368	None	2012	TAGIKLTVPIEKFPVTTQTFWG	TG23	22	Linear	L	None	Free	Free	Anticancer	Derived from the SAG1 surface protein from the parasite Toxoplasma gondii	COLO-205	Colon Cancer	MTT/MTS assay	<5% cytotoxicity at 1 µM	24-h	Colon	WO_2012042540_A2
3338	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =2.1 ± 0.1 µM	2-h	Skin	None
3339	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =1.8 ± 0.1 µM	4-h	Skin	None
3340	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =1.4 ± 0.1 µM	24-h	Skin	None
3329	23893605	2013	KILRGVAKKIMRTFLRRILTGKK	C7A-Δ	24	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =7.5 ± 0.4 µM	30-Min	Skin	None
3330	23893605	2013	KILRGVAKKIMRTFLRRILTGKK	C7A-Δ	24	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =13.8 ± 2.0 µM	2-h	Skin	None
3331	23893605	2013	KILRGVAKKIMRTFLRRILTGKK	C7A-Δ	24	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =9.3 ± 1.5 µM	4-h	Skin	None
3332	23893605	2013	KILRGVAKKIMRTFLRRILTGKK	C7A-Δ	24	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =13.1 ± 0.9 µM	24-h	Skin	None
3337	23893605	2013	GIGAVLKVLTTGLPALISWIKRKRQQ	Melittin	26	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =3.2 ± 0.1 µM	30-Min	Skin	None
3328	23893605	2013	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =12.3 ± 1.0 µM	24-h	Skin	None
3327	23893605	2013	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =8.3 ± 0.5 µM	4-h	Skin	None
3326	23893605	2013	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =12.3 ± 2.0 µM	2-h	Skin	None
3325	23893605	2013	KILRGVAKKIMRTFLRRISKKILTGKK	C7A-D21K	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =8.4 ± 0.2 µM	30-Min	Skin	None
3324	23893605	2013	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =37 ± 4.3 µM	24-h	Skin	None
3323	23893605	2013	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =12.1 ± 1.6 µM	4-h	Skin	None
3322	23893605	2013	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =13.0 ± 1.0 µM	2-h	Skin	None
3321	23893605	2013	KILRGVAKKIMRTFLRRISKDILTGKK	C7A	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ =10.6 ± 0.4 µM	30-Min	Skin	None
3320	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ = ~40 µM	24-h	Skin	None
3319	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ = ~50 µM	4-h	Skin	None
3318	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ = ~50 µM	2-h	Skin	None
3317	23893605	2013	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Antimicrobial	Synthetic peptide	E42/02	Skin Cancer	MTT/MTS assay	IC₅₀ = ~70 µM	30-Min	Skin	None
3289	19527490	2009	KAAKKAAKAAKKAAKAAKKAA	KW5	21	Linear	L	None	Free	Free	Anticancer	Synthetic peptide	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀ =55±14 µM	NA	Colon	None
3288	19527490	2009	KAAKKAAKAAKKAAKAAKKAA	KW5	21	Linear	L	None	Free	Free	Anticancer	Bovine lactoferrin (Lf-B)	FEMX	Skin Cancer	MTT/MTS assay	IC₅₀ =30±3 µM	NA	Skin	None
3278	18815734	2008	KKKFPWWWPFKKKKKKFPWWWPFKKKK	di-PST13-RK-K	27	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of tritrpticin	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀ =10 µg/ml	NA	Breast	None
3277	18815734	2008	KKKFPWWWPFKKKKKKFPWWWPFKKKK	di-PST13-RK-K	27	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of tritrpticin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =15 µg/ml	NA	Lung	None
3275	18815734	2008	KKKFPWWWPFKKKCKKKFPWWWPFKKKC	di-PST13-RK-C	28	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of tritrpticin	MDA-MB-361	Breast Cancer	MTT/MTS assay	IC₅₀ =17 µg/ml	NA	Breast	None
3274	18815734	2008	KKKFPWWWPFKKKCKKKFPWWWPFKKKC	di-PST13-RK-C	28	Linear	L	None	Amidation	Free	Antimicrobial	Derivative of tritrpticin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀ =17 µg/ml	NA	Lung	None
3265	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SNU-1	Gastric Cancer	Cell Viability assay	<40% cell viability at 50 µM	NA	Stomach	None
3264	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SNU-1	Gastric Cancer	Cell Viability assay	100% cell viability at 5 µM	NA	Stomach	None
3263	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	U-937	Lymphoma Cancer	Cell Viability assay	<60% cell viability at 50 µM	NA	Blood	None
3262	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	U-937	Lymphoma Cancer	Cell Viability assay	100% cell viability at 5 µM	NA	Blood	None
3261	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SW-480	Colon Cancer	Cell Viability assay	60% cell viability at 50 µM	NA	Colon	None
3260	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SW-480	Colon Cancer	Cell Viability assay	>100% cell viability at 5 µM	NA	Colon	None
3259	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SNU-1	Gastric Cancer	Cell Viability assay	<20% cell viability at 50 µM	NA	Stomach	None
3258	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SNU-1	Gastric Cancer	Cell Viability assay	<100% cell viability at 5 µM	NA	Stomach	None
3257	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	U-937	Lymphoma Cancer	Cell Viability assay	<40% cell viability at 50 µM	NA	Blood	None
3256	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	U-937	Lymphoma Cancer	Cell Viability assay	100% cell viability at 5 µM	NA	Blood	None
3255	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SW-480	Colon Cancer	Cell Viability assay	40% cell viability at 50 µM	NA	Colon	None
3254	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SW-480	Colon Cancer	Cell Viability assay	100% cell viability at 5 µM	NA	Colon	None
3112	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SNU-1	Gastric Cancer	Cell Viability assay	<100% cell viability at 5 µM	24-h	Stomach	None
3113	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SNU-1	Gastric Cancer	Cell Viability assay	<40% cell viability at 50 µM	24-h	Stomach	None
3109	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SW-480	Colon Cancer	Cell Viability assay	60% cell viability at 50 µM	24-h	Colon	None
3110	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	U-937	Lymphoma Cancer	Cell Viability assay	100% cell viability at 5 µM	24-h	Blood	None
3111	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	U-937	Lymphoma Cancer	Cell Viability assay	<60% cell viability at 50 µM	24-h	Blood	None
3108	22783018	2012	PDEDAINDALNKVCSTGRRQRSICKQLLKK	N29D	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SW-480	Colon Cancer	Cell Viability assay	>100% cell viability at 5 µM	24-h	Colon	None
3107	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SNU-1	Gastric Cancer	Cell Viability assay	<20% cell viability at 50 µM	24-h	Stomach	None
3106	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SNU-1	Gastric Cancer	Cell Viability assay	<100% cell viability at 5 µM	24-h	Stomach	None
3105	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	U-937	Lymphoma Cancer	Cell Viability assay	<40% cell viability at 50 µM	24-h	Blood	None
3104	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	U-937	Lymphoma Cancer	Cell Viability assay	100% cell viability at 5 µM	24-h	Blood	None
3103	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SW-480	Colon Cancer	Cell Viability assay	40% cell viability at 50 µM	24-h	Colon	None
3102	22783018	2012	PDEDAINNALNKVCSTGRRQRSICKQLLKK	N29N	30	Linear	L	None	Free	Free	Antibacterial and Anticancer	Synthetic peptide	SW-480	Colon Cancer	Cell Viability assay	100% cell viability at 5 µM	24-h	Colon	None
3101	16004618	2005	MWKWFHNVLSSGQLLADKWWAWWYNWW	Pep27anal5	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=>70 µM	19.17-Min	Breast	None
3100	16004618	2005	MWKEFHNVLSSGQLLADKRWARWYNRW	Pep27anal4	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀= 29 µM	19.15-Min	Breast	None
3099	16004618	2005	MRKWFHNVLSSGQLLADKWPAWDYNRK	Pep27anal3	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀= 38 µM	20.08-Min	Breast	None
3098	16004618	2005	MWKWFHNVLSWWWLLADKRPARDYNRK	Pep27anal2	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀= <10 µM	22.5-Min	Breast	None
3097	16004618	2005	MWKWFHNVLSSWQLLADKRPARDYNRK	Pep27anal1	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀= 55 µM	18.67-Min	Breast	None
3096	16004618	2005	MRKEFHNVLSSGQLLADKRPARDYNRK	Pep27	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀= >70 µM	14.54-Min	Breast	None
3095	16004618	2005	MWKWFHNVLSSGQLLADKWWAWWYNWW	Pep27anal5	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	SNU-601	Gastric Cancer	MTT/MTS assay	IC₅₀=>70 µM	19.17-Min	Stomach	None
3094	16004618	2005	MWKEFHNVLSSGQLLADKRWARWYNRW	Pep27anal4	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	SNU-601	Gastric Cancer	MTT/MTS assay	IC₅₀= 37 µM	19.15-Min	Stomach	None
3093	16004618	2005	MRKWFHNVLSSGQLLADKWPAWDYNRK	Pep27anal3	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	SNU-601	Gastric Cancer	MTT/MTS assay	IC₅₀= 50 µM	20.08-Min	Stomach	None
3092	16004618	2005	MWKWFHNVLSWWWLLADKRPARDYNRK	Pep27anal2	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	SNU-601	Gastric Cancer	MTT/MTS assay	IC₅₀= 25 µM	22.5-Min	Stomach	None
3091	16004618	2005	MWKWFHNVLSSWQLLADKRPARDYNRK	Pep27anal1	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	SNU-601	Gastric Cancer	MTT/MTS assay	IC₅₀= 37 µM	18.67-Min	Stomach	None
3089	16004618	2005	MWKWFHNVLSSGQLLADKWWAWWYNWW	Pep27anal5	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=>70 µM	19.17-Min	Blood	None
3090	16004618	2005	MRKEFHNVLSSGQLLADKRPARDYNRK	Pep27	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	SNU-601	Gastric Cancer	MTT/MTS assay	IC₅₀= >70 µM	14.54-Min	Stomach	None
3088	16004618	2005	MWKEFHNVLSSGQLLADKRWARWYNRW	Pep27anal4	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀= 46 µM	19.15-Min	Blood	None
3087	16004618	2005	MRKWFHNVLSSGQLLADKWPAWDYNRK	Pep27anal3	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀= 50 µM	20.08-Min	Blood	None
3086	16004618	2005	MWKWFHNVLSWWWLLADKRPARDYNRK	Pep27anal2	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀= 23 µM	22.5-Min	Blood	None
3085	16004618	2005	MWKWFHNVLSSWQLLADKRPARDYNRK	Pep27anal1	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀= 47 µM	18.67-Min	Blood	None
3084	16004618	2005	MRKEFHNVLSSGQLLADKRPARDYNRK	Pep27	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	Jurkat	Blood Cancer	MTT/MTS assay	IC₅₀=>70 µM	14.54-Min	Blood	None
3083	16004618	2005	MWKWFHNVLSSGQLLADKWWAWWYNWW	Pep27anal5	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀= >70 µM	19.17-Min	Blood	None
3082	16004618	2005	MWKEFHNVLSSGQLLADKRWARWYNRW	Pep27anal4	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀=51 µM	19.15-Min	Blood	None
3081	16004618	2005	MRKWFHNVLSSGQLLADKWPAWDYNRK	Pep27anal3	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀= 52 µM	20.08-Min	Blood	None
3080	16004618	2005	MWKWFHNVLSWWWLLADKRPARDYNRK	Pep27anal2	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀= 20 µM	22.5-Min	Blood	None
3079	16004618	2005	MWKWFHNVLSSWQLLADKRPARDYNRK	Pep27anal1	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀= 53 µM	18.67-Min	Blood	None
3078	16004618	2005	MRKEFHNVLSSGQLLADKRPARDYNRK	Pep27	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀= >70 µM	14.54-Min	Blood	None
3077	16004618	2005	MWKWFHNVLSSGQLLADKWWAWWYNWW	Pep27anal5	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	AML-2	Leukemia Cancer	MTT/MTS assay	IC₅₀= >70 µM	19.17-Min	Blood	None
3076	16004618	2005	MWKEFHNVLSSGQLLADKRWARWYNRW	Pep27anal4	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	AML-2	Leukemia Cancer	MTT/MTS assay	IC₅₀= 50 µM	19.15-Min	Blood	None
3075	16004618	2005	MRKWFHNVLSSGQLLADKWPAWDYNRK	Pep27anal3	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	AML-2	Leukemia Cancer	MTT/MTS assay	IC₅₀= 67 µM	20.08-Min	Blood	None
3074	16004618	2005	MWKWFHNVLSWWWLLADKRPARDYNRK	Pep27anal2	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	AML-2	Leukemia Cancer	MTT/MTS assay	IC₅₀= 29 µM	22.5-Min	Blood	None
3073	16004618	2005	MWKWFHNVLSSWQLLADKRPARDYNRK	Pep27anal1	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	AML-2	Leukemia Cancer	MTT/MTS assay	IC₅₀= 50 µM	18.67-Min	Blood	None
3072	16004618	2005	MRKEFHNVLSSGQLLADKRPARDYNRK	Pep27	27	Linear	L	None	Free	Free	Anticancer	S. pneumoniae	AML-2	Leukemia Cancer	MTT/MTS assay	Not Available	14.54-Min	Blood	None
3071	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	10 % Cytotoxicity at 3.125 mg/L	24-h	Fibrous connective tissue	None
3070	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	1 % Cytotoxicity at 6.25 mg/L	24-h	Fibrous connective tissue	None
3069	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	20 % Cytotoxicity at 12.5 mg/L	24-h	Fibrous connective tissue	None
3068	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	90 % Cytotoxicity at 25 mg/L	24-h	Fibrous connective tissue	None
3067	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	90 % Cytotoxicity at 50 mg/L	24-h	Fibrous connective tissue	None
3066	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	15 % Cytotoxicity at 3.125 mg/L	12-h	Fibrous connective tissue	None
3065	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	35 % Cytotoxicity at 6.25 mg/L	12-h	Fibrous connective tissue	None
3064	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	30 % Cytotoxicity at 12.5 mg/L	12-h	Fibrous connective tissue	None
3063	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	85 % Cytotoxicity at 25 mg/L	12-h	Fibrous connective tissue	None
3062	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	90 % Cytotoxicity at 50 mg/L	12-h	Fibrous connective tissue	None
3061	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	35 % Cytotoxicity at 3.125 mg/L	6-h	Fibrous connective tissue	None
3060	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	30 % Cytotoxicity at 6.25 mg/L	6-h	Fibrous connective tissue	None
3059	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	48 % Cytotoxicity at 12.5 mg/L	6-h	Fibrous connective tissue	None
3058	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	84% Cytotoxicity at 25 mg/L	6-h	Fibrous connective tissue	None
3057	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	84 % Cytotoxicity at 50 mg/L	6-h	Fibrous connective tissue	None
3056	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	25 % Cytotoxicity at 3.125 mg/L	3-h	Fibrous connective tissue	None
3055	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	30 % Cytotoxicity at 6.25 mg/L	3-h	Fibrous connective tissue	None
3054	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	45 % Cytotoxicity at 12.5 mg/L	3-h	Fibrous connective tissue	None
3053	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	85 % Cytotoxicity at 25 mg/L	3-h	Fibrous connective tissue	None
3052	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	80 % Cytotoxicity at 50 mg/L	3-h	Fibrous connective tissue	None
3051	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	18 % Cytotoxicity at 3.125 mg/L	24-h	Cervix	None
3050	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	18 % Cytotoxicity at 6.25 mg/L	24-h	Cervix	None
3049	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	18 % Cytotoxicity at 12.5 mg/L	24-h	Cervix	None
3048	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	82 % Cytotoxicity at 25 mg/L	24-h	Cervix	None
3047	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	90 % Cytotoxicity at 50 mg/L	24-h	Cervix	None
3046	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	10 % Cytotoxicity at 3.125 mg/L	12-h	Cervix	None
3045	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	4 % Cytotoxicity at 6.25 mg/L	12-h	Cervix	None
3044	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	18 % Cytotoxicity at 12.5 mg/L	12-h	Cervix	None
3043	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	70 % Cytotoxicity at 25 mg/L	12-h	Cervix	None
3042	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	82 % Cytotoxicity at 50 mg/L	12-h	Cervix	None
3041	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	5 % Cytotoxicity at 3.125 mg/L	6-h	Cervix	None
3040	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	10 % Cytotoxicity at 6.25 mg/L	6-h	Cervix	None
3039	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	10 % Cytotoxicity at 12.5 mg/L	6-h	Cervix	None
3038	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	70 % Cytotoxicity at 25 mg/L	6-h	Cervix	None
3037	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	78 % Cytotoxicity at 50 mg/L	6-h	Cervix	None
3036	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	1 % Cytotoxicity at 3.125 mg/L	3-h	Cervix	None
3035	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	5 % Cytotoxicity at 6.25 mg/L	3-h	Cervix	None
3034	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	4 % Cytotoxicity at 12.5 mg/L	3-h	Cervix	None
3033	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	60 % Cytotoxicity at 25 mg/L	3-h	Cervix	None
3032	23598079	2013	GFFALIPKIISSPLFKTLLSAVGSALS	Pardaxin-6	27	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	70 % Cytotoxicity at 50 mg/L	3-h	Cervix	None
2955	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	28 % Cytotoxicity at 3.125 mg/L	24-h	Fibrous connective tissue	None
2954	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	30 % Cytotoxicity at 6.25 mg/L	24-h	Fibrous connective tissue	None
2952	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	85 % Cytotoxicity at 25 mg/L	24-h	Fibrous connective tissue	None
2953	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	38 % Cytotoxicity at 12.5 mg/L	24-h	Fibrous connective tissue	None
2951	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	84 % Cytotoxicity at 50 mg/L	24-h	Fibrous connective tissue	None
2950	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	28 % Cytotoxicity at 3.125 mg/L	12-h	Fibrous connective tissue	None
2949	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	30 % Cytotoxicity at 6.25 mg/L	12-h	Fibrous connective tissue	None
2948	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	46 % Cytotoxicity at 12.5 mg/L	12-h	Fibrous connective tissue	None
2947	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	96 % Cytotoxicity at 25 mg/L	12-h	Fibrous connective tissue	None
2946	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	95 % Cytotoxicity at 50 mg/L	12-h	Fibrous connective tissue	None
2945	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	25 % Cytotoxicity at 3.125 mg/L	6-h	Fibrous connective tissue	None
2944	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	25 % Cytotoxicity at 6.25 mg/L	6-h	Fibrous connective tissue	None
2943	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	45 % Cytotoxicity at 12.5 mg/L	6-h	Fibrous connective tissue	None
2942	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	95 % Cytotoxicity at 25 mg/L	6-h	Fibrous connective tissue	None
2941	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	90 % Cytotoxicity at 50 mg/L	6-h	Fibrous connective tissue	None
2940	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	41 % Cytotoxicity at 6.25 mg/L	3-h	Fibrous connective tissue	None
2939	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	41 % Cytotoxicity at 6.25 mg/L	3-h	Fibrous connective tissue	None
2938	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	41 % Cytotoxicity at 6.25 mg/L	3-h	Fibrous connective tissue	None
2937	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	39 % Cytotoxicity at 3.125 mg/L	3-h	Fibrous connective tissue	None
2936	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	41 % Cytotoxicity at 6.25 mg/L	3-h	Fibrous connective tissue	None
2935	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	42 % Cytotoxicity at 12.5 mg/L	3-h	Fibrous connective tissue	None
2934	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	85 % Cytotoxicity at 25 mg/L	3-h	Fibrous connective tissue	None
2933	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HT-1080	Fibrosarcoma	MTT/MTS assay	82 % Cytotoxicity at 50 mg/L	3-h	Fibrous connective tissue	None
2932	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	77 % Cytotoxicity at 25 mg/L	24-h	Cervix	None
2931	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	83% Cytotoxicity at 50 mg/L	24-h	Cervix	None
2930	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	65% Cytotoxicity at 25 mg/L	12-h	Cervix	None
2929	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	75 % Cytotoxicity at 50 mg/L	12-h	Cervix	None
2928	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	65% Cytotoxicity at 25 mg/L	6-h	Cervix	None
2927	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	75% Cytotoxicity at 50 mg/L	6-h	Cervix	None
2926	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	38% Cytotoxicity at 25 mg/L	3-h	Cervix	None
2925	23598079	2013	GFIFHIIKGLFHAGKMIHGLV	Epinecidin-1	21	Linear	L	None	Free	Free	Antimicrobial	Epinephelus nebulosus	HeLa	Cervical Cancer	MTT/MTS assay	45% Cytotoxicity at 50 mg/L	3-h	Cervix	None
2809	None	2005	FAKKLAKKLKKLAKKLAKLAKKL	Anubis-2	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =100 µg/ml	24-h	Cervix	US_06875744_B2
2805	None	2005	FAKKFAKKFKKFAKKFAKFAFAF	D2A21	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Cervix	US_06875744_B2
2804	None	2005	GIGKFLHAAKKFAKAFVAEIMNS	Magainin2wisc	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =125 µg/ml	24-h	Cervix	US_06875744_B2
2783	None	2005	FAVGLRAIKRALKKLRRGVRKVAKDL	FAGVL	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2761	None	2005	FAKLWAKLAFGKGIGKVGKKLL	FLAK50 Z4	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =215 µg/ml	24-h	Cervix	US_06875744_B2
2760	None	2005	FAKAIAKIAFGKGIGKVGKKLL	FLAK50 Z3	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2736	None	2005	GIGAVLKVLTTGLPALISWIKRKRQQ	MELITTIIN	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =35 µg/ml	24-h	Cervix	US_06875744_B2
2733	None	2005	KIAKVALAKLGIGAVLKVLTTGL	PYL-ME	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ = >1000 µg/ml	24-h	Cervix	US_06875744_B2
2728	None	2005	FAKKLAKKLKKLAKKLIGAVLKV	SHIVA 11[(1-16)ME(2-9]-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =180 µg/ml	24-h	Cervix	US_06875744_B2
2720	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =19 µg/ml	24-h	Cervix	US_06875744_B2
2719	None	2005	KTKLFKKFAKKLAKKLKKLAKKL	SHIVA 10 (1-16) Ac	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =97 µg/ml	24-h	Cervix	US_06875744_B2
2713	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =270 µg/ml	24-h	Cervix	US_06875744_B2
2712	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA 10 PEPTIDE 71 + KWKL	22	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Cervix	US_06875744_B2
2710	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA DERIV P69 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =28 µg/ml	24-h	Cervix	US_06875744_B2
2688	None	2005	GIGKFLKKAKKFGKAFVKILKK	MSI-78 AM	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	Not Available	24-h	Cervix	US_06875744_B2
2683	None	2005	FALALKALKKALkkLKKALKKAL	HECATE 2DAc	23	Linear	Mix	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	Not Available	24-h	Cervix	US_06875744_B2
2679	None	2005	VALALKALKKALKKLKKALKKAL	KAL V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =190 µg/ml	24-h	Cervix	US_06875744_B2
2675	None	2005	FALAKLAKKAKAKLKKALKAL	FLAK05 AM	21	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Cervix	US_06875744_B2
2674	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =20 µg/ml	24-h	Cervix	US_06875744_B2
2673	None	2005	FALALKALKKLLKKLKKLAKKAL	FLAK03 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =145 µg/ml	24-h	Cervix	US_06875744_B2
2672	None	2005	FALAAKALKKLAKKLKKLAKKAL	FLAK01 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =82 µg/ml	24-h	Cervix	US_06875744_B2
2671	None	2005	FAKKLAKKLKKLAKKLAKLALAL	SHIVA 10 AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Cervix	US_06875744_B2
2668	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =50 µg/ml	24-h	Cervix	US_06875744_B2
2667	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	HeLa	Cervical Cancer	MTT/MTS assay	LD₅₀ =95 µg/ml	24-h	Cervix	US_06875744_B2
2666	None	2005	FAKKLAKKLKKLAKKLAKLAKKL	Anubis-2	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =66 µg/ml	24-h	Prostate	US_06875744_B2
2662	None	2005	FAKKFAKKFKKFAKKFAKFAFAF	D2A21	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =45 µg/ml	24-h	Prostate	US_06875744_B2
2661	None	2005	GIGKFLHAAKKFAKAFVAEIMNS	Magainin2wisc	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =45 µg/ml	24-h	Prostate	US_06875744_B2
2640	None	2005	FAVGLRAIKRALKKLRRGVRKVAKDL	FAGVL	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =375 µg/ml	24-h	Prostate	US_06875744_B2
2618	None	2005	FAKLWAKLAFGKGIGKVGKKLL	FLAK50 Z4	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =310 µg/ml	24-h	Prostate	US_06875744_B2
2617	None	2005	FAKAIAKIAFGKGIGKVGKKLL	FLAK50 Z3	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Prostate	US_06875744_B2
2593	None	2005	GIGAVLKVLTTGLPALISWIKRKRQQ	MELITTIIN	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =13 µg/ml	24-h	Prostate	US_06875744_B2
2590	None	2005	KIAKVALAKLGIGAVLKVLTTGL	PYL-ME	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	Not Available	24-h	Prostate	US_06875744_B2
2585	None	2005	FAKKLAKKLKKLAKKLIGAVLKV	SHIVA 11[(1-16)ME(2-9]-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =28 µg/ml	24-h	Prostate	US_06875744_B2
2577	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =170 µg/ml	24-h	Prostate	US_06875744_B2
2576	None	2005	KTKLFKKFAKKLAKKLKKLAKKL	SHIVA 10 (1-16) Ac	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =28 µg/ml	24-h	Prostate	US_06875744_B2
2570	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7)Shiva10(1-16)	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =97 µg/ml	24-h	Prostate	US_06875744_B2
2569	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA 10 PEPTIDE 71 + KWKL	22	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =63 µg/ml	24-h	Prostate	US_06875744_B2
2567	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA DERIV P69 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =82 µg/ml	24-h	Prostate	US_06875744_B2
2545	None	2005	GIGKFLKKAKKFGKAFVKILKK	MSI-78 AM	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =66 µg/ml	24-h	Prostate	US_06875744_B2
2540	None	2005	FALALKALKKALkkLKKALKKAL	HECATE 2DAc	23	Linear	Mix	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =64 µg/ml	24-h	Prostate	US_06875744_B2
2536	None	2005	VALALKALKKALKKLKKALKKAL	KAL V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =65 µg/ml	24-h	Prostate	US_06875744_B2
2532	None	2005	FALAKLAKKAKAKLKKALKAL	FLAK05 AM	21	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =125 µg/ml	24-h	Prostate	US_06875744_B2
2531	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =12 µg/ml	24-h	Prostate	US_06875744_B2
2530	None	2005	FALALKALKKLLKKLKKLAKKAL	FLAK03 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =38 µg/ml	24-h	Prostate	US_06875744_B2
2529	None	2005	FALAAKALKKLAKKLKKLAKKAL	FLAK01 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =41 µg/ml	24-h	Prostate	US_06875744_B2
2528	None	2005	FAKKLAKKLKKLAKKLAKLALAL	SHIVA 10 AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =83 µg/ml	24-h	Prostate	US_06875744_B2
2525	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =44 µg/ml	24-h	Prostate	US_06875744_B2
2523	None	2005	FAKKLAKKLKKLAKKLAKLAKKL	Anubis-2	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Lung	US_06875744_B2
2524	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	PC-3	Prostate Cancer	MTT/MTS assay	LD₅₀ =61 µg/ml	24-h	Prostate	US_06875744_B2
2519	None	2005	FAKKFAKKFKKFAKKFAKFAFAF	D2A21	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =77 µg/ml	24-h	Lung	US_06875744_B2
2518	None	2005	GIGKFLHAAKKFAKAFVAEIMNS	Magainin2wisc	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =60 µg/ml	24-h	Lung	US_06875744_B2
2497	None	2005	FAVGLRAIKRALKKLRRGVRKVAKDL	FAGVL	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =315 µg/ml	24-h	Lung	US_06875744_B2
2475	None	2005	FAKLWAKLAFGKGIGKVGKKLL	FLAK50 Z4	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =115 µg/ml	24-h	Lung	US_06875744_B2
2474	None	2005	FAKAIAKIAFGKGIGKVGKKLL	FLAK50 Z3	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2450	None	2005	GIGAVLKVLTTGLPALISWIKRKRQQ	MELITTIIN	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =25 µg/ml	24-h	Lung	US_06875744_B2
2447	None	2005	KIAKVALAKLGIGAVLKVLTTGL	PYL-ME	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2442	None	2005	FAKKLAKKLKKLAKKLIGAVLKV	SHIVA 11[(1-16)ME(2-9]-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =54 µg/ml	24-h	Lung	US_06875744_B2
2434	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =22 µg/ml	24-h	Lung	US_06875744_B2
2433	None	2005	KTKLFKKFAKKLAKKLKKLAKKL	SHIVA 10 (1-16)	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =64 µg/ml	24-h	Lung	US_06875744_B2
2427	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7)Shiva10(1-16)	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =115 µg/ml	24-h	Lung	US_06875744_B2
2426	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA 10 PEPTIDE 71 + KWKL	22	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Lung	US_06875744_B2
2424	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA DERIV P69 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =63 µg/ml	24-h	Lung	US_06875744_B2
2402	None	2005	GIGKFLKKAKKFGKAFVKILKK	MSI-78 AM	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Lung	US_06875744_B2
2397	None	2005	FALALKALKKALkkLKKALKKAL	HECATE 2DAc	23	Linear	Mix	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Lung	US_06875744_B2
2393	None	2005	VALALKALKKALKKLKKALKKAL	KAL V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =125 µg/ml	24-h	Lung	US_06875744_B2
2389	None	2005	FALAKLAKKAKAKLKKALKAL	FLAK05 AM	21	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =84 µg/ml	24-h	Lung	US_06875744_B2
2388	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =37 µg/ml	24-h	Lung	US_06875744_B2
2387	None	2005	FALALKALKKLLKKLKKLAKKAL	FLAK03 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =72 µg/ml	24-h	Lung	US_06875744_B2
2386	None	2005	FALAAKALKKLAKKLKKLAKKAL	FLAK01 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =64 µg/ml	24-h	Lung	US_06875744_B2
2385	None	2005	FAKKLAKKLKKLAKKLAKLALAL	SHIVA 10 AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Lung	US_06875744_B2
2382	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Lung	US_06875744_B2
2381	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	H-1299	Lung Cancer	MTT/MTS assay	LD₅₀ =44 µg/ml	24-h	Lung	US_06875744_B2
2379	None	2005	VALALKALKKLAKKLKKLAKKAL	FLAK04 AM V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2378	None	2005	VALALKALKKALKKLKKALKKAL	Hecate AC V	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2377	None	2005	VALALKALKKALKKLKKALKKAL	Hecate AM V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2373	None	2005	VAKKFAKKFKKFAKKFAKFAFAF	D2A21V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2370	None	2005	FAKKLAKKLKKLAKKLAKLAKKL	Anubis-2	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =83 µg/ml	24-h	Skin	US_06875744_B2
2366	None	2005	FAKKFAKKFKKFAKKFAKFAFAF	D2A21	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2365	None	2005	GIGKFLHAAKKFAKAFVAEIMNS	Magainin2wisc	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =130 µg/ml	24-h	Skin	US_06875744_B2
2344	None	2005	FAVGLRAIKRALKKLRRGVRKVAKDL	FAGVL	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Skin	US_06875744_B2
2321	None	2005	FAKAIAKIAFGKGIGKVGKKLL	FLAK50 Z3	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2322	None	2005	FAKLWAKLAFGKGIGKVGKKLL	FLAK50 Z4	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =155 µg/ml	24-h	Skin	US_06875744_B2
2294	None	2005	KIAKVALAKLGIGAVLKVLTTGL	PYL-ME	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2297	None	2005	GIGAVLKVLTTGLPALISWIKRKRQQ	MELITTIIN	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =18 µg/ml	24-h	Skin	US_06875744_B2
2289	None	2005	FAKKLAKKLKKLAKKLIGAVLKV	SHIVA 11[(1-16)ME(2-9]-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =94 µg/ml	24-h	Skin	US_06875744_B2
2282	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =12 µg/ml	24-h	Skin	US_06875744_B2
2281	None	2005	KTKLFKKFAKKLAKKLKKLAKKL	SHIVA 10 (1-16) Ac	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =76 µg/ml	24-h	Skin	US_06875744_B2
2275	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7)Shiva10(1-16)	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =360 µg/ml	24-h	Skin	US_06875744_B2
2274	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA 10 PEPTIDE 71 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =290 µg/ml	24-h	Skin	US_06875744_B2
2272	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA DERIV P69 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =94 µg/ml	24-h	Skin	US_06875744_B2
2250	None	2005	GIGKFLKKAKKFGKAFVKILKK	MSI-78 AM	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2245	None	2005	FALALKALKKALkkLKKALKKAL	HECATE 2DAc	23	Linear	Mix	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Skin	US_06875744_B2
2241	None	2005	VALALKALKKALKKLKKALKKAL	KAL V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2235	None	2005	FALALKALKKLLKKLKKLAKKAL	FLAK03 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =85 µg/ml	24-h	Skin	US_06875744_B2
2236	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =36 µg/ml	24-h	Skin	US_06875744_B2
2237	None	2005	FALAKLAKKAKAKLKKALKAL	FLAK05 AM	21	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =94 µg/ml	24-h	Skin	US_06875744_B2
2233	None	2005	FAKKLAKKLKKLAKKLAKLALAL	SHIVA 10 AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2234	None	2005	FALAAKALKKLAKKLKKLAKKAL	FLAK01 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =27 µg/ml	24-h	Skin	US_06875744_B2
2230	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =128 µg/ml	24-h	Skin	US_06875744_B2
2229	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =72 µg/ml	24-h	Skin	US_06875744_B2
2227	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2226	None	2005	VALALKALKKALKKLKKALKKAL	Hecate AC V	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2225	None	2005	VALALKALKKALKKLKKALKKAL	Hecate AM V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2221	None	2005	VAKKFAKKFKKFAKKFAKFAFAF	D2A21V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2218	None	2005	FAKKLAKKLKKLAKKLAKLAKKL	Anubis-2	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =83 µg/ml	24-h	Skin	US_06875744_B2
2214	None	2005	FAKKFAKKFKKFAKKFAKFAFAF	D2A21	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2213	None	2005	GIGKFLHAAKKFAKAFVAEIMNS	Magainin2wisc	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =130 µg/ml	24-h	Skin	US_06875744_B2
2192	None	2005	FAVGLRAIKRALKKLRRGVRKVAKDL	FAGVL	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =600 µg/ml	24-h	Skin	US_06875744_B2
2169	None	2005	FAKAIAKIAFGKGIGKVGKKLL	FLAK50 Z3	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Skin	US_06875744_B2
2170	None	2005	FAKLWAKLAFGKGIGKVGKKLL	FLAK50 Z4	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =155 µg/ml	24-h	Skin	US_06875744_B2
2145	None	2005	GIGAVLKVLTTGLPALISWIKRKRQQ	MELITTIIN	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =18 µg/ml	24-h	Skin	US_06875744_B2
2142	None	2005	KIAKVALAKLGIGAVLKVLTTGL	PYL-ME	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2137	None	2005	FAKKLAKKLKKLAKKLIGAVLKV	SHIVA 11[(1-16)ME(2-9]-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =94 µg/ml	24-h	Skin	US_06875744_B2
2130	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =12 µg/ml	24-h	Skin	US_06875744_B2
2129	None	2005	KTKLFKKFAKKLAKKLKKLAKKL	SHIVA 10 (1-16) Ac	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =76 µg/ml	24-h	Skin	US_06875744_B2
2123	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7)Shiva10(1-16)	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =360 µg/ml	24-h	Skin	US_06875744_B2
2122	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA 10 PEPTIDE 71 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =290 µg/ml	24-h	Skin	US_06875744_B2
2120	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA DERIV P69 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =94 µg/ml	24-h	Skin	US_06875744_B2
2098	None	2005	GIGKFLKKAKKFGKAFVKILKK	MSI-78 AM	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2093	None	2005	FALALKALKKALkkLKKALKKAL	HECATE 2DAc	23	Linear	Mix	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Skin	US_06875744_B2
2089	None	2005	VALALKALKKALKKLKKALKKAL	KAL V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =140 µg/ml	24-h	Skin	US_06875744_B2
2085	None	2005	FALAKLAKKAKAKLKKALKAL	FLAK05 AM	21	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =94 µg/ml	24-h	Skin	US_06875744_B2
2084	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =36 µg/ml	24-h	Skin	US_06875744_B2
2083	None	2005	FALALKALKKLLKKLKKLAKKAL	FLAK03 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =85 µg/ml	24-h	Skin	US_06875744_B2
2082	None	2005	FALAAKALKKLAKKLKKLAKKAL	FLAK01 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =27 µg/ml	24-h	Skin	US_06875744_B2
2081	None	2005	FAKKLAKKLKKLAKKLAKLALAL	SHIVA 10 AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	Not Available	24-h	Skin	US_06875744_B2
2078	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =128 µg/ml	24-h	Skin	US_06875744_B2
2077	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	BMKC	Skin Cancer	MTT/MTS assay	LD₅₀ =72 µg/ml	24-h	Skin	US_06875744_B2
2075	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2074	None	2005	VALALKALKKALKKLKKALKKAL	Hecate AC V	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2073	None	2005	VALALKALKKALKKLKKALKKAL	Hecate AM V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2069	None	2005	VAKKFAKKFKKFAKKFAKFAFAF	D2A21V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
2066	None	2005	FAKKLAKKLKKLAKKLAKLAKKL	Anubis-2	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =73 µg/ml	24-h	Colon	US_06875744_B2
2062	None	2005	FAKKFAKKFKKFAKKFAKFAFAF	D2A21	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =76 µg/ml	24-h	Colon	US_06875744_B2
2061	None	2005	GIGKFLHAAKKFAKAFVAEIMNS	Magainin2wisc	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =60 µg/ml	24-h	Colon	US_06875744_B2
2040	None	2005	FAVGLRAIKRALKKLRRGVRKVAKDL	FAGVL	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =530 µg/ml	24-h	Colon	US_06875744_B2
2018	None	2005	FAKLWAKLAFGKGIGKVGKKLL	FLAK50 Z4	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =80 µg/ml	24-h	Colon	US_06875744_B2
2017	None	2005	FAKAIAKIAFGKGIGKVGKKLL	FLAK50 Z3	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =740 µg/ml	24-h	Colon	US_06875744_B2
1993	None	2005	GIGAVLKVLTTGLPALISWIKRKRQQ	MELITTIIN	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =23 µg/ml	24-h	Colon	US_06875744_B2
1990	None	2005	KIAKVALAKLGIGAVLKVLTTGL	PYL-ME	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Colon	US_06875744_B2
1985	None	2005	FAKKLAKKLKKLAKKLIGAVLKV	SHIVA 11[(1-16)ME(2-9]-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =120 µg/ml	24-h	Colon	US_06875744_B2
1978	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =13 µg/ml	24-h	Colon	US_06875744_B2
1977	None	2005	KTKLFKKFAKKLAKKLKKLAKKL	SHIVA 10 (1-16) Ac	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =35 µg/ml	24-h	Colon	US_06875744_B2
1971	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =70 µg/ml	24-h	Colon	US_06875744_B2
1970	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA 10 PEPTIDE 71 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =82 µg/ml	24-h	Colon	US_06875744_B2
1968	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA DERIV P69 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =11 µg/ml	24-h	Colon	US_06875744_B2
1946	None	2005	GIGKFLKKAKKFGKAFVKILKK	MSI-78 AM	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =34 µg/ml	24-h	Colon	US_06875744_B2
1941	None	2005	FALALKALKKALkkLKKALKKAL	HECATE 2DAc	23	Linear	Mix	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =57 µg/ml	24-h	Colon	US_06875744_B2
1937	None	2005	VALALKALKKALKKLKKALKKAL	KAL V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =62 µg/ml	24-h	Colon	US_06875744_B2
1933	None	2005	FALAKLAKKAKAKLKKALKAL	FLAK05 AM	21	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =8 µg/ml	24-h	Colon	US_06875744_B2
1932	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =12 µg/ml	24-h	Colon	US_06875744_B2
1931	None	2005	FALALKALKKLLKKLKKLAKKAL	FLAK03 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =38 µg/ml	24-h	Colon	US_06875744_B2
1930	None	2005	FALAAKALKKLAKKLKKLAKKAL	FLAK01 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =5 µg/ml	24-h	Colon	US_06875744_B2
1929	None	2005	FAKKLAKKLKKLAKKLAKLALAL	SHIVA 10 AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	Not Available	24-h	Colon	US_06875744_B2
1926	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =46 µg/ml	24-h	Colon	US_06875744_B2
1925	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	SW-480	Colon Cancer	MTT/MTS assay	LD₅₀ =6 µg/ml	24-h	Colon	US_06875744_B2
1923	None	2005	VALALKALKKLAKKLKKLAKKAL	FLAK04 AM V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =84 µg/ml	24-h	Breast	US_06875744_B2
1922	None	2005	VALALKALKKALKKLKKALKKAL	Hecate AC V	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =160 µg/ml	24-h	Breast	US_06875744_B2
1921	None	2005	VALALKALKKALKKLKKALKKAL	Hecate AM V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =340 µg/ml	24-h	Breast	US_06875744_B2
1917	None	2005	VAKKFAKKFKKFAKKFAKFAFAF	D2A21V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =210 µg/ml	24-h	Breast	US_06875744_B2
1914	None	2005	FAKKLAKKLKKLAKKLAKLAKKL	Anubis-2	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =38 µg/ml	24-h	Breast	US_06875744_B2
1910	None	2005	FAKKFAKKFKKFAKKFAKFAFAF	D2A21	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =64 µg/ml	24-h	Breast	US_06875744_B2
1909	None	2005	GIGKFLHAAKKFAKAFVAEIMNS	Magainin2wisc	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =22 µg/ml	24-h	Breast	US_06875744_B2
1888	None	2005	FAVGLRAIKRALKKLRRGVRKVAKDL	FAGVL	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =240 µg/ml	24-h	Breast	US_06875744_B2
1866	None	2005	FAKLWAKLAFGKGIGKVGKKLL	FLAK50 Z4	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =54 µg/ml	24-h	Breast	US_06875744_B2
1865	None	2005	FAKAIAKIAFGKGIGKVGKKLL	FLAK50 Z3	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1841	None	2005	GIGAVLKVLTTGLPALISWIKRKRQQ	MELITTIIN	26	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =9 µg/ml	24-h	Breast	US_06875744_B2
1838	None	2005	KIAKVALAKLGIGAVLKVLTTGL	PYL-ME	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =635 µg/ml	24-h	Breast	US_06875744_B2
1833	None	2005	FAKKLAKKLKKLAKKLIGAVLKV	SHIVA 11[(1-16)ME(2-9]-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =95 µg/ml	24-h	Breast	US_06875744_B2
1826	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA(1-7) Shiva10(1-16)-COOH	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =63 µg/ml	24-h	Breast	US_06875744_B2
1825	None	2005	KTKLFKKFAKKLAKKLKKLAKKL	SHIVA 10 (1-16) Ac	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =29 µg/ml	24-h	Breast	US_06875744_B2
1819	None	2005	KWKLFKKKTKLFKKFAKKLAKKL	CA (1-7) Shiva10 (1-16)	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =150 µg/ml	24-h	Breast	US_06875744_B2
1818	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA 10 PEPTIDE 71 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =93 µg/ml	24-h	Breast	US_06875744_B2
1816	None	2005	FAKKLAKKLKKLAKKLAKKWKL	SHIVA DERIV P69 + KWKL	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =44 µg/ml	24-h	Breast	US_06875744_B2
1794	None	2005	GIGKFLKKAKKFGKAFVKILKK	MSI-78 AM	22	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =31 µg/ml	24-h	Breast	US_06875744_B2
1789	None	2005	FALALKALKKALkkLKKALKKAL	HECATE 2DAc	23	Linear	Mix	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =14 µg/ml	24-h	Breast	US_06875744_B2
1785	None	2005	VALALKALKKALKKLKKALKKAL	KAL V	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =72 µg/ml	24-h	Breast	US_06875744_B2
1781	None	2005	FALAKLAKKAKAKLKKALKAL	FLAK05 AM	21	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =74 µg/ml	24-h	Breast	US_06875744_B2
1780	None	2005	FALALKALKKLAKKLKKLAKKAL	FLAK04 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =10 µg/ml	24-h	Breast	US_06875744_B2
1779	None	2005	FALALKALKKLLKKLKKLAKKAL	FLAK03 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =26 µg/ml	24-h	Breast	US_06875744_B2
1778	None	2005	FALAAKALKKLAKKLKKLAKKAL	FLAK01 AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =62 µg/ml	24-h	Breast	US_06875744_B2
1777	None	2005	FAKKLAKKLKKLAKKLAKLALAL	SHIVA 10 AC	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =>1000 µg/ml	24-h	Breast	US_06875744_B2
1774	None	2005	FALALKALKKALKKLKKALKKAL	Hecate AM	23	Linear	L	None	Amidation	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =23 µg/ml	24-h	Breast	US_06875744_B2
1773	None	2005	FALALKALKKALKKLKKALKKAL	Hecate Ac	23	Linear	L	None	Free	Free	Anticancer	FLAK peptides	MCF-7	Breast Cancer	MTT/MTS assay	LD₅₀ =54 µg/ml	24-h	Breast	US_06875744_B2
1707	9614066	1998	ALWKDILKNVGKAAGKAVLNTVTDMVNQ	DRS B4	28	Linear	L	None	Amidation	Free	Antimicrobial	Dermaseptins B	MCF-7	Breast Cancer	Thymidine Incorporation assay	Cytotoxicity =15 µM	6-h	Breast	None
1706	9614066	1998	ALWKNMLKGIGKLAGQAALGAVKTLVGA	DRS B3	28	Linear	L	None	Free	Free	Antimicrobial	Dermaseptins B	MCF-7	Breast Cancer	Thymidine Incorporation assay	Cytotoxicity =12 µM	6-h	Breast	None
1669	15796184	2005	LRVRLASHLRKLRKRLLRDADDLQKRLAVY	Apo E	30	Linear	L	None	Free	Free	Antibacterial	Apoprotein E	COLO-201	Colon Cancer	MTT/MTS assay	65 % Cytotoxity at 40 µg/ml	4-h	Colon	None
1668	15796184	2005	LRVRLASHLRKLRKRLLRDADDLQKRLAVY	Apo E	30	Linear	L	None	Free	Free	Antibacterial	Apoprotein E	MKN-7	Gastric Cancer	MTT/MTS assay	35 % Cytotoxity at 40 µg/ml	4-h	Stomach	None
1667	15796184	2005	LRVRLASHLRKLRKRLLRDADDLQKRLAVY	Apo E	30	Linear	L	None	Free	Free	Antibacterial	Apoprotein E	MKN-1	Gastric Cancer	MTT/MTS assay	60 % Cytotoxity at 40 µg/ml	4-h	Stomach	None
1666	15796184	2005	LRVRLASHLRKLRKRLLRDADDLQKRLAVY	Apo E	30	Linear	L	None	Free	Free	Antibacterial	Apoprotein E	Paca-2	Pancreatic Cancer	MTT/MTS assay	55 % Cytotoxity at 40 µg/ml	4-h	Pancreatic	None
1665	15796184	2005	LRVRLASHLRKLRKRLLRDADDLQKRLAVY	Apo E	30	Linear	L	None	Free	Free	Antibacterial	Apoprotein E	PANC-1	Pancreatic Cancer	MTT/MTS assay	55 % Cytotoxity at 40 µg/ml	4-h	Pancreatic	None
1664	11835991	2001	SIGAKILGGVKTFFKGALKELASTYLQ	maximin5	27	Linear	L	None	Free	Free	Antimicrobial	Bombina maxima	T-24	Bladder Cancer	MTT/MTS assay	IC₅₀=>50 µg/ml	48-h	Bladder	None
1663	11835991	2001	GIGVLLSAGKAALKGLAKVLAEKYAN	maximin4	26	Linear	L	None	Amidation	Free	Antimicrobial	Bombina maxima	T-24	Bladder Cancer	MTT/MTS assay	IC₅₀=>50 µg/ml	48-h	Bladder	None
1662	11835991	2001	GIGGKILSGLKTALKGAAKELASTYLH	maximin3	27	Linear	L	None	Free	Free	Antimicrobial	Bombina maxima	T-24	Bladder Cancer	MTT/MTS assay	IC₅₀ =18 µg/ml	48-h	Bladder	None
1661	11835991	2001	GIGTKILGGVKTALKGALKELASTYAN	maximin1	27	Linear	L	None	Amidation	Free	Antimicrobial	Bombina maxima	T-24	Bladder Cancer	MTT/MTS assay	IC₅₀ =35.4 µg/ml	48-h	Bladder	None
1660	11835991	2001	SIGAKILGGVKTFFKGALKELASTYLQ	maximin5	27	Linear	L	None	Free	Free	Antimicrobial	Bombina maxima	BIU-87	Bladder Cancer	MTT/MTS assay	IC₅₀ =>50 µg/ml	48-h	Bladder	None
1659	11835991	2001	GIGVLLSAGKAALKGLAKVLAEKYAN	maximin4	26	Linear	L	None	Amidation	Free	Antimicrobial	Bombina maxima	BIU-87	Bladder Cancer	MTT/MTS assay	IC₅₀ =>50 µg/ml	48-h	Bladder	None
1658	11835991	2001	GIGGKILSGLKTALKGAAKELASTYLH	maximin3	27	Linear	L	None	Free	Free	Antimicrobial	Bombina maxima	BIU-87	Bladder Cancer	MTT/MTS assay	IC₅₀=28 µg/ml	48-h	Bladder	None
1657	11835991	2001	GIGTKILGGVKTALKGALKELASTYAN	maximin1	27	Linear	L	None	Amidation	Free	Antimicrobial	Bombina maxima	BIU-87	Bladder Cancer	MTT/MTS assay	IC₅₀=20.5 µg/ml	48-h	Bladder	None
1656	11835991	2001	SIGAKILGGVKTFFKGALKELASTYLQ	maximin5	27	Linear	L	None	Free	Free	Antimicrobial	Bombina maxima	MOLT-4	Leukemia Cancer	MTT/MTS assay	IC₅₀ >50 µg/ml	48-h	Blood	None
1655	11835991	2001	GIGVLLSAGKAALKGLAKVLAEKYAN	maximin4	26	Linear	L	None	Amidation	Free	Antimicrobial	Bombina maxima	MOLT-4	Leukemia Cancer	MTT/MTS assay	IC₅₀ =53.4 µg/ml	48-h	Blood	None
1654	11835991	2001	GIGGKILSGLKTALKGAAKELASTYLH	maximin3	27	Linear	L	None	Free	Free	Antimicrobial	Bombina maxima	MOLT-4	Leukemia Cancer	MTT/MTS assay	IC₅₀ =25.2 µg/ml	48-h	Blood	None
1653	11835991	2001	GIGTKILGGVKTALKGALKELASTYAN	maximin1	27	Linear	L	None	Amidation	Free	Antimicrobial	Bombina maxima	MOLT-4	Leukemia Cancer	MTT/MTS assay	IC₅₀=24.3 µg/ml	48-h	Blood	None
1652	11835991	2001	SIGAKILGGVKTFFKGALKELASTYLQ	maximin5	27	Linear	L	None	Free	Free	Antimicrobial	Bombina maxima	C8166	Leukemia Cancer	MTT/MTS assay	IC₅₀=34.4 µg/ml	48-h	Blood	None
1651	11835991	2001	GIGVLLSAGKAALKGLAKVLAEKYAN	maximin4	26	Linear	L	None	Amidation	Free	Antimicrobial	Bombina maxima	C8166	Leukemia Cancer	MTT/MTS assay	IC₅₀=24.2 µg/ml	48-h	Blood	None
1650	11835991	2001	GIGGKILSGLKTALKGAAKELASTYLH	maximin3	27	Linear	L	None	Free	Free	Antimicrobial	Bombina maxima	C8166	Leukemia Cancer	MTT/MTS assay	IC₅₀=11.4 µg/ml	48-h	Blood	None
1649	11835991	2001	GIGTKILGGVKTALKGALKELASTYAN	maximin1	27	Linear	L	None	Amidation	Free	Antimicrobial	Bombina maxima	C8166	Leukemia Cancer	MTT/MTS assay	IC₅₀=15.3 µg/ml	48-h	Blood	None
1549	18656352	2008	KAQIRAMECNILGRKKRRQRRR	Tat-a5	22	Linear	L	None	Free	Free	Anticancer	HIV-Tat (49-57)	HCT-116	Colon Cancer	MTT/MTS assay	~80% Cytotoxicity at 100 µM	24-h	Colon	None
1538	16637646	2006	IGKEFKRIVQRIKDFLRNLVPRTES	LL-37(13-37)	25	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	HBMEC	Prostate Cancer	MTT/MTS assay	LC₅₀=38 µM	24-h	Not Available	None
1532	16637646	2006	IGKEFKRIVQRIKDFLRNLVPRTES	LL-37(13-37)	25	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	KB	Oral Cancer	MTT/MTS assay	LC₅₀=40 µM	24-h	Not Available	None
1526	16637646	2006	IGKEFKRIVQRIKDFLRNLVPRTES	LL-37(13-37)	25	Linear	L	None	Free	Free	Antibacterial	LL-37,a series of peptide fragments	KBv	Tumor	MTT/MTS assay	LC₅₀=39 µM	24-h	Not Available	None
1524	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKLISS	A12L/A20L/A23L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=2.2 µMo/L	36-h	Cervix	None
1523	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKAISS	A12L/A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=2 µMo/L	36-h	Cervix	None
1522	21252288	2011	KWKSFLKTFKSAKKTVLHTLLKAISS	A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=4.3 µMo/L	36-h	Cervix	None
1521	21252288	2011	KWKSFLKTFKSLKKTVLHTALKAISS	A12L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=3.8 µMo/L	36-h	Cervix	None
1520	21252288	2011	KWKSFLKTFKSAKKTVLHTALKAISS	P	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=10.4 µMo/L	36-h	Cervix	None
1519	21252288	2011	KWKSFAKTFKSAKKTVLHTALKAISS	L6A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=58.6 µMo/L	36-h	Cervix	None
1518	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=64.7 µMo/L	36-h	Cervix	None
1517	21252288	2011	KWKSFLKTFKSAKKTVAHTALKAISS	L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Cervix	None
1516	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L17A/L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Cervix	None
1515	21252288	2011	KWKSFAKTFKSAKKTVAHTALKAISS	L6A/L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	HeLa	Cervical Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Cervix	None
1514	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKLISS	A12L/A20L/A23L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=4.6 µMo/L	36-h	Skin	None
1513	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKAISS	A12L/A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=4.4 µMo/L	36-h	Skin	None
1512	21252288	2011	KWKSFLKTFKSAKKTVLHTLLKAISS	A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=7.8 µMo/L	36-h	Skin	None
1511	21252288	2011	KWKSFLKTFKSLKKTVLHTALKAISS	A12L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=5.2 µMo/L	36-h	Skin	None
1510	21252288	2011	KWKSFLKTFKSAKKTVLHTALKAISS	P	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=11.5 µMo/L	36-h	Skin	None
1509	21252288	2011	KWKSFAKTFKSAKKTVLHTALKAISS	L6A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=62.5 µMo/L	36-h	Skin	None
1508	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=63.5 µMo/L	36-h	Skin	None
1507	21252288	2011	KWKSFLKTFKSAKKTVAHTALKAISS	L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Skin	None
1506	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L17A/L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Skin	None
1505	21252288	2011	KWKSFAKTFKSAKKTVAHTALKAISS	L6A/L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	B-16	Skin Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Skin	None
1504	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKLISS	A12L/A20L/A23L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=2.7 µMo/L	36-h	Lung	None
1503	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKAISS	A12L/A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=4.1 µMo/L	36-h	Lung	None
1502	21252288	2011	KWKSFLKTFKSAKKTVLHTLLKAISS	A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=2.9 µMo/L	36-h	Lung	None
1501	21252288	2011	KWKSFLKTFKSLKKTVLHTALKAISS	A12L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=4.4 µMo/L	36-h	Lung	None
1500	21252288	2011	KWKSFLKTFKSAKKTVLHTALKAISS	P	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=4.7 µMo/L	36-h	Lung	None
1499	21252288	2011	KWKSFAKTFKSAKKTVLHTALKAISS	L6A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=14 µMo/L	36-h	Lung	None
1498	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=15.6 µMo/L	36-h	Lung	None
1497	21252288	2011	KWKSFLKTFKSAKKTVAHTALKAISS	L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=16.4 µMo/L	36-h	Lung	None
1496	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L17A/L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=37.7 µMo/L	36-h	Lung	None
1495	21252288	2011	KWKSFAKTFKSAKKTVAHTALKAISS	L6A/L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	H-1299	Lung Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Lung	None
1494	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKLISS	A12L/A20L/A23L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=5.5 µMo/L	36-h	Muscle	None
1493	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKAISS	A12L/A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=6.4 µMo/L	36-h	Muscle	None
1492	21252288	2011	KWKSFLKTFKSAKKTVLHTLLKAISS	A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=9.8 µMo/L	36-h	Muscle	None
1491	21252288	2011	KWKSFLKTFKSLKKTVLHTALKAISS	A12L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=7.5 µMo/L	36-h	Muscle	None
1490	21252288	2011	KWKSFLKTFKSAKKTVLHTALKAISS	P	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=25.2 µMo/L	36-h	Muscle	None
1488	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Muscle	None
1489	21252288	2011	KWKSFAKTFKSAKKTVLHTALKAISS	L6A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Muscle	None
1487	21252288	2011	KWKSFLKTFKSAKKTVAHTALKAISS	L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Muscle	None
1486	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L17A/L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Muscle	None
1484	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKLISS	A12L/A20L/A23L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=3.5 µMo/L	36-h	Colon	None
1485	21252288	2011	KWKSFAKTFKSAKKTVAHTALKAISS	L6A/L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	RD	Rhabdomyosarcoma Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Muscle	None
1483	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKAISS	A12L/A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=4.3 µMo/L	36-h	Colon	None
1482	21252288	2011	KWKSFLKTFKSAKKTVLHTLLKAISS	A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=5 µMo/L	36-h	Colon	None
1481	21252288	2011	KWKSFLKTFKSLKKTVLHTALKAISS	A12L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=6.4 µMo/L	36-h	Colon	None
1480	21252288	2011	KWKSFLKTFKSAKKTVLHTALKAISS	P	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=11.1 µMo/L	36-h	Colon	None
1479	21252288	2011	KWKSFAKTFKSAKKTVLHTALKAISS	L6A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Colon	None
1478	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Colon	None
1477	21252288	2011	KWKSFLKTFKSAKKTVAHTALKAISS	L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Colon	None
1476	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L17A/L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Colon	None
1475	21252288	2011	KWKSFAKTFKSAKKTVAHTALKAISS	L6A/L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	SW-1116	Colorectal Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Colon	None
1474	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKLISS	A12L/A20L/A23L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=5.7 µMo/L	36-h	Breast	None
1473	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKAISS	A12L/A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=6.2 µMo/L	36-h	Breast	None
1472	21252288	2011	KWKSFLKTFKSAKKTVLHTLLKAISS	A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=5.1 µMo/L	36-h	Breast	None
1471	21252288	2011	KWKSFLKTFKSLKKTVLHTALKAISS	A12L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=5 µMo/L	36-h	Breast	None
1470	21252288	2011	KWKSFLKTFKSAKKTVLHTALKAISS	P	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=15.8 µMo/L	36-h	Breast	None
1469	21252288	2011	KWKSFAKTFKSAKKTVLHTALKAISS	L6A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=62.3 µMo/L	36-h	Breast	None
1468	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=70.8 µMo/L	36-h	Breast	None
1467	21252288	2011	KWKSFLKTFKSAKKTVAHTALKAISS	L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Breast	None
1466	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L17A/L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Breast	None
1465	21252288	2011	KWKSFAKTFKSAKKTVAHTALKAISS	L6A/L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Breast	None
1464	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKLISS	A12L/A20L/A23L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=7.2 µMo/L	36-h	Skin	None
1463	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKAISS	A12L/A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=8.7 µMo/L	36-h	Skin	None
1462	21252288	2011	KWKSFLKTFKSAKKTVLHTLLKAISS	A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=6.5 µMo/L	36-h	Skin	None
1461	21252288	2011	KWKSFLKTFKSLKKTVLHTALKAISS	A12L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=4.3 µMo/L	36-h	Skin	None
1460	21252288	2011	KWKSFLKTFKSAKKTVLHTALKAISS	P	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=17.8 µMo/L	36-h	Skin	None
1458	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=59.8 µMo/L	36-h	Skin	None
1459	21252288	2011	KWKSFAKTFKSAKKTVLHTALKAISS	L6A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=58.7 µMo/L	36-h	Skin	None
1455	21252288	2011	KWKSFAKTFKSAKKTVAHTALKAISS	L6A/L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Skin	None
1456	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L17A/L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Skin	None
1457	21252288	2011	KWKSFLKTFKSAKKTVAHTALKAISS	L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-375	Skin Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Skin	None
1452	21252288	2011	KWKSFLKTFKSAKKTVLHTLLKAISS	A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=8.7 µMo/L	36-h	Lung	None
1453	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKAISS	A12L/A20L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=9.7 µMo/L	36-h	Lung	None
1454	21252288	2011	KWKSFLKTFKSLKKTVLHTLLKLISS	A12L/A20L/A23L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=9.2 µMo/L	36-h	Lung	None
1449	21252288	2011	KWKSFAKTFKSAKKTVLHTALKAISS	L6A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=53 µMo/L	36-h	Lung	None
1450	21252288	2011	KWKSFLKTFKSAKKTVLHTALKAISS	P	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=33 µMo/L	36-h	Lung	None
1451	21252288	2011	KWKSFLKTFKSLKKTVLHTALKAISS	A12L	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=11.1 µMo/L	36-h	Lung	None
1446	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L17A/L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Lung	None
1447	21252288	2011	KWKSFLKTFKSAKKTVAHTALKAISS	L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Lung	None
1448	21252288	2011	KWKSFLKTFKSAKKTVAHTAAKAISS	L21A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=71 µMo/L	36-h	Lung	None
1445	21252288	2011	KWKSFAKTFKSAKKTVAHTALKAISS	L6A/L17A	26	Linear	L	None	Free	Free	Anticancer	PeptideV13K	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=>83.6 µMo/L	36-h	Lung	None
1438	21955251	2011	GIIKKIIIKKIIIKKIIIKKI	Cationic Amphiphilic	21	Cyclic	L	None	Free	Free	Antimicrobial	AMP	HL-60	Pancreatic Cancer	WST-1 assay	IC₅₀ = 10 µM	Not Available	Pancreatic	None
1435	21955251	2011	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Free	Free	Antimicrobial	Xenopus laevis	HeLa	Pancreatic Cancer	WST-1 assay	IC₅₀ = >60 µM	Not Available	Pancreatic	None
1434	21955251	2011	GIIKKIIIKKIIIKKIIIKKI	Cationic Amphiphilic	21	Cyclic	L	None	Free	Free	Antimicrobial	AMP	HeLa	Pancreatic Cancer	WST-1 assay	IC₅₀ = 4 µM	Not Available	Pancreatic	None
1431	16269280	2005	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Antibacterial	NK-lysin	SW-480	Leukemia Cancer	PI-uptake assay	LD₅₀=1-4 µM	Not Available	Blood	None
1430	16269280	2005	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Antibacterial	NK-lysin	U-937	Lymphoma Cancer	PI-uptake assay	LD₅₀=30 µM	Not Available	Blood	None
1429	16269280	2005	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Antibacterial	NK-lysin	SH-SY5Y	Brain Tumor	PI-uptake assay	LD₅₀=1-4 µM	Not Available	Brain	None
1428	16269280	2005	KILRGVCKKIMRTFLRRISKDILTGKK	NK-2	27	Linear	L	None	Amidation	Free	Antibacterial	NK-lysin	NB LA-N-1	Colorectal Cancer	PI-uptake assay	LD₅₀=1-4 µM	Not Available	Colon	None
1425	7768152, 21403917	1994	GIGKFLKKAKKFGKAFVKILKK	PexigaNAn MSI-78	22	Linear	L	None	Amidation	Free	Antimicrobial	Helical peptide with a predominance of one or more amino acids tryptophane-rich	U-937	Lymphoma Cancer	MTT/MTS assay	75% Cytotoxicity at 0.5 µg/ml	6-h	Blood	None
1420	8573171, 21403917	1996	TRSSRAGLQFPVGRVHRLLRK	Buforin2	21	Linear	L	None	Amidation	Free	Antimicrobial	Bufo Bufo Gargarizans	U-937	Lymphoma Cancer	MTT/MTS assay	5% Cytotoxicity at 0.5 µg/ml	6-h	Blood	None
1413	1708887, 2285300	1990	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	PC-3	Prostate Cancer	Trypan blue assay	IC₅₀ >200 µg/ml	72-h	Prostate	None
1412	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z24	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	PC-3	Prostate Cancer	Trypan blue assay	Not Available	72-h	Prostate	None
1411	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z44	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	PC-3	Prostate Cancer	Trypan blue assay	Not Available	72-h	Prostate	None
1410	1708887, 2285300	1990	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	PC-3	Prostate Cancer	Trypan blue assay	IC₅₀=53 µg/ml	72-h	Prostate	None
1409	1708887, 2285300	1990	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	PC-3	Prostate Cancer	Trypan blue assay	IC₅₀=47 µg/ml	72-h	Prostate	None
1408	1708887, 2285300	1990	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	PC-3	Prostate Cancer	Trypan blue assay	IC₅₀=41 µg/ml	72-h	Prostate	None
1407	1708887, 2285300	1990	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	MCF-7	Breast Cancer	Trypan blue assay	IC₅₀ >200 µg/ml	72-h	Breast	None
1406	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z24	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	MCF-7	Breast Cancer	Trypan blue assay	Not Available	72-h	Breast	None
1405	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z44	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	MCF-7	Breast Cancer	Trypan blue assay	Not Available	72-h	Breast	None
1404	1708887, 2285300	1990	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	MCF-7	Breast Cancer	Trypan blue assay	IC₅₀=49 µg/ml	72-h	Breast	None
1403	1708887, 2285300	1990	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	MCF-7	Breast Cancer	Trypan blue assay	IC₅₀=42 µg/ml	72-h	Breast	None
1402	1708887, 2285300	1990	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	MCF-7	Breast Cancer	Trypan blue assay	IC₅₀=37 µg/ml	72-h	Breast	None
1401	1708887, 2285300	1990	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	CHP-100	Ewing sarcoma	Trypan blue assay	IC₅₀ >200 µg/ml	72-h	Blood	None
1400	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z24	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	CHP-100	Ewing sarcoma	Trypan blue assay	Not Available	72-h	Blood	None
1399	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z44	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	CHP-100	Ewing sarcoma	Trypan blue assay	Not Available	72-h	Blood	None
1398	1708887, 2285300	1990	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	CHP-100	Ewing sarcoma	Trypan blue assay	IC₅₀=45 µg/ml	72-h	Blood	None
1397	1708887, 2285300	1990	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	CHP-100	Ewing sarcoma	Trypan blue assay	IC₅₀=39 µg/ml	72-h	Blood	None
1396	1708887, 2285300	1990	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	CHP-100	Ewing sarcoma	Trypan blue assay	IC₅₀=32 µg/ml	72-h	Blood	None
1395	1708887, 2285300	1990	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	K-562	Leukemia Cancer	Trypan blue assay	IC₅₀ >150 µg/ml	72-h	Blood	None
1394	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z24	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	K-562	Leukemia Cancer	Trypan blue assay	IC₅₀=112 µg/ml	72-h	Blood	None
1393	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z44	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	K-562	Leukemia Cancer	Trypan blue assay	IC₅₀=98 µg/ml	72-h	Blood	None
1392	1708887, 2285300	1990	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	K-562	Leukemia Cancer	Trypan blue assay	IC₅₀=40 µg/ml	72-h	Blood	None
1391	1708887, 2285300	1990	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	K-562	Leukemia Cancer	Trypan blue assay	IC₅₀=37 µg/ml	72-h	Blood	None
1390	1708887, 2285300	1990	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	K-562	Leukemia Cancer	Trypan blue assay	IC₅₀=32 µg/ml	72-h	Blood	None
1389	1708887, 2285300	1990	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	Raji	Lymphoma Cancer	Trypan blue assay	IC₅₀ >150 µg/ml	72-h	Blood	None
1388	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z24	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	Raji	Lymphoma Cancer	Trypan blue assay	IC₅₀=72 µg/ml	72-h	Blood	None
1387	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z44	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	Raji	Lymphoma Cancer	Trypan blue assay	IC₅₀=64 µg/ml	72-h	Blood	None
1386	1708887, 2285300	1990	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	Raji	Lymphoma Cancer	Trypan blue assay	IC₅₀=20 µg/ml	72-h	Blood	None
1385	1708887, 2285300	1990	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	Raji	Lymphoma Cancer	Trypan blue assay	IC₅₀=25 µg/ml	72-h	Blood	None
1384	1708887, 2285300	1990	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	Raji	Lymphoma Cancer	Trypan blue assay	IC₅₀=23 µg/ml	72-h	Blood	None
1383	1708887, 2285300	1990	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	MLA	Leukemia Cancer	Trypan blue assay	IC₅₀ >150 µg/ml	72-h	Blood	None
1382	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z24	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	MLA	Leukemia Cancer	Trypan blue assay	IC₅₀=102 µg/ml	72-h	Blood	None
1381	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z44	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	MLA	Leukemia Cancer	Trypan blue assay	IC₅₀=80 µg/ml	72-h	Blood	None
1380	1708887, 2285300	1990	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	MLA	Leukemia Cancer	Trypan blue assay	IC₅₀=34 µg/ml	72-h	Blood	None
1379	1708887, 2285300	1990	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	MLA	Leukemia Cancer	Trypan blue assay	IC₅₀=33 µg/ml	72-h	Blood	None
1378	1708887, 2285300	1990	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	MLA	Leukemia Cancer	Trypan blue assay	IC₅₀=30 µg/ml	72-h	Blood	None
1377	1708887, 2285300	1990	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	Daudi	Colon Cancer	Trypan blue assay	IC₅₀ >150 µg/ml	72-h	Blood	None
1375	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z44	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	Daudi	Brain Tumor	Trypan blue assay	IC₅₀=115 µg/ml	72-h	Blood	None
1376	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z24	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	Daudi	Leukemia Cancer	Trypan blue assay	IC₅₀=143 µg/ml	72-h	Blood	None
1374	1708887, 2285300	1990	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	Daudi	Lung Cancer	Trypan blue assay	IC₅₀=30 µg/ml	72-h	Blood	None
1373	1708887, 2285300	1990	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	Daudi	Renal Cancer	Trypan blue assay	IC₅₀=38 µg/ml	72-h	Blood	None
1372	1708887, 2285300	1990	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	Daudi	Ovarian Cancer	Trypan blue assay	IC₅₀=28 µg/ml	72-h	Blood	None
1371	1708887, 2285300	1990	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	SSKT-1	Hematopoietic Cancer	Trypan blue assay	IC₅₀ >150 µg/ml	72-h	Blood	None
1370	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z24	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	SSKT-1	Hematopoietic Cancer	Trypan blue assay	IC₅₀=109 µg/ml	72-h	Blood	None
1369	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z44	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	SSKT-1	Hematopoietic Cancer	Trypan blue assay	IC₅₀=107 µg/ml	72-h	Blood	None
1367	1708887, 2285300	1990	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	SSKT-1	Hematopoietic Cancer	Trypan blue assay	IC₅₀=29 µg/ml	72-h	Blood	None
1368	1708887, 2285300	1990	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	SSKT-1	Hematopoietic Cancer	Trypan blue assay	IC₅₀=23 µg/ml	72-h	Blood	None
1366	1708887, 2285300	1990	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	SSKT-1	Hematopoietic Cancer	Trypan blue assay	IC₅₀=27 µg/ml	72-h	Blood	None
1365	1708887, 2285300	1990	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	8402	Leukemia Cancer	Trypan blue assay	IC₅₀ >150 µg/ml	72-h	Blood	None
1364	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z24	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	8402	Leukemia Cancer	Trypan blue assay	IC₅₀=83 µg/ml	72-h	Blood	None
1363	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z44	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	8402	Leukemia Cancer	Trypan blue assay	IC₅₀=60 µg/ml	72-h	Blood	None
1362	1708887, 2285300	1990	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	8402	Leukemia Cancer	Trypan blue assay	IC₅₀=18 µg/ml	72-h	Blood	None
1361	1708887, 2285300	1990	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	8402	Leukemia Cancer	Trypan blue assay	IC₅₀=16 µg/ml	72-h	Blood	None
1360	1708887, 2285300	1990	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	8402	Leukemia Cancer	Trypan blue assay	IC₅₀=12 µg/ml	72-h	Blood	None
1359	1708887, 2285300	1990	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	U-937	Lymphoma Cancer	Trypan blue assay	IC₅₀ >150 µg/ml	72-h	Blood	None
1358	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z24	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	U-937	Lymphoma Cancer	Trypan blue assay	IC₅₀=123 µg/ml	72-h	Blood	None
1357	1708887, 2285300	1990	ALSKALSKALSKALSKALSKALSK	Z44	24	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	U-937	Lymphoma Cancer	Trypan blue assay	IC₅₀=97 µg/ml	72-h	Blood	None
1356	1708887, 2285300	1990	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	U-937	Lymphoma Cancer	Trypan blue assay	IC₅₀=16 µg/ml	72-h	Blood	None
1355	1708887, 2285300	1990	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	Xenopus laevis	U-937	Lymphoma Cancer	Trypan blue assay	IC₅₀=19 µg/ml	72-h	Blood	None
1354	1708887, 2285300	1990	GIGKFLHAAKKFAKAFVAEIMNS	Magainin B	23	Linear	L	None	Amidation	Free	Antibacterial	Xenopus laevis	U-937	Lymphoma Cancer	Trypan blue assay	IC₅₀=17 µg/ml	72-h	Blood	None
1353	18425992	2008	RKAFRWAWRMLKKAAPSITCVR	mPep1	22	Linear	L	None	Free	Free	Antimicrobial	Bovine lactoferrin (Lf-B)	HL-60	Skin Cancer	MTT/MTS assay	IC₅₀=8 µM	24-h	Blood	None
1352	18425992	2008	FKCRRWQWRMKKLGAPSITCVR	pep1	22	Linear	L	None	Free	Free	Antimicrobial	Bovine lactoferrin (Lf-B)	HL-60	Prostate Cancer	MTT/MTS assay	IC₅₀=77 µM	24-h	Blood	None
1314	16476519	2006	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antimicrobial	African clawed frog Xenopus laevis skin	486P(G4)	Bladder Cancer	Cell Viability assay	IC₅₀=59.4 µM	48-h	Bladder	None
1313	16476519	2006	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antimicrobial	African clawed frog Xenopus laevis skin	647V(G2)	Bladder Cancer	Cell Viability assay	IC₅₀=31 µM	48-h	Bladder	None
1312	16476519	2006	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antimicrobial	African clawed frog Xenopus laevis skin	RT4(G1)	Bladder Cancer	Cell Viability assay	IC₅₀=135.3 µM	48-h	Bladder	None
1311	16476519	2006	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antimicrobial	African clawed frog Xenopus laevis skin	486P(G4)	Bladder Cancer	WST-1 assay	IC₅₀=57.8 µM	48-h	Bladder	None
1310	16476519	2006	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antimicrobial	African clawed frog Xenopus laevis skin	647V(G2)	Bladder Cancer	WST-1 assay	IC₅₀=52.4 µM	48-h	Bladder	None
1308	16476519	2006	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antimicrobial	African clawed frog Xenopus laevis skin	486P(G4)	Bladder Cancer	LDH leakage assay	IC₅₀=28.6 µM	48-h	Bladder	None
1309	16476519	2006	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antimicrobial	African clawed frog Xenopus laevis skin	RT4(G1)	Bladder Cancer	WST-1 assay	IC₅₀=484 µM	48-h	Bladder	None
1307	16476519	2006	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antimicrobial	African clawed frog Xenopus laevis skin	647V(G2)	Bladder Cancer	LDH leakage assay	IC₅₀=54.1 µM	48-h	Bladder	None
1306	16476519	2006	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antimicrobial	African clawed frog Xenopus laevis skin	RT4(G1)	Bladder Cancer	LDH leakage assay	IC₅₀=32.3 µM	48-h	Bladder	None
1118	8319212	1993	gigkflkkakkfakafvkiinn	MSI-238	22	Linear	D	None	Amidation	Free	Antibacterial	African clawed frog Xenopus laevis skin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=6 µM	48-h	Lung	None
1117	8319212	1993	GIGKFLKKAKKFAKAFVKIINN	MSI-136	22	Linear	L	None	Amidation	Free	Antibacterial	African clawed frog Xenopus laevis skin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=10 µM	48-h	Lung	None
1116	8319212	1993	GIGKFLHSAKKFGKAFVGEIMNS	Magainin 2	23	Linear	L	None	Amidation	Free	Antibacterial	African clawed frog Xenopus laevis skin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=110 µM	48-h	Lung	None
1110	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	DU-145	Prostate Cancer	MTT/MTS assay	IC₅₀=15.3 µg/ml	48-h	Prostate	None
1108	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	SW-620	Colon Cancer	MTT/MTS assay	IC₅₀=12.7 µg/ml	48-h	Colon	None
1109	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀=12 µg/ml	48-h	Prostate	None
1107	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	KM12	Colon Cancer	MTT/MTS assay	IC₅₀=12 µg/ml	48-h	Colon	None
1106	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	HT-29	Colon Cancer	MTT/MTS assay	IC₅₀=17.6 µg/ml	48-h	Colon	None
1105	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	HCT-15	Colon Cancer	MTT/MTS assay	IC₅₀=13.2 µg/ml	48-h	Colon	None
1103	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	COLO-205	Colon Cancer	MTT/MTS assay	IC₅₀=11.2 µg/ml	48-h	Colon	None
1104	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	HCT-116	Colon Cancer	MTT/MTS assay	IC₅₀=14.6 µg/ml	48-h	Colon	None
1102	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	Histone H2A	SK-OV-3	Ovarian Cancer	MTT/MTS assay	IC₅₀=12.6 µg/ml	48-h	Ovary	None
1101	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	OVRCAR-8	Ovarian Cancer	MTT/MTS assay	IC₅₀=13 µg/ml	48-h	Ovary	None
1100	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	OVRCAR-5	Ovarian Cancer	MTT/MTS assay	IC₅₀=13.8 µg/ml	48-h	Ovary	None
1099	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	OVRCAR-4	Ovarian Cancer	MTT/MTS assay	IC₅₀=17.6 µg/ml	48-h	Ovary	None
1098	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	OVRCAR-3	Ovarian Cancer	MTT/MTS assay	IC₅₀=15.2 µg/ml	48-h	Ovary	None
1097	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	IGROV1	Ovarian Cancer	MTT/MTS assay	IC₅₀=9 µg/ml	48-h	Ovary	None
1096	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	UO-31	Renal Cancer	MTT/MTS assay	IC₅₀=10.6 µg/ml	48-h	Renal	None
1094	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	SN-12C	Renal Cancer	MTT/MTS assay	IC₅₀=11.4 µg/ml	48-h	Renal	None
1095	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	TK-10	Renal Cancer	MTT/MTS assay	IC₅₀=13.1 µg/ml	48-h	Renal	None
1093	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	RFX393	Renal Cancer	MTT/MTS assay	IC₅₀=11 µg/ml	48-h	Renal	None
1092	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	CAKI-1	Renal Cancer	MTT/MTS assay	IC₅₀=14.1 µg/ml	48-h	Renal	None
1091	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	ACHN	Renal Cancer	MTT/MTS assay	IC₅₀=12 µg/ml	48-h	Renal	None
1090	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	A-498	Renal Cancer	MTT/MTS assay	IC₅₀=10 µg/ml	48-h	Renal	None
1089	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	786-0	Renal Cancer	MTT/MTS assay	IC₅₀=12.2 µg/ml	48-h	Renal	None
1088	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	UACC-62	Skin Cancer	MTT/MTS assay	IC₅₀=10.6 µg/ml	48-h	Skin	None
1087	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	UACC-257	Skin Cancer	MTT/MTS assay	IC₅₀=12.5 µg/ml	48-h	Skin	None
1086	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	SK-MEL-5	Skin Cancer	MTT/MTS assay	IC₅₀=8.9 µg/ml	48-h	Skin	None
1085	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	SK-MEL-2	Skin Cancer	MTT/MTS assay	IC₅₀=11.1 µg/ml	48-h	Skin	None
1083	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	MALME-3M	Skin Cancer	MTT/MTS assay	IC₅₀=10.9 µg/ml	48-h	Skin	None
1084	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	M14	Skin Cancer	MTT/MTS assay	IC₅₀=15.1 µg/ml	48-h	Skin	None
1082	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	LOXIMVI	Skin Cancer	MTT/MTS assay	IC₅₀=9.5 µg/ml	48-h	Skin	None
1080	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	SNB-75	Brain Tumor	MTT/MTS assay	IC₅₀=15.5 µg/ml	48-h	Brain	None
1081	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	U-251	Brain Tumor	MTT/MTS assay	IC₅₀=10.6 µg/ml	48-h	Brain	None
1079	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	SNB-19	Brain Tumor	MTT/MTS assay	IC₅₀=13.8 µg/ml	48-h	Brain	None
1078	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	SF-539	Brain Tumor	MTT/MTS assay	IC₅₀=9.5 µg/ml	48-h	Brain	None
1077	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	SF-295	Brain Tumor	MTT/MTS assay	IC₅₀=12.9 µg/ml	48-h	Brain	None
1076	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	SF-268	Brain Tumor	MTT/MTS assay	IC₅₀=12.4 µg/ml	48-h	Brain	None
1075	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	NCI-H522	Lung Cancer	MTT/MTS assay	IC₅₀=11.2 µg/ml	48-h	Lung	None
1074	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	NCI-H460	Lung Cancer	MTT/MTS assay	IC₅₀=12.1 µg/ml	48-h	Lung	None
1073	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	NCI-H322M	Lung Cancer	MTT/MTS assay	IC₅₀=10.7 µg/ml	48-h	Lung	None
1072	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	NCI-H23	Lung Cancer	MTT/MTS assay	IC₅₀=10.8 µg/ml	48-h	Lung	None
1071	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	NCI-H226	Lung Cancer	MTT/MTS assay	IC₅₀=13.3 µg/ml	48-h	Lung	None
1070	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	HOP-92	Lung Cancer	MTT/MTS assay	IC₅₀=7.2 µg/ml	48-h	Lung	None
1069	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	HOP-62	Lung Cancer	MTT/MTS assay	IC₅₀=12.6 µg/ml	48-h	Lung	None
1068	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	EKVX	Lung Cancer	MTT/MTS assay	IC₅₀=12.1 µg/ml	48-h	Lung	None
1067	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=11.7 µg/ml	48-h	Lung	None
1066	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	T-47D	Breast Cancer	MTT/MTS assay	IC₅₀=23.9 µg/ml	48-h	Breast	None
1065	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	BT-549	Breast Cancer	MTT/MTS assay	IC₅₀=12.9 µg/ml	48-h	Breast	None
1064	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	MDA-N	Breast Cancer	MTT/MTS assay	IC₅₀=10.6 µg/ml	48-h	Breast	None
1063	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	MDA-MB-435	Breast Cancer	MTT/MTS assay	IC₅₀=11.3 µg/ml	48-h	Breast	None
1062	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	HS578T	Breast Cancer	MTT/MTS assay	IC₅₀=11.7 µg/ml	48-h	Breast	None
1061	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	MDA-MB-231	Breast Cancer	MTT/MTS assay	IC₅₀=11.3 µg/ml	48-h	Breast	None
1060	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	NCI/ADR-RES	Breast Cancer	MTT/MTS assay	IC₅₀=11.5 µg/ml	48-h	Breast	None
1059	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=15.1 µg/ml	48-h	Breast	None
1058	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	SR	Leukemia Cancer	MTT/MTS assay	IC₅₀=20.2 µg/ml	48-h	Blood	None
1057	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	RPMI-8226	Leukemia Cancer	MTT/MTS assay	IC₅₀=10.5 µg/ml	48-h	Blood	None
1056	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	MOLT-4	Leukemia Cancer	MTT/MTS assay	IC₅₀=17 µg/ml	48-h	Blood	None
1055	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	K-562	Leukemia Cancer	MTT/MTS assay	IC₅₀=8.2 µg/ml	48-h	Blood	None
1054	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	HL-60	Leukemia Cancer	MTT/MTS assay	IC₅₀=11.3 µg/ml	48-h	Blood	None
1053	18617323	2008	RAGLQFPVGRLLRRLLRRLLR	Buforin IIb	21	Linear	L	None	Free	Free	Antibacterial	histone H2A	CCRF-CEM	Leukemia Cancer	MTT/MTS assay	IC₅₀=14.7 µg/ml	48-h	Blood	None
1052	1319823, 2285300	1992	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	African clawed frog Xenopus laevis skin	NCI-H889	Lung Cancer	MTT/MTS assay	IC₅₀=6.57 µM	24-h	Lung	None
1051	1319823, 2285300	1992	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	African clawed frog Xenopus laevis skin	NCI-H841	Lung Cancer	MTT/MTS assay	IC₅₀=11.7 µM	24-h	Lung	None
1050	1319823, 2285300	1992	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	African clawed frog Xenopus laevis skin	NCI-H735	Lung Cancer	MTT/MTS assay	IC₅₀=7.23 µM	24-h	Lung	None
1049	1319823, 2285300	1992	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	African clawed frog Xenopus laevis skin	NCI-H678	Lung Cancer	MTT/MTS assay	IC₅₀=4.44 µM	24-h	Lung	None
1048	1319823, 2285300	1992	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	African clawed frog Xenopus laevis skin	NCI-H526	Lung Cancer	MTT/MTS assay	IC₅₀=10.5 µM	24-h	Lung	None
1047	1319823, 2285300	1992	GIGKFLHSAKKFAKAFVAEIMNS	Magainin G	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	African clawed frog Xenopus laevis skin	NCI-H182	Lung Cancer	MTT/MTS assay	IC₅₀=12.5 µM	24-h	Lung	None
1046	1319823, 2285300	1992	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	African clawed frog Xenopus laevis skin	NCI-H889	Lung Cancer	MTT/MTS assay	IC₅₀=6.56 µM	24-h	Lung	None
1045	1319823, 2285300	1992	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	African clawed frog Xenopus laevis skin	NCI-H841	Lung Cancer	MTT/MTS assay	IC₅₀=9.7 µM	24-h	Lung	None
1044	1319823, 2285300	1992	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	African clawed frog Xenopus laevis skin	NCI-H735	Lung Cancer	MTT/MTS assay	IC₅₀=10.4 µM	24-h	Lung	None
1043	1319823, 2285300	1992	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	African clawed frog Xenopus laevis skin	NCI-H678	Lung Cancer	MTT/MTS assay	IC₅₀=6.23 µM	24-h	Lung	None
1042	1319823, 2285300	1992	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	African clawed frog Xenopus laevis skin	NCI-H526	Lung Cancer	MTT/MTS assay	IC₅₀=11.7 µM	24-h	Lung	None
1041	1319823, 2285300	1992	AIGKFLHSAKKFGKAFVGEIMNS	Magainin A	23	Linear	L	None	Amidation	Beta-alanine	Antibacterial	African clawed frog Xenopus laevis skin	NCI-H182	Lung Cancer	MTT/MTS assay	IC₅₀=7.28 µM	24-h	Lung	None
1036	14499271	2003	FLKLLKKLAAKFLPTIICKISYKC	PTP4	24	Linear	L	None	Free	Free	Antibacterial	Gaegurin	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=18.1 µg/ml	96-h	Breast	None
1034	14499271	2003	LLAGLAANFLPTIICKISYKC	PTP1	21	Cyclic(C15-C21)	L	None	Free	Free	Antibacterial	Gaegurin	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Breast	None
1033	14499271	2003	FLPLLAGLAANFLPTIICKISYKC	GGN6	24	Cyclic(C18-C24)	L	None	Free	Free	Antibacterial	Gaegurin	MCF-7	Breast Cancer	MTT/MTS assay	IC₅₀=4.88 µg/ml	96-h	Breast	None
1028	14499271	2003	FLKLLKKLAAKFLPTIICKISYKC	PTP4	24	Linear	L	None	Free	Free	Antibacterial	Gaegurin	Hep3B	Liver Cancer	MTT/MTS assay	IC₅₀=18.18 µg/ml	96-h	Liver	None
1025	14499271	2003	FLPLLAGLAANFLPTIICKISYKC	GGN6	24	Cyclic(C18-C24)	L	None	Free	Free	Antibacterial	Gaegurin	Hep3B	Liver Cancer	MTT/MTS assay	IC₅₀=4.91 µg/ml	96-h	Liver	None
1026	14499271	2003	LLAGLAANFLPTIICKISYKC	PTP1	21	Cyclic(C15-C21)	L	None	Free	Free	Antibacterial	Gaegurin	Hep3B	Liver Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Liver	None
1020	14499271	2003	FLKLLKKLAAKFLPTIICKISYKC	PTP4	24	Linear	L	None	Free	Free	Antibacterial	Gaegurin	PC-3	Prostate Cancer	MTT/MTS assay	IC₅₀=18.63 µg/ml	96-h	Prostate	None
1018	14499271	2003	LLAGLAANFLPTIICKISYKC	PTP1	21	Cyclic(C15-C21)	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Renal	None
1017	14499271	2003	FLPLLAGLAANFLPTIICKISYKC	GGN6	24	Cyclic(C18-C24)	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=5.75 µg/ml	96-h	Renal	None
1012	14499271	2003	FLKLLKKLAAKFLPTIICKISYKC	PTP4	24	Linear	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=26.15 µg/ml	96-h	Renal	None
1010	14499271	2003	LLAGLAANFLPTIICKISYKC	PTP1	21	Cyclic(C15-C21)	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=>100 µg/ml	96-h	Renal	None
1009	14499271	2003	FLPLLAGLAANFLPTIICKISYKC	GGN6	24	Cyclic(C18-C24)	L	None	Free	Free	Antibacterial	Gaegurin	293	Renal Cancer	MTT/MTS assay	IC₅₀=5.62 µg/ml	96-h	Renal	None
1004	14499271	2003	FLKLLKKLAAKFLPTIICKISYKC	PTP4	24	Linear	L	None	Free	Free	Antibacterial	Gaegurin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=13.71 µg/ml	96-h	Lung	None
1001	14499271	2003	FLPLLAGLAANFLPTIICKISYKC	GGN6	24	Cyclic(C18-C24)	L	None	Free	Free	Antibacterial	Gaegurin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀=6.49 µg/ml	96-h	Lung	None
1002	14499271	2003	LLAGLAANFLPTIICKISYKC	PTP1	21	Cyclic(C15-C21)	L	None	Free	Free	Antibacterial	Gaegurin	A-549	Lung Cancer	MTT/MTS assay	IC₅₀= >100 µg/ml	96-h	Lung	None
7723	None	2020	LKKWWKKVKGLLGGLLGKVKKVIK	Seq ID No. 17 from patent ID US202000079827A1	24	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Synthetic	Calu-1	Lung Cancer	Tetrazolium-based assay	Cell viability > 50% at 20 μM	2-h	Lung	US20200079827A1
7724	None	2020	RRWVRRVRRVWRRVVRVVRRWVRR	Seq ID No. 26 from patent ID US202000079827A1	24	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Synthetic	H-460	Lung Cancer	Tetrazolium-based assay	Cell viability < 50% at 20 μM	2-h	Lung	US20200079827A1
7725	None	2020	RRWVRRVRRVWRRVVRVVRRWVRR	Seq ID No. 26 from patent ID US202000079827A1	24	Linear	L	None	Free	Free	Antimicrobial and Anticancer	Synthetic	Calu-1	Lung Cancer	Tetrazolium-based assay	Cell viability > 50% at 20 μM	2-h	Lung	US20200079827A1
7726	None	2020	RRWvRRvRRvWRRvvRvvRRWvRR	Seq ID No. 34 from patent ID US202000079827A1	24	Linear	Mix	None	Free	Free	Antimicrobial and Anticancer	Synthetic	NCI-H460	Lung Cancer	Tetrazolium-based assay	Cell viability < 25% at 20 μM	2-h	Lung	US20200079827A1
7727	None	2020	RRWvRRvRRvWRRvvRvvRRWvRR	Seq ID No. 34 from patent ID US202000079827A1	24	Linear	Mix	None	Free	Free	Antimicrobial and Anticancer	Synthetic	Calu-1	Lung Cancer	Tetrazolium-based assay	Cell viability > 50% at 20 μM	2-h	Lung	US20200079827A1
7754	None	2020	RRRRRRRSKAPKVVILSKALEYLQA	IDP-LLCb01	25	Linear	L	None	Free	Free	Anticancer	Synthetic	NCl-H187	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 5 μM	48-72 h	Lung	US20200239547A1
7755	None	2020	RRRRRRRSKAPKVVILSKALEYLQA	IDP-LLCb01	25	Linear	L	None	Free	Free	Anticancer	Synthetic	NCl-H82	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 2.5 μM	48-72 h	Lung	US20200239547A1
7756	None	2020	RRRRRRRSKAPKVVILSKALEYLQA	IDP-LLCb01	25	Linear	L	None	Free	Free	Anticancer	Synthetic	NCl-H510A	Lung Cancer	MTT/Alamamar-Blue/Hexosaminidase activity test	EC₅₀ ~ 5 μM	48-72 h	Lung	US20200239547A1
7828	None	2023	MQIPQAPWPVVWAVLQLGWRRKKRRQRRR	Sample Peptide 2 from EP3604345B1	29	Linear	L	None	Amidation	Free	Anticancer	Synthetic	NCI-H2444	Lung Cancer	CCK-8 / WST-8	Cell Viability = 3.6% at 25 μM	48-h	Lung	EP3604345B1
7831	None	2023	MQIPQAPWPVVWAVLQLGWRRKKRRQRRR	Sample Peptide 2 from EP3604345B1	29	Linear	L	None	Amidation	Free	Anticancer	Synthetic	HCC-827	Lung Cancer	CCK-8 / WST-8	Cell Viability = 4.9% at 25 μM	48-h	Lung	EP3604345B1
7835	None	2023	MQIPQAPWPVVWAVLQLGWRRKKRRQRRR	Sample Peptide 2 from EP3604345B1	29	Linear	L	None	Amidation	Free	Anticancer	Synthetic	A-549	Lung Cancer	CCK-8 / WST-8	Cell Viability = 9.1% at 25 μM	48-h	Lung	EP3604345B1